Menu
 
Research menu
Jump to menu

Publications:  Prof Paolo Pozzilli

Maddaloni E, D'Onofrio L, Alessandri F, Mignogna C, Leto G, Pascarella G, Mezzaroma I, Lichtner M et al.(2020). Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II). Cardiovasc Diabetol vol. 19, (1)
10.1186/s12933-020-01140-2
Battisti S, Pedone C, Napoli N, Russo E, Agnoletti V, Nigra SG, Dengo C, Mughetti M et al.(2020). Computed tomography highlights increased visceral adiposity associated with critical illness in covid-19. Diabetes Care vol. 43, (10) e129-e130.
10.2337/dc20-1333
Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD(2020). Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes vol. 69, (10) 2037-2047.
10.2337/dbi20-0017
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67010
Maddaloni E, D'Onofrio L, Alessandri F, Mignogna C, Leto G, Coraggio L, Sterpetti S, Pascarella G et al.(2020). Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I). Diabetes Res Clin Pract vol. 169,
10.1016/j.diabres.2020.108454
Strollo R, Maddaloni E, Dauriz M, Pedone C, Buzzetti R, Pozzilli P(2020). Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths. Diabetes Res Clin Pract
10.1016/j.diabres.2020.108444
Cannata F, Vadalà G, Russo F, Papalia R, Napoli N, Pozzilli P(2020). Beneficial Effects of Physical Activity in Diabetic Patients. Journal of Functional Morphology and Kinesiology vol. 5, (3)
10.3390/jfmk5030070
Piemonti L, Lampasona V, Marzinotto I, Bosi E, Pozzilli P, Giorgino F, Cossu E, Linn T et al. (2020). MiR-375 levels in newly diagnosed type 1 diabetes: results from a phase 2, multicentre, randomised, placebo controlled trial (MEX0114). DIABETOLOGIA. vol. 63, S183-S184.
Cavallari I, Maddaloni E, Pieralice S, Mulè MT, Buzzetti R, Ussia GP, Pozzilli P, Grigioni F(2020). The Vicious Circle of Left Ventricular Dysfunction and Diabetes: From Pathophysiology to Emerging Treatments. The Journal of clinical endocrinology and metabolism vol. 105, (9)
10.1210/clinem/dgaa427
Tramontana F, Maddaloni E, Greci S, Defeudis G, Strollo R, Pozzilli P, Napoli N (2020). The effect of dietary fiber on glycaemic control in patients with type 2 diabetes on metformin monotherapy. DIABETOLOGIA. vol. 63, S105-S105.
Cesareo R, Maurizio PC, Pasqualini V, Campagna G, Lauria PA, Pozzilli P, Cianni R, Manfrini S et al.(2020). Llaser ablation vs radiofrequency ablation for benign non-functioning thyroid nodules: six-month results of a randomised, parallel, open-label, trial (LARA trial). Endocrine Abstracts
10.1530/endoabs.70.oc7.6
Maddaloni E, Briganti SI, Crescenzi A, Anguissola GB, Perrella E, Taffon C, Palermo A, Manfrini S et al.(2020). Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules. European Thyroid Journal1-6.
10.1159/000509325
Alhamar GE, Strollo R, Pozzilli P(2020). Autoantibody reversion: Changing risk categories in multiple-autoantibody– positive individuals. Diabetes care 2020;43:913–917. Diabetes Care vol. 43, (8)
10.2337/dc20-0409
Maddaloni E, Coraggio L, Pieralice S, Carlone A, Pozzilli P, Buzzetti R(2020). Effects of covid-19 lockdown on glucose control: Continuous glucose monitoring data from people with diabetes on intensive insulin therapy. Diabetes Care vol. 43, (8) e86-e87.
10.2337/dc20-0954
Vinci C, Infantino M, Raturi S, Tindell A, Topping LM, Strollo R, Amital H, Shoenfeld Y et al.(2020). Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis. Scandinavian Journal of Rheumatology vol. 49, (4) 281-291.
10.1080/03009742.2020.1713395
Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI et al.(2020). Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism. The Journal of clinical endocrinology and metabolism vol. 105, (7)
10.1210/clinem/dgaa174
Buzzetti R, Zampetti S, Pozzilli P(2020). Impact of obesity on the increasing incidence of type 1 diabetes. Diabetes, Obesity and Metabolism vol. 22, (7) 1009-1013.
10.1111/dom.14022
Pozzilli P, Lazzeri D(2020). Our Lady of Carmel and Saints of Pietro Novelli (1603–1647). Journal of Endocrinological Investigation vol. 43, (7) 1045-1046.
10.1007/s40618-020-01194-9
Pozzilli P, Lenzi A(2020). Testosterone, a key hormone in the context of COVID-19 pandemic. Metabolism: Clinical and Experimental vol. 108,
10.1016/j.metabol.2020.154252
PIERALICE S, TUCCINARDI D, KYANVASH S, MAGGI D, MONTE L, BRIGANTI SI, MANFRINI S, POZZILLI P(2020). 1124-P: SGLT2 Inhibitors as Adjuvant Therapy for Type 1 Diabetes: An Italian Center Experience. Diabetes vol. 69, (Supplement 1) 1124-p.
10.2337/db20-1124-p
PIERALICE S, MADDALONI E, MORETTI C, MAURIZI AR, MIGNOGNA C, DINATALE S, POZZILLI P, BUZZETTI R(2020). 1217-P: Improvement of Metabolic Control in Type 1 Diabetes after Transition Is Independent from Referral Center and Insulin Regimen. Diabetes vol. 69, (Supplement 1) 1217-p.
10.2337/db20-1217-p
RENARD E, BOSNYAK Z, LAUAND F, POZZILLI P, IKEGAMI H, KESAVADEV J, VIANNA AG(2020). 1514-P: Suboptimal Glycemic Control and High Prevalence of Diabetes Complications in Adults with Type 1 Diabetes (T1D) in the SAGE Study. Diabetes vol. 69, (Supplement 1) 1514-p.
10.2337/db20-1514-p
MAURO AD, TUCCINARDI D, TORO RD, MONTE L, GIORGINO R, RAMPA L, ROSSINI G, KYANVASH S et al.(2020). 226-OR: The Mediterranean Diet Increases GLP-1 and Oxyntomodulin Compared with Vegetarian Diet in Type 2 Diabetes Subjects. Diabetes vol. 69, (Supplement 1) 226-or.
10.2337/db20-226-or
TRAMONTANA F, MADDALONI E, GRECI S, DEFEUDIS G, STROLLO R, POZZILLI P, NAPOLI N(2020). 227-OR: The Effect of Dietary Fiber in Combination with Metformin Therapy in Type 2 Diabetes. Diabetes vol. 69, (Supplement 1) 227-or.
10.2337/db20-227-or
BOSI E, POZZILLI P, GIORGINO F, COSSU E, LINN T, ROSE L, KEYMEULEN B, GILLARD P et al.(2020). 249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes. Diabetes vol. 69, (Supplement 1) 249-or.
10.2337/db20-249-or
MADDALONI E, PARK K, GUIDA MD, CORAGGIO L, LUORDI C, D¿ONOFRIO L, BARONI MG, CAVALLO MG et al.(2020). 570-P: Osteoprotegerin Induces Endothelial Dysfunction and Is Associated with Vascular Complications In Type 2 Diabetes. Diabetes vol. 69, (Supplement 1) 570-p.
10.2337/db20-570-p
Cesareo R, Pacella CM, Pasqualini V, Campagna G, Iozzino M, Gallo A, Lauria Pantano A, Cianni R et al.(2020). Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial). Thyroid vol. 30, (6) 847-856.
10.1089/thy.2019.0660
Pozzilli P, Bosi E, Cirkel D, Harris J, Leech N, Tinahones FJ, Vantyghem MC, Vlasakakis G et al.(2020). Randomized 52-week phase 2 trial of albiglutide versus placebo in adult patients with newly diagnosed type 1 diabetes. Journal of Clinical Endocrinology and Metabolism vol. 105, (6)
10.1210/clinem/dgaa149
Cesareo R, Pacella CM, Pasqualini V, Campagna G, Iozzino M, Gallo A, Pantano AL, Cianni R et al.(2020). OR18-07 Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomised, Parallel, Open-Label, Trial (Lara Trial). Journal of the Endocrine Society vol. 4, (Supplement_1)
10.1210/jendso/bvaa046.058
Creta A, Providência R, Adragão P, de Asmundis C, Chun J, Chierchia G, Defaye P, Schmidt B et al.(2020). Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study). American Journal of Cardiology vol. 125, (6) 901-906.
10.1016/j.amjcard.2019.12.037
Cannata F, Vadalà G, Ambrosio L, Napoli N, Papalia R, Denaro V, Pozzilli P(2020). Osteoarthritis and type 2 diabetes: From pathogenetic factors to therapeutic intervention. Diabetes/Metabolism Research and Reviews vol. 36, (3)
10.1002/dmrr.3254
Amisi CA, Ciccozzi M, Pozzilli P(2020). Wrist circumference: A new marker for insulin resistance in African women with polycystic ovary syndrome. World J Diabetes vol. 11, (2) 42-51.
10.4239/wjd.v11.i2.42
Tabacco G, Naciu AM, Cesareo R, Maggi D, Pedone C, Lelli D, Santonati A, Bosco D et al.(2020). Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism. Endocrine vol. 67, (1) 198-203.
10.1007/s12020-019-02101-w
Strollo R, Pozzilli P(2020). DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19?. Diabetes/Metabolism Research and Reviews
10.1002/dmrr.3330
Ibrahim M, Baker J, Cahn A, Eckel RH, El Sayed NA, Fischl AH, Gaede P, Leslie RD et al.(2020). Hypoglycaemia and its management in primary care setting. Diabetes/Metabolism Research and Reviews
10.1002/dmrr.3332
Cannata F, Vadalà G, Ambrosio L, Fallucca S, Napoli N, Papalia R, Pozzilli P, Denaro V(2020). Intervertebral disc degeneration: A focus on obesity and type 2 diabetes. Diabetes/Metabolism Research and Reviews vol. 36, (1)
10.1002/dmrr.3224
Piccoli A, Cannata F, Strollo R, Pedone C, Leanza G, Russo F, Greto V, Isgrò C et al.(2020). Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes. Journal of Bone and Mineral Research
10.1002/jbmr.4153
Pozzilli P, Lazzeri D(2020). The Altarpiece of Saint Joseph’s Church in Scicli (Sicily). Journal of Endocrinological Investigation vol. 43, (1) 121-122.
10.1007/s40618-019-01067-w
Di Mauro A, Tuccinardi D, Watanabe M, Del Toro R, Monte L, Giorgino R, Rampa L, Rossini G et al.(2020). The Mediterranean diet increases glucagon-like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross-over trial. Diabetes/Metabolism Research and Reviews
10.1002/dmrr.3406
Gentilella R, Sesti G, Vazquez L, Sapin H, Reed V, Romera I, Pozzilli P(2019). Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index. Diabetes, Obesity and Metabolism vol. 21, (12) 2660-2666.
10.1111/dom.13853
Leanza G, Fontana F, Alippe Y, Lee S-Y, Remedi M, Napoli N, Civitelli R, Strollo R et al. (2019). Resistance to Lrp5 Inhibitors Protects Bone Mass and Improves Glucose Metabolism in Type 1 Diabetes. JOURNAL OF BONE AND MINERAL RESEARCH. vol. 34, 19-19.
Piccoli A, Cannata F, Russo F, Greto V, Isgro C, Strollo R, Massaroni C, Pedone C et al. (2019). Wnt Signaling and Bone Fragility in Elderly Postmenopausal Women with Type 2 Diabetes. JOURNAL OF BONE AND MINERAL RESEARCH. vol. 34, 357-357.
Nusca A, Tuccinardi D, Proscia C, Melfi R, Manfrini S, Nicolucci A, Ceriello A, Pozzilli P et al.(2019). Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention. Cardiovascular Diabetology vol. 18, (1)
10.1186/s12933-019-0952-8
Pieralice S, Vari R, Minutolo A, Maurizi AR, Fioriti E, Napoli N, Pozzilli P, Manfrini S et al.(2019). Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy. Endocrine vol. 66, (2) 178-184.
10.1007/s12020-019-01917-w
Pozzilli P, Vollero L, Colao AM(2019). Venus by botticelli and her pituitary adenoma. Endocrine Practice vol. 25, (10) 1067-1073.
10.4158/EP-2019-0024
Leanza G, Fontana F, Alippe Y, Lee S-Y, Strollo R, Pozzilli P, Remedi M, Civitelli R et al. (2019). Sclerostin resistance improves glucose metabolism and protects bone mass in a mouse model of type 1 diabetes. DIABETOLOGIA. vol. 62, S270-S270.
Renard E, Pozzilli P, Wilmot EG, Peters A, Bosnyak Z, Castro R, Lauand F, Pilorget V et al. (2019). Suboptimal glycaemic control globally in all age groups of adults with type 1 diabetes: results of a multinational, observational study (SAGE). DIABETOLOGIA. vol. 62, S8-S9.
Tramontana F, Maddaloni E, Pozzilli P, Napoli N (2019). The effect of high-fiber diet in combination with metformin therapy in type 2 diabetes. DIABETOLOGIA. vol. 62, S338-S338.
Leanza G, Maddaloni E, Pitocco D, Conte C, Palermo A, Maurizi AR, Pantano AL, Suraci C et al. (2019). Risk factors for fragility fractures in type 1 diabetes. Bone. vol. 125, 194-199.
10.1016/j.bone.2019.04.017
Tabacco G, Naciu AM, Maggi D, Pedone C, Lelli D, Cesareo R, Santonati A, Bosco D et al. (2019). CARDIOVASCULAR AUTONOMIC NEUROPATHY CAUSES AN IMPAIRMENT OF QUALITY OF LIFE IN SUBJECTS WITH CHRONIC HYPOPARATHYROIDISM. OSTEOPOROSIS INTERNATIONAL. vol. 30, S293-S293.
Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI, Castellitto D et al. (2019). CLINICAL, BIOCHEMICAL AND RADIOLOGICAL PROFILE OF NORMOCALCAEMIC HYPERPARATHYROIDISM: A MULTICENTRIC CROSS-SECTIONAL EVALUATION. OSTEOPOROSIS INTERNATIONAL. vol. 30, S412-S412.
D'Antoni F, Merone M, Piemonte V, Pozzilli P, Iannello G, Soda P (2019). Early Experience in Forecasting Blood Glucose Levels Using a Delayed and Auto-Regressive Jump Neural Network. vol. 00, 394-402.
10.1109/iccicc46617.2019.9146049
Verma S, Wanner C, Zwiener I, Ofstad AP, George JT, Fitchett D, Zinman B, EMPA-REG OUTCOME Investigators(2019). Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes. J Am Coll Cardiol vol. 73, (21) 2780-2782.
10.1016/j.jacc.2019.03.002
PIERALICE S, TORO RD, KHAZRAI YM, MADDALONI E, MAURIZI AR, MANFRINI S, POZZILLI P (2019). 1581-P: Increase of Diabetes and Obesity among Descendants of First-Generation Filipino Immigrants to Italy. Diabetes. vol. 68, 1581-p.
10.2337/db19-1581-p
LEANZA G, ALIPPE Y, LEE S-Y, STROLLO R, POZZILLI P, CIVITELLI R, NAPOLI N (2019). 1964-P: Type 1 Diabetes: Sclerostin Resistance Improves Glucose Metabolism and Protects Bone Mass. Diabetes. vol. 68, 1964-p.
10.2337/db19-1964-p
PICCOLI A, CANNATA F, RUSSO F, GRETO VL, ISGRÒ C, LEANZA G, STROLLO R, MASSARONI C et al. (2019). 1983-P: WNT Pathway and Bone Fragility in Postmenopausal Women with Type 2 Diabetes. Diabetes. vol. 68, 1983-p.
10.2337/db19-1983-p
TUCCINARDI D, ROSSINI G, MADDALONI E, MAGGI D, MONTE L, FIORITI E, KYANVASH S, POZZILLI P et al. (2019). 2069-P: Energy Expenditure during Sleep Is an Independent Marker of Prediabetes—A Cross-Sectional Study of Overweight/Obese Subjects. Diabetes. vol. 68, 2069-p.
10.2337/db19-2069-p
Rosenson RS, Daviglus ML, Handelsman Y, Pozzilli P, Bays H, Monsalvo ML, Elliott-Davey M, Somaratne R et al.(2019). Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study. Diabetologia vol. 62, (6) 948-958.
10.1007/s00125-019-4856-7
Strollo R, Vinci C, Napoli N, Fioriti E, Maddaloni E, Åkerman L, Casas R, Pozzilli P et al.(2019). Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies. Diabetes/Metabolism Research and Reviews vol. 35, (4)
10.1002/dmrr.3132
Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI, Castellitto D et al. (2019). Clinical, biochemical and radiological profile of normocalcaemic hyperparathyroidism: a multicentric cross-sectional evaluation. Endocrine Abstracts.
10.1530/endoabs.63.gp20
Pozzilli P, Signore A(2019). The reconstructed natural history of type 1 diabetes mellitus. Nature Reviews Endocrinology vol. 15, (5) 256-257.
10.1038/s41574-019-0192-8
Tabacco G, Naciu A, Maggi D, Pedone C, Lelli D, Santonati A, Bosco D, Cesareo R et al.(2019). MON-527 Cardiovascular Autonomic Neuropathy As A Cause Of Quality Of Life Impairment In Subjects With Chronic Hypoparathyroidism. Journal of the Endocrine Society vol. 3, (Suppl 1)
10.1210/js.2019-mon-527
Pozzilli P(2019). A tribute to Professor Domenico Andreani. Diabetes/metabolism research and reviews vol. 35, (3)
10.1002/dmrr.3136
Tabacco G, Naciu AM, Maggi D, Santonati A, Pedone C, Cesareo R, Bosco D, Gaspa G et al.(2019). Cardiovascular Autonomic Neuropathy as a New Complication of Postsurgical Chronic Hypoparathyroidism. Journal of Bone and Mineral Research vol. 34, (3) 475-481.
10.1002/jbmr.3623
Pugliese G, Pozzilli P(2019). Domenico Andreani (1925–2018). L'Endocrinologo vol. 20, (1) 2-3.
10.1007/s40619-019-00516-1
Maurizi AR, Pieralice S, Pozzilli P(2019). Il trattamento del diabete di tipo 1: dalle nuove insuline ai farmaci orali. L'Endocrinologo vol. 20, (1) 21-26.
10.1007/s40619-019-00514-3
Maddaloni E, Coleman RL, Pozzilli P, Holman RR(2019). Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85). Diabetes, Obesity and Metabolism vol. 21, (9) 2115-2122.
10.1111/dom.13788
Cavallari I, Delli Veneri A, Maddaloni E, Melfi R, Patti G, Napoli N, Pozzilli P, Di Sciascio G(2018). Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes. Current Diabetes Reports vol. 18, (12)
10.1007/s11892-018-1117-y
Lazzeri D, Pozzilli P(2018). Exophthalmos or pseudo-exophthalmos in the Last Judgement (1535–1541) by Michelangelo Buonarroti (1475–1564). Journal of Endocrinological Investigation vol. 41, (12) 1485-1486.
10.1007/s40618-018-0962-5
Pieralice S, Pozzilli P(2018). Latent autoimmune diabetes in adults: A review on clinical implications and management. Diabetes and Metabolism Journal vol. 42, (6) 451-464.
10.4093/dmj.2018.0190
Tabacco G, Naciu AM, Cesareo R, Pedone C, Gaspa G, Santonati A, Bosco D, Maggi D et al. (2018). Cardiovascular Autonomic Neuropathy as a new complication of chronic hypoparathyroidism. JOURNAL OF BONE AND MINERAL RESEARCH. vol. 33, 203-203.
Wanner C, Heerspink HJL, Zinman B, Inzucchi SE, Koitka-Weber A, Mattheus M, Hantel S, Woerle H-J et al.(2018). Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial. J Am Soc Nephrol vol. 29, (11) 2755-2769.
10.1681/ASN.2018010103
Nusca A, Tuccinardi D, Albano M, Cavallaro C, Ricottini E, Manfrini S, Pozzilli P, Di Sciascio G(2018). Glycemic variability in the development of cardiovascular complications in diabetes. Diabetes/Metabolism Research and Reviews vol. 34, (8)
10.1002/dmrr.3047
Leanza G, Fontana F, Strollo R, Pozzilli P, Napoli N, Civitelli R (2018). Sclerostin Resistance Protects Bone Mass and Improves Insulin Sensitivity in a Mouse Model of Type 1 Diabetes. JOURNAL OF BONE AND MINERAL RESEARCH. vol. 33, 41-41.
Piccoli A, Bisogno T, Maccarrone M, Pozzilli P, Napoli N, Strollo R (2018). Effects of glycated insulin on adipogenic differentiation. DIABETOLOGIA. vol. 61, S277-S278.
Pieralice S, Del Toro R, Pesce G, Jansen K, Khazrai M, Maurizi A, Manfrini S, Pozzilli P (2018). Integration increases the risk of diabetes and obesity in the Filipino population resident in Rome. DIABETOLOGIA. vol. 61, S184-S184.
Writing GFTTSG, M K, HK Å, E AT, D B, J B, L C, T D et al.(2018). Effect of hydrolyzed infant formula vs conventional formula on risk of T1DM. The TRIGR randomized clinical trial.
10.1530/ey.15.10.20
Palermo A, Capoluongo E, Del Toro R, Manfrini S, Pozzilli P, Maggi D, Defeudis G, Pantano F et al.(2018). A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins. Hormones vol. 17, (3) 427-435.
10.1007/s42000-018-0044-2
Leslie RD, Pozzilli P, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J et al.(2018). Response to the comment on: “Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 trials”. Diabetes, Obesity and Metabolism vol. 20, (9) 2319-2320.
10.1111/dom.13366
Maddaloni E, Pozzilli P(2018). Diabetes: the disease of the 10 D. Endocrine vol. 61, (2) 353-354.
10.1007/s12020-017-1454-7
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33583
Ricottini E, Gatto L, Melfi R, Nusca A, Cavallaro C, Albano M, Giannone S, Patti G et al.(2018). P4766Hyperleptinemia as risk factor for high platelet reactivity and cardiovascular events in patients undergoing percutaneous coronary intervention. European Heart Journal vol. 39, (suppl_1)
10.1093/eurheartj/ehy563.p4766
(2018). Addendum. Diabetes Metab Res Rev vol. 34, (5)
10.1002/dmrr.3017
Zinman B, Inzucchi SE, Wanner C, Hehnke U, George JT, Johansen OE, Fitchett D, EMPA-REG OUTCOME® investigators(2018). Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®. Diabetologia vol. 61, (7) 1522-1527.
10.1007/s00125-018-4630-2
Lazzeri D, Pozzilli P(2018). “Madonna of the carnation”: Leonardo da Vinci (1452–1519). Journal of Endocrinological Investigation vol. 41, (7) 879-880.
10.1007/s40618-018-0842-z
Capocelli M, De Santis L, Maurizi A, Pozzilli P, Piemonte V(2018). Model predictive control for the artificial pancreas. Biomedical Engineering Challenges: A Chemical Engineering Insight,
Ibrahim M, Tuomilehto J, Aschner P, Beseler L, Cahn A, Eckel RH, Fischl AH, Guthrie G et al.(2018). Global status of diabetes prevention and prospects for action: A consensus statement. Diabetes - Metabolism: Research and Reviews vol. 34, (6)
10.1002/dmrr.3021
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62769
Defeudis G, Fioriti E, Palermo A, Tuccinardi D, Minucci A, Capoluongo E, Pozzilli P, Manfrini S(2018). A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction. Hormones vol. 17, (2) 279-284.
10.1007/s42000-018-0037-1
Lauria Pantano A, Maddaloni E, Briganti SI, Beretta Anguissola G, Perrella E, Taffon C, Palermo A, Pozzilli P et al.(2018). Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules. European Journal of Endocrinology vol. 178, (6) 595-603.
10.1530/EJE-18-0083
Pozzilli P, Leslie RD, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J et al.(2018). Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials. Diabetes, Obesity and Metabolism vol. 20, (6) 1490-1498.
10.1111/dom.13237
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62740
Pozzilli P, Pieralice S(2018). Latent autoimmune diabetes in adults: Current status and new horizons. Endocrinology and Metabolism vol. 33, (2) 147-159.
10.3803/EnM.2018.33.2.147
https://qmro.qmul.ac.uk/xmlui/handle/123456789/51664
Grieco D, Palamà Z, Borrelli A, De Ruvo E, Sciarra L, Scarà A, Goanta E, Calabrese V et al.(2018). Diabetes mellitus and atrial remodelling in patients with paroxysmal atrial fibrillation: Role of electroanatomical mapping and catheter ablation. Diabetes and Vascular Disease Research vol. 15, (3) 185-195.
10.1177/1479164117752492
ROSENSON RS, DAVIGLUS ML, REAVEN P, POZZILLI P, BAYS H, MONSALVO ML, ELLIOTT M, SOMARATNE R et al. (2018). Efficacy and Safety of Evolocumab in Patients with Type 2 Diabetes Mellitus and Hypercholesterolemia or Mixed Dyslipidemia. Diabetes. vol. 67, 128-or.
10.2337/db18-128-or
TUCCINARDI D, MADDALONI E, CAPASSO I, RAMPA L, SOARE A, MAGGI D, DEFEUDIS G, KYANVASH S et al. (2018). Energy Expenditure during Sleep Is an Independent Marker of Insulin-Resistance—A Cross-Sectional Study of Overweight/Obese Subjects. Diabetes. vol. 67, 2094-p.
10.2337/db18-2094-p
MADDALONI E, MAURIZI AR, MINUTOLO A, FIORITI E, TORO RD, NACIU AM, PIERALICE S, ROSATI MM et al. (2018). Palmitoylethanolamide in Add-On to Alpha Lipoic Acid for Control of Symptoms of Diabetic Peripheral Neuropathy. Diabetes. vol. 67, 564-p.
10.2337/db18-564-p
MAURIZI AR, PIERALICE S, TUCCINARDI D, GUGLIELMI C, LAURIA A, MADDALONI E, FIORITI E, MANFRINI S et al. (2018). Rapid Improvement of Metabolic Control in Type 1 Diabetes after Transition from Paediatric Clinics to an Adult Diabetes Center. Diabetes. vol. 67, 716-p.
10.2337/db18-716-p
Ricottini E, Mangiacapra F, Nusca A, Melfi R, Cavallari I, Miglionico M, Gallo P, Pozzilli P et al.(2018). Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty. American Journal of Cardiology vol. 121, (9) 1027-1031.
10.1016/j.amjcard.2018.01.013
LEANZA G, STROLLO R, POZZILLI P, CIVITELLI R, NAPOLI N (2018). Sclerostin Resistance Protects Bone Mass and Retards the Onset of Metabolic Abnormalities in a Mouse Model of Type 1 Diabetes. Diabetes. vol. 67, 1701-p.
10.2337/db18-1701-p
Napoli N, Strollo R, Defeudis G, Leto G, Moretti C, Zampetti S, D'Onofrio L, Campagna G et al.(2018). Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults. Journal of Clinical Endocrinology and Metabolism vol. 103, (5) 1921-1928.
10.1210/jc.2017-02274
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62238
Garg S, Henry R, Banks P, Buse J, Davies M, Fulcher G, Pozzilli P, Gesty-Palmer D et al. (2018). Efficacy of sotagliflozin 400 mg/day in 1402 patients with type 1 diabetes treated with any insulin regimen (inTandem 3). Diabetologie und Stoffwechsel. vol. 13, s29-s29.
10.1055/s-0038-1641841
Lepore G, Bonfanti R, Bozzetto L, Di Blasi V, Girelli A, Grassi G, Iafusco D, Laviola L et al.(2018). Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion. Nutrition, Metabolism and Cardiovascular Diseases vol. 28, (4) 335-342.
10.1016/j.numecd.2017.12.001
Pozzilli P, Leslie R, Peters A, Buzzetti R, Shankar S, Milicevic Z, Pavo I, Lebrec J et al. (2018). Reduction of HbA1c with dulaglutide in type 2 diabetes (T2D) patients negative, low positive or high positive for GAD antibodies (GADA): a post hoc analysis of AWARD -2, -4 and -5. Diabetologie und Stoffwechsel. vol. 13, s50-s51.
10.1055/s-0038-1641908
Naciu AM, Pozzilli P(2018). Novel blood glucose lowering therapies for managing type 1 diabetes in paediatric patients. Expert Opinion on Pharmacotherapy vol. 19, (4) 355-364.
10.1080/14656566.2018.1441288
Defeudis G, Khazrai YM, Di Rosa C, Secchi C, Montedoro A, Maurizi AR, Palermo A, Pozzilli P et al.(2018). Conversation Maps™, an effective tool for the management of males and females with type 2 diabetes and mildly impaired glycemic control. Hormones vol. 17, (1) 113-117.
10.1007/s42000-018-0005-9
Maurizi AR, Piemonte V, Pozzilli P(2018). Diabetes on demand and novel technologies. Diabetes/Metabolism Research and Reviews vol. 34, (2)
10.1002/dmrr.2985
Fitchett D, Butler J, van de Borne P, Zinman B, Lachin JM, Wanner C, Woerle HJ, Hantel S et al.(2018). Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial. Eur Heart J vol. 39, (5) 363-370.
10.1093/eurheartj/ehx511
Wanner C, Lachin JM, Inzucchi SE, Fitchett D, Mattheus M, George J, Woerle HJ, Broedl UC et al.(2018). Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease. Circulation vol. 137, (2) 119-129.
10.1161/CIRCULATIONAHA.117.028268
Knip M, Åkerblom HK, Altaji E, Becker D, Bruining J, Castano L, Danne T, De Beaufort C et al.(2018). Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial. JAMA - Journal of the American Medical Association vol. 319, (1) 38-48.
10.1001/jama.2017.19826
Palermo A, Fosca M, Tabacco G, Marini F, Graziani V, Santarsia MC, Longo F, Lauria A et al.(2018). Raman Spectroscopy Applied to Parathyroid Tissues: A New Diagnostic Tool to Discriminate Normal Tissue from Adenoma. Analytical Chemistry vol. 90, (1) 847-854.
10.1021/acs.analchem.7b03617
Guglielmi C, Leslie RD, Pozzilli P(2018). Epidemiology and Risk Factors of Type 1 Diabetes. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment,
Pozzilli P(2018). Fast publication, a must for a journal. Diabetes/Metabolism Research and Reviews vol. 34, (1)
10.1002/dmrr.2978
Pozzilli P(2018). In memoriam. Diabetes Metab Res Rev vol. 34, (1)
10.1002/dmrr.2956
Garg SK, Henry RR, Banks P, Buse JB, Davies MJ, Fulcher GR, Pozzilli P, Gesty-Palmer D et al.(2017). Effects of sotagliflozin added to insulin in patients with type 1 diabetes. New England Journal of Medicine vol. 377, (24) 2337-2348.
10.1056/NEJMoa1708337
Piemonte V, Capocelli M, De Santis L, Maurizi AR, Pozzilli P(2017). A Novel Three-Compartmental Model for Artificial Pancreas: Development and Validation. Artificial Organs vol. 41, (12) E326-E336.
10.1111/aor.12980
Rau JV, Fosca M, Graziani V, Taffon C, Rocchia M, Caricato M, Pozzilli P, Onetti Muda A et al.(2017). Proof-of-concept Raman spectroscopy study aimed to differentiate thyroid follicular patterned lesions. Sci Rep vol. 7, (1) 14970-14970.
10.1038/s41598-017-14872-1
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33647
Quercia S, Turroni S, Fiori J, Soverini M, Rampelli S, Biagi E, Castagnetti A, Consolandi C et al.(2017). Gut microbiome response to short-term dietary interventions in reactive hypoglycemia subjects. Diabetes/Metabolism Research and Reviews vol. 33, (8)
10.1002/dmrr.2927
Maddaloni E, Pastore G, Del Buono MG, Porcari A, Fittipaldi M, Garilli F, Tiberti C, Angeletti S et al.(2017). High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja. J Diabetes Res vol. 2017, 3860674-3860674.
10.1155/2017/3860674
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33444
Guglielmi C, Del Toro R, Lauria A, Maurizi AR, Fallucca S, Cappelli A, Angeletti S, Lachin JM et al.(2017). Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes. Diabetes/Metabolism Research and Reviews vol. 33, (6)
10.1002/dmrr.2899
Maddaloni E, Strollo R, Pozzilli P, Napoli N (2017). Effect of calcidiol on insulin resistance and beta cell function in subjects with pre-diabetes. DIABETOLOGIA. vol. 60, S252-S252.
Pozzilli P, Leslie RD, Peters A, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J et al. (2017). Reduction of HbA1c with dulaglutide in type 2 diabetes (T2D) patients negative, low positive or high positive for GAD antibodies (GADA): a post hoc analysis of AWARD-2,-4 and-5. DIABETOLOGIA. vol. 60, S68-S68.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/66861
Del Toro R, Maddaloni E, Fioriti E, Tabacco G, Defeudis G, Caggiano C, Manfrini S, Pozzilli P (2017). Valsalva test alone is the best and economically valued tool for diagnosing cardiac autonomic neuropathy. DIABETOLOGIA. vol. 60, S458-S458.
Nusca A, Albano M, Cavallaro C, Borrelli E, Palumo M, Proscia C, Lauria Pantano A, Manfrini S et al.(2017). 2870Glycemic variability assessed by continuous glucose monitoring and antiplatelet responsiveness in patients undergoing coronary stenting: results from the observational GLYVAR study. European Heart Journal vol. 38, (suppl_1)
10.1093/eurheartj/ehx504.2870
Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A(2017). Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children. Diabetologia vol. 60, (8) 1467-1474.
10.1007/s00125-017-4296-1
Pozzilli P, Guglielmi C(2017). Prevention of type 1 diabetes mellitus. Principles of Diabetes Mellitus: Third Edition,
Napoli N, Strollo R, Paladini A, Briganti SI, Pozzilli P, Epstein S(2017). Corrigendum to "The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes". Int J Endocrinol vol. 2017, Article 5924671, 5924671-5924671.
10.1155/2017/5924671
https://qmro.qmul.ac.uk/xmlui/handle/123456789/35007
Pozzilli P, Norwood P, Jódar E, Davies MJ, Ivanyi T, Jiang H, Woodward DB, Milicevic Z(2017). Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9). Diabetes, Obesity and Metabolism vol. 19, (7) 1024-1031.
10.1111/dom.12937
Nucci AM, Virtanen SM, Sorkio S, Bärlund S, Cuthbertson D, Uusitalo U, Lawson ML, Salonen M et al.(2017). Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial. Maternal and Child Nutrition vol. 13, (3)
10.1111/mcn.12354
Pozzilli P, Cappa M(2017). Sleeping cupid by caravaggio: What diagnosis?. Endocrine Practice vol. 23, (7) 881-884.
10.4158/EP171854.CO
Maurizi AR, Maddaloni E, Del Toro R, Pieralice S, Fioriti E, Manfrini S, Pozzilli P (2017). An Automated Bolus Calculator for the Control of Glucose Variability in Type 1 Diabetes. DIABETES. vol. 66, A238-A238.
Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A (2017). Antibodies to Posttranslationally Modified Insulin for Prediction of Type 1 Diabetes in Children. DIABETES. vol. 66, A58-A58.
Leanza G, Maddaloni E, Pitocco D, Strollo R, Pozzilli P, Napoli N (2017). Association between Glycemic Control and the Occurrence of the First Fragility Fracture in Type 1 Diabetes. DIABETES. vol. 66, A463-A463.
Maddaloni E, Del Toro R, Fioriti E, Tabacco G, Defeudis G, Caggiano C, Manfrini S, Pozzilli P (2017). Cardiac Autonomic Neuropathy Is Efficiently Diagnosed by Valsalva Maneuver Alone. DIABETES. vol. 66, A150-A150.
Maddaloni E, Strollo R, Del Toro R, Pozzilli P, Napoli N (2017). Effect of Calcidiol on Insulin Resistance and beta-Cell Function in Subjects with Prediabetes. DIABETES. vol. 66, A349-A349.
Vinci C, Infantino M, Pozzilli P, Grossi V, Manfredi M, Bandinelli F, Gobbi FL, Damiani A et al. (2017). FRI0423 Antibodies to type ii collagen: a novel tool for the spondyloarthritis diagnosis?. Annals of the Rheumatic Diseases. vol. 76,
10.1136/annrheumdis-2017-eular.3498
Pantano AL, Nusca A, Del Toro R, Maddaloni E, Borrelli E, Zappia L, Proscia C, Melfi R et al. (2017). Glycemic Variability Assessed by Continuous Glucose Monitoring and Antiplatelet Responsiveness in Patients Undergoing Coronary Stenting: Results from the Observational Glyvar Study. DIABETES. vol. 66, A243-A243.
Strollo R, Soare A, Manon Khazrai Y, Di Mauro A, Palermo A, Del Toro R, Fallucca S, Giovanna Belluomo M et al.(2017). Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial. Endocrine vol. 56, (3) 667-674.
10.1007/s12020-016-1171-7
Maurizi AR, Pozzilli P(2017). Ipoglicemia cronica e deficit di memoria. L'Endocrinologo vol. 18, (Suppl 1) 22-23.
10.1007/s40619-017-0321-3
Khazrai YM, Fioriti E, Lattanzi G, Pozzilli P, Manfrini S (2017). Person-Centered Approach: A Valuable Tool for the Management of Type 2 Diabetes. DIABETES. vol. 66, A183-A183.
Pantano AL, Nusca A, Del Toro R, Maddaloni E, Borrelli E, Zappia L, Proscia C, Melfi R et al. (2017). Pleiotropic Effects of Ranolazine in Diabetic Patients Undergoing Percutaneous Coronary Intervention: Preliminary Results of an Observational, Prospective Study. DIABETES. vol. 66, A592-A592.
Zinman B, Inzucchi SE, Lachin JM, Wanner C, Fitchett D, Kohler S, Mattheus M, Woerle HJ et al.(2017). Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk. Stroke vol. 48, (5) 1218-1225.
10.1161/STROKEAHA.116.015756
Palermo A, Tuccinardi D, D'Onofrio L, Watanabe M, Maggi D, Maurizi AR, Greto V, Buzzetti R et al.(2017). Vitamin K and osteoporosis: Myth or reality?. Metabolism: Clinical and Experimental vol. 70, 57-71.
10.1016/j.metabol.2017.01.032
Maurizi AR, Menduni M, Del Toro R, Kyanvash S, Maggi D, Guglielmi C, Pantano AL, Defeudis G et al.(2017). A pilot study of d-chiro-inositol plus folic acid in overweight patients with type 1 diabetes. Acta Diabetologica vol. 54, (4) 361-365.
10.1007/s00592-016-0954-x
Soare A, Khazrai YM, Fontana L, Del Toro R, Lazzaro MC, Di Rosa C, Buldo A, Fioriti E et al.(2017). Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial. Metabolism: Clinical and Experimental vol. 69, 148-156.
10.1016/j.metabol.2017.01.023
Rizzo P, Pitocco D, Zaccardi F, Di Stasio E, Strollo R, Rizzi A, Scavone G, Costantini F et al.(2017). Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews vol. 33, (2)
10.1002/dmrr.2839
Kaku K, Lee J, Mattheus M, Kaspers S, George J, Woerle H-J, EMPA-REG OUTCOME® Investigators(2017). Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME®. Circ J vol. 81, (2) 227-234.
10.1253/circj.CJ-16-1148
Pozzilli P, Napoli N, Naciu AM, Soare A (2017). PRESENT AND FUTURE OF THE RELATIONSHIP BETWEEN GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND INSULIN FOR THE TREATMENT OF TYPE 2 DIABETES. INTERDIAB 2017: DIABETES MELLITUS IN INTERNAL MEDICINE. 78-85.
Pozzilli P, Lazzeri D(2016). A Goiter in Christ in Crucifixion. Thyroid vol. 26, (11) 1646-1647.
10.1089/thy.2016.0006
Schloot NC, Pham MN, Hawa MI, Pozzilli P, Scherbaum W, Schott M, Kolb H, Hunter S et al.(2016). Inverse relationship between organ-specific autoantibodies and systemic immune mediators in type 1 diabetes and type 2 diabetes: Action LADA 11. Diabetes Care vol. 39, (11) 1932-1939.
10.2337/dc16-0293
https://qmro.qmul.ac.uk/xmlui/handle/123456789/22373
Rau JV, Graziani V, Fosca M, Taffon C, Rocchia M, Crucitti P, Pozzilli P, Onetti Muda A et al.(2016). RAMAN spectroscopy imaging improves the diagnosis of papillary thyroid carcinoma. Scientific Reports vol. 6,
10.1038/srep35117
Maddaloni E, Cavallari I, De Pascalis M, Keenan H, Park K, Manfrini S, Buzzetti R, Patti G et al.(2016). Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects. American Journal of Cardiology vol. 118, (6) 822-827.
10.1016/j.amjcard.2016.06.044
Mangiacapra F, Panaioli E, Colaiori I, Ricottini E, Lauria Pantano A, Pozzilli P, Barbato E, Di Sciascio G(2016). Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated with Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients). Circulation vol. 134, (11) 835-837.
10.1161/CIRCULATIONAHA.116.023743
Giorgino F, Bonadonna RC, Gentile S, Vettor R, Pozzilli P(2016). Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists. Diabetes/Metabolism Research and Reviews vol. 32, (6) 497-511.
10.1002/dmrr.2775
Soare A, Del Toro R, Khazrai YM, Di Mauro A, Fallucca S, Angeletti S, Skrami E, Gesuita R et al.(2016). A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes. Nutrition & Diabetes vol. 6, (8) e222-e222.
10.1038/nutd.2016.29
Palermo A, Mangiameli G, Tabacco G, Longo F, Pedone C, Briganti SI, Maggi D, Vescini F et al.(2016). PTH(1-34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS Trial. J Clin Endocrinol Metab vol. 101, (11) 4039-4045.
10.1210/jc.2016-2530
Mangiacapra F, Panaioli E, Colaiori I, Ricottini E, Pantano AL, Pozzilli P, Barbato E, Di Sciascio G (2016). CLOpidogrel versus TIcagreLor for antiplatelet maintenance in DIAbetic patients treated with percutaneous coronary intervention: results of the CLOTILDIA study. EUROPEAN HEART JOURNAL. vol. 37, 385-385.
Pozzilli P, Norwood P, Jodar E, Davies M, Ivanyi T, Jiang H, Woodward B, Milicevic Z (2016). Improved glycaemic control and weight loss with once weekly dulaglutide versus placebo, both added to titrated daily insulin glargine in type 2 diabetes patients (AWARD-9). DIABETOLOGIA. vol. 59, S75-S75.
Khazrai Y, Soare A, Fontana L, Del Toro R, Lazzaro M, Di Rosa C, Buldo A, Fioriti E et al. (2016). Treatment of reactive hypoglycaemia with macrobiotic Ma-Pi 2 diet for prevention of type 2 diabetes: the MAHYP randomised crossover trial. DIABETOLOGIA. vol. 59, S334-S335.
Wanner C, Inzucchi SE, Lachin JM, Fitchett D, Von Eynatten M, Mattheus M, Johansen OE, Woerle HJ et al.(2016). Empagliflozin and progression of kidney disease in type 2 diabetes. New England Journal of Medicine vol. 375, (4) 323-334.
10.1056/NEJMoa1515920
Maddaloni E, Pozzilli P(2016). Why China guidelines for type 2 diabetes represent an opportunity for treating this disease. Diabetes Metab Res Rev vol. 32, (5) 438-439.
10.1002/dmrr.2825
Nicoli F, Pozzilli P, Lazzeri D(2016). “The Penitent Magdalene”: Tiziano Vecellio (1488/1490–1576). Journal of Endocrinological Investigation vol. 39, (7) 835-836.
10.1007/s40618-016-0436-6
Maurizi AR, Anda N, Del Toro R, Pantano AL, Fioriti E, Manfrini S, Pozzilli P (2016). A Bolus Advisor System for the Management of Insulin Therapy in Type 1 Diabetes. DIABETES. vol. 65, A227-A228.
Palermo A, Tuccinardi D, Defeudis G, Watanabe M, D¿Onofrio L, Lauria AP, Napoli N, Pozzilli P et al.(2016). BMI and BMD: The potential interplay between obesity and bone fragility. International Journal of Environmental Research and Public Health vol. 13, (6)
10.3390/ijerph13060544
Epstein S, Defeudis G, Manfrini S, Napoli N, Pozzilli P(2016). Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition. Osteoporosis International vol. 27, (6) 1931-1951.
10.1007/s00198-015-3454-x
Zanoboni L, Leanza G, Pitocco D, Costantino F, Schwartz AV, Pozzilli P, Napoli N (2016). Importance of Medical Nutrition Therapy on Long-Term Glycemic Control in Type 1 Diabetes Patients. DIABETES. vol. 65, A559-A560.
Pozzilli P, Norwood P, Jodar E, Ivanyi T, Jiang H, Woodward B, Milicevic Z (2016). Improved Glycemic Control and Weight Loss with Once-Weekly Dulaglutide vs. Placebo, Both Added to Titrated Daily Insulin Glargine, in Type 2 Diabetes Patients (AWARD-9). DIABETES. vol. 65, A62-A62.
Khazrai YM, Maurizi AR, Piccirilli S, Pipolo G, Costantino F, Pozzilli P, Manfrini S (2016). Person-Centred Approach Counselling: A Useful Tool to Reduce Burden of Care in Adolescents with Type 1 Diabetes. DIABETES. vol. 65, A177-A177.
Del Toro R, Maddaloni E, Montedoro A, Lauria A, Maurizi AR, Guglielmi C, Manfrini S, Pozzilli P (2016). Risk Factors for Cardiac Autonomic Neuropathy: The Role of HDL. DIABETES. vol. 65, A149-A149.
Strollo R, Soare A, Khazrai YM, Del Toro R, Fallucca S, Di Mauro A, Pozzilli P, Napoli N (2016). The Effect of Diet-induced Weight Loss on Bone Turnover in Patients with Type 2 Diabetes. DIABETES. vol. 65, A195-A195.
Fitchett D, Zinman B, Wanner C, Lachin JM, Hantel S, Salsali A, Johansen OE, Woerle HJ et al.(2016). Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial. Eur Heart J vol. 37, (19) 1526-1534.
10.1093/eurheartj/ehv728
Guglielmi C, Williams SR, Del Toro R, Pozzilli P(2016). Efficacy and safety of otelixizumab use in new-onset type 1 diabetes mellitus. Expert Opin Biol Ther vol. 16, (6) 841-846.
10.1080/14712598.2016.1180363
Candela M, Biagi E, Soverini M, Consolandi C, Quercia S, Severgnini M, Peano C, Turroni S et al.(2016). Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet. Br J Nutr vol. 116, (1) 80-93.
10.1017/S0007114516001045
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34343
Amed S, Pozzilli P(2016). Diagnosis of diabetes type in children and young people: Challenges and recommendations. The Lancet Diabetes and Endocrinology vol. 4, (5) 385-386.
10.1016/S2213-8587(16)00080-2
Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B(2016). Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA). Diabetes/Metabolism Research and Reviews vol. 32, (3) 289-296.
10.1002/dmrr.2717
Modesti PA, Omboni S, Taddei S, Ghione S, Portaluppi F, Pozzilli P, Volpe M, Arca M et al.(2016). Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: A double-blind, randomized study. Journal of Hypertension vol. 34, (3) 576-587.
10.1097/HJH.0000000000000805
Pozzilli P (2016). CSII AND OTHER TECHNOLOGIES FOR PREVENTING BETA CELL FAILURE IN TYPE 2 DIABETES. DIABETES TECHNOLOGY & THERAPEUTICS. vol. 18, A1-A2.
Maddaloni E, D'Onofrio L, Pozzilli P(2016). Frailty and geography: Should these two factors be added to the ABCDE contemporary guide to diabetes therapy?. Diabetes/Metabolism Research and Reviews vol. 32, (2) 169-175.
10.1002/dmrr.2762
Aronson R, Gottlieb PA, Christiansen JS, Donner TW, Bosi E, Bode BW, Pozzilli P(2016). Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: Results of the randomized phase III study in recent-onset human type 1 diabetes. Diabetes Technology and Therapeutics vol. 18,
10.1089/dia.2016.2507
Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E(2016). Continuous subcutaneous insulin infusion in diabetes: Patient populations, safety, efficacy, and pharmacoeconomics. Diabetes/Metabolism Research and Reviews vol. 32, (1) 21-39.
10.1002/dmrr.2653
Dang MN, Bradford CM, Pozzilli P, Leslie RD(2016). Methylation analysis in distinct immune cell subsets in type 1 diabetes. Methods in Molecular Biology vol. 1433, 143-151.
10.1007/7651_2015_286
Maurizi AR, Suraci C, Pitocco D, Schiaffini R, Tubili C, Morviducci L, Giordano R, Manfrini S et al.(2016). Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience. Journal of Diabetes vol. 8, (1) 41-44.
10.1111/1753-0407.12321
Hernandez M, Mollo A, Marsal JR, Esquerda A, Capel I, Puig-Domingo M, Pozzilli P, de Leiva A et al.(2015). Insulin secretion in patients with latent autoimmune diabetes (LADA): Half way between type 1 and type 2 diabetes: Action LADA 9. BMC Endocrine Disorders vol. 15, (1)
10.1186/1472-6823-15-1
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T et al.(2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine vol. 373, (22) 2117-2128.
10.1056/NEJMoa1504720
Weng J, Pozzilli P(2015). Hot topics on diabetes in China. Diabetes/Metabolism Research and Reviews vol. 31, (8) 779-780.
10.1002/dmrr.2766
Barchetta I, Guglielmi C, Bertoccini L, Calella D, Manfrini S, Secchi C, Pozzilli P, Cavallo MG(2015). Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control. Acta Diabetologica vol. 52, (5) 873-880.
10.1007/s00592-015-0721-4
Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P et al.(2015). Antibodies to post-translationally modified insulin in type 1 diabetes. Diabetologia vol. 58, (12) 2851-2860.
10.1007/s00125-015-3746-x
Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P et al. (2015). Autoantibodies to posttranslationally modified insulin in type 1 diabetes. DIABETOLOGIA. vol. 58, S102-S103.
Maurizi A, Del Toro R, Menduni M, Pantano AL, Kyanvash S, Manfrini S, Pozzilli P (2015). D-chiro-inositol improves metabolic control in overweight patients with type 1 diabetes. DIABETOLOGIA. vol. 58, S255-S256.
Defeudis G, Gianfrilli D, Di Emidio C, Pofi R, Tuccinardi D, Palermo A, Lenzi A, Pozzilli P(2015). Erectile dysfunction and its management in patients with diabetes mellitus. Reviews in Endocrine and Metabolic Disorders vol. 16, (3) 213-231.
10.1007/s11154-015-9321-4
Pozzilli P(2015). Osteocalcin, glucose tolerance and diabetes. Annales d Endocrinologie vol. 76, (4)
10.1016/j.ando.2015.07.042
Palermo A, D¿Onofrio L, Eastell R, Schwartz AV, Pozzilli P, Napoli N(2015). Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporosis International vol. 26, (8) 2073-2089.
10.1007/s00198-015-3123-0
Maddaloni E, Lessan N, Tikriti AA, Buzzetti R, Pozzilli P, Barakat MT(2015). Latent autoimmune diabetes in adults in the United Arab Emirates: Clinical features and factors related to insulin-requirement. PLoS ONE vol. 10, (8)
10.1371/journal.pone.0131837
Ibrahim M, Abu Al Magd M, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, Karadeniz S, Meriden T et al.(2015). Recommendations for management of diabetes during Ramadan: Update 2015. BMJ Open Diabetes Research and Care vol. 3, (1)
10.1136/bmjdrc-2015-000108
Napoli N, Mazzanti F, Giambra E, Strollo R, Mottini G, Pozzilli P (2015). Prevalent Gestational Diabetes Mellitus in HIV-Infected and -Uninfected Pregnant Women Living in Sub-Saharan Africa. DIABETES. vol. 64, A381-A381.
Napoli N, Strollo R, Defeudis G, Leto G, Hawa MI, Leslie RDG, Pozzilli P, Buzzetti R et al. (2015). Serum Sclerostin and Bone Turnover in Relation to Metabolic Syndrome in Patients with Type 2 Diabetes or LADA. DIABETES. vol. 64, A129-A129.
Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A et al.(2015). Subcutaneous insulin infusion (CSII) in italy: The third national survey. Giornale Italiano di Diabetologia e Metabolismo vol. 35, (2) 121-129.
Defeudis G, Di Emidio C, Strollo R, Rinati MV, Tuccinardi D, Palermo A, Angeletti S, Manfrini S et al. (2015). The Efficacy of Continuous Glucose Monitoring to Improve BMI and Glycaemic Control in Prediabetes: The OBIG Trial. DIABETES. vol. 64, A240-A240.
Pozzilli P, Maddaloni E, Buzzetti R(2015). Combination immunotherapies for type 1 diabetes mellitus. Nature Reviews Endocrinology vol. 11, (5) 289-297.
10.1038/nrendo.2015.8
Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P et al.(2015). Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. American Heart Journal vol. 169, (5) 631-638.e7.
10.1016/j.ahj.2015.02.002
Elias D, Avron A, Tamir M, Eren R, Peled D, Dagan S, Raz I, Pozzilli P et al.(2015). Retraction Note: Abstracts of the 50th Annual Meeting of the EASD, Vienna 2014. ‘Evaluation of DiaPep277<sup>®</sup> treatment in type 1 diabetes by integrated analysis’[Diabetologia(2015), DOI 10.1007/s00125-014-3355-0]. Diabetologia vol. 58, (5)
10.1007/s00125-015-3542-7
Khazrai YM, Buzzetti R, Del Prato S, Cahn A, Raz I, Pozzilli P(2015). The addition of e (Empowerment and Economics) to the ABCD algorithm in diabetes care. Journal of Diabetes and its Complications vol. 29, (4) 599-606.
10.1016/j.jdiacomp.2015.03.004
Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B, Löffler T(2015). Erhöhung der β-Zellfunktion und Verbesserung des HOMA-2β-Index durch Saxagliptin bei Erwachsenen mit latentem Autoimmundiabetes. Diabetologie und Stoffwechsel vol. 10, (S 01)
10.1055/s-0035-1549719
Signore A, Capriotti G, Chianelli M, Bonanno E, Galli F, Catalano C, Quintero AM, De Toma G et al.(2015). Detection of insulitis by pancreatic scintigraphy with <sup>99m</sup>Tc-Labeled IL-2 and MRI in patients with LADA (Action LADA 10). Diabetes Care vol. 38, (4) 652-658.
10.2337/dc14-0580
Palermo A, Strollo R, Maddaloni E, Tuccinardi D, D'Onofrio L, Briganti SI, Defeudis G, De Pascalis M et al.(2015). Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clin Endocrinol (Oxf) vol. 82, (4) 615-619.
10.1111/cen.12672
Soare A, Toro RD, Roncella E, Khazrai YM, Angeletti S, Dugo L, Fallucca S, Fontana L et al.(2015). The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: A post hoc analysis of the MADIAB trial. BMJ Open Diabetes Research and Care vol. 3, (1)
10.1136/bmjdrc-2014-000079
Lauria A, Barker A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M et al.(2015). BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children. Eur J Endocrinol vol. 172, (2) 107-113.
10.1530/EJE-14-0522
Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A et al.(2015). Continuous subcutaneous insulin infusion in Italy: Third national survey. Diabetes Technology and Therapeutics vol. 17, (2) 96-104.
10.1089/dia.2014.0242
Maddaloni E, Sabatino F, Del Toro R, Crugliano S, Grande S, Lauria Pantano A, Maurizi AR, Palermo A et al.(2015). In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes. Diabet Med vol. 32, (2) 262-266.
10.1111/dme.12583
Pozzilli P (2015). THE IMPACT OF NEW TECHNOLOGY IN TYPE 2 DIABETES. DIABETES TECHNOLOGY & THERAPEUTICS. vol. 17, A2-A2.
Lazzeri D, Pozzilli P, Persichetti P(2015). "the Annunciation" - Girolamo Francesco Maria Mazzola called Parmigianino (1503-1540). Journal of Endocrinological Investigation vol. 38, (11) 1247-1248.
10.1007/s40618-015-0358-8
Pozzilli P (2015). ARE THE NEW ANTIDIABETIC DRUGS SIMPLIFYING OR COMPLICATING THE TYPE 2 DIABETES MANAGEMENT?. INTERDISCIPLINARY APPROACHES IN DIABETIC CHRONIC KIDNEY DISEASE. 25-27.
PLOS ONE Staff(2015). Correction: Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement. PLoS One vol. 10, (8)
10.1371/journal.pone.0137152
Pozzilli P, Raz I, Peled D, Elias D, Avron A, Tamir M, Eren R, Dagan S et al.(2015). Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: Differences after stimulation with glucagon or a mixed meal. Diabetes Technology and Therapeutics vol. 17, S83-S84.
10.1089/dia.2015.1510
(2015). Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal. Diabetes Care 2014;37:1384-1391. DOI: 10.2337/dc13-1392. Diabetes Care vol. 38, (1)
10.2337/dc15-rt01a
Nusca A, Lauria Pantano A, Melfi R, Proscia C, Maddaloni E, Contuzzi R, Mangiacapra F, Palermo A et al.(2015). Glycemic variability assessed by continuous glucose monitoring and short-term outcome in diabetic patients undergoing percutaneous coronary intervention: An observational pilot study. Journal of Diabetes Research vol. 2015,
10.1155/2015/250201
Lazzeri D, Pozzilli P, Zhang YX, Persichetti P(2015). Goiter in paintings by Rogier van der Weyden (1399-1464). Thyroid vol. 25, (5) 559-562.
10.1089/thy.2014.0494
Napoli N, Pozzilli P(2015). Obesity and glucose metabolism. Multidisciplinary Approach to Obesity: From Assessment to Treatment,
Pozzilli P, Guglielmi C(2015). Prevention of Type 1 Diabetes Mellitus. Principles of Diabetes Mellitus,
(2015). Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial. Diabetes Care 2014;37:1392-1400. DOI: 10.2337/dc13-1391. Diabetes Care vol. 38, (1)
10.2337/dc15-rt01
Zampetti S, Campagna G, Tiberti C, Songini M, Arpi ML, De Simone G, Cossu E, Cocco L et al.(2014). High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7). European Journal of Endocrinology vol. 171, (6) 697-704.
10.1530/EJE-14-0342
Palermo A, Strollo R, Papalia R, D'Onofrio L, Maddaloni E, Briganti SI, Napoli N, Vespasiani U et al.(2014). Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: a case report. Endocr Pract vol. 20, (12) e246-e249.
10.4158/EP14251.CR
Guglielmi C, Secchi C, Maddaloni E, Manfrini S, Pozzilli P(2014). 10. Effects of Treatment with Proton Pump Inhibitors on Metabolic Control in Patients with Type 2 Diabetes (2425-PO). Nederlands Tijdschrift voor Diabetologie vol. 12, (4) 14-14.
10.1007/s12467-014-0035-0
Aronson R, Gottlieb PA, Christiansen JS, Donner TW, Bosi E, Bode BW, Pozzilli P, DEFEND Investigator Group(2014). Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes. Diabetes Care vol. 37, (10) 2746-2754.
10.2337/dc13-0327
Weng J, Pozzilli P(2014). Diabetes Metabolism: Research and Reviews--Chinese Diabetes Society special issue: a small but encouraging step toward the successful control of diabetes in China. Diabetes Metab Res Rev vol. 30, (6) 445-446.
10.1002/dmrr.2579
Elias D, Avron A, Tamir M, Eren R, Peled D, Dagan S, Raz I, Pozzilli P et al. (2014). Evaluation of DiaPep277 (R) treatment in type 1 diabetes by integrated analysis. DIABETOLOGIA. vol. 57, S190-S191.
Guglielmi C, Valente L, Fallucca S, Angeletti S, Briganti S, De Pascalis M, Lachin JM, Pozzilli P (2014). Glucagon and mixed-meal tests to estimate beta cell and incretin functions in normals: relevance for studies in type 1 diabetes. DIABETOLOGIA. vol. 57, S189-S189.
Proscia C, Nusca A, Melfi R, Pantano AL, Maddaloni E, Contuzzi R, Campanale CM, Pozzilli P et al. (2014). Glycemic variability assessed by continuous glucose monitoring and its correlation with renal and myocardial damage after coronary stenting. EUROPEAN HEART JOURNAL. vol. 35, 394-395.
Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B (2014). Increase in beta cell function and improvement in HOMA-2beta index induced by saxagliptin in patients with latent autoimmune diabetes in adults. DIABETOLOGIA. vol. 57, S355-S355.
Modesti PA, Omboni S, Zava D, Taddei S, Ghione S, Portaluppi F, Pozzilli P, Volpe M et al.(2014). Efficacy of zofenopril or irbesartan both combined with hydrochlorothiazide in elderly subjects with isolated systolic hypertension untreated or uncontrolled by monotherapy. Journal of the American Society of Hypertension vol. 8,
10.1016/j.jash.2014.07.022
Maddaloni E, D'Onofrio L, Lauria A, Maurizi AR, Strollo R, Palermo A, Napoli N, Angeletti S et al.(2014). Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes. J Endocrinol Invest vol. 37, (7) 661-666.
10.1007/s40618-014-0092-7
Mitrea A, Fallucca S, Angeletti S, Soare A, Vernieri F, Ursini F, Trotta L, Mota M et al. (2014). Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes?. DIABETES. vol. 63, A487-A487.
Khazrai YM, Defeudis G, Di Rosa C, Roncella E, Secchi C, Pozzilli P, Manfrini S (2014). Conversation Maps (TM), an Effective Tool for Type 2 Diabetes Treatment. DIABETES. vol. 63, A178-A179.
Guglielmi C, Secchi C, Maddaloni E, Manfrini S, Pozzilli P (2014). Effects of Treatment with Proton Pump Inhibitors on Metabolic Control in Patients with Type 2 Diabetes. DIABETES. vol. 63, A615-A615.
Guglielmi C, Valente L, Fallucca S, Angeletti S, Lachin JM, Pozzilli P (2014). Glucagon and Mixed-Meal Tests to Evaluate Beta-Cell Function and Incretin Axis: Relevance for Immunointervention Trials in Type 1 Diabetes. DIABETES. vol. 63, A75-A75.
Maddaloni E, Lessan N, Al Tikriti A, Pozzilli P, Barakat MT (2014). Prevalence and Features of Adult-Onset Autoimmune Diabetes in the United Arab Emirates (UAE). DIABETES. vol. 63, A399-A399.
Pozzilli P, Buzzetti R, Frederich R, Iqbal N, Hirshberg B (2014). Saxagliptin Increases beta-Cell Function and Improves HOMA Index in Patients with Latent Autoimmune Diabetes in Adults. DIABETES. vol. 63, A41-A41.
Soare A, Manon KY, Silvia A, Dugo L, Fallucca S, Fontana L, Altomare M, Gesuita R et al. (2014). The Effect of Macrobiotic (Ma-Pi 2) Diet on Systemic Inflammation in Patients with Type 2 Diabetes. DIABETES. vol. 63, A192-A192.
Piccirilli S, Khazrai YM, Soare A, Buzzetti R, Pozzilli P (2014). Wrist Circumference, a Simple and Economic Marker for Obese Type 2 Diabetes Subjects. DIABETES. vol. 63, A634-A634.
Maddaloni E, Pozzilli P(2014). SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes). Endocrine vol. 46, (1) 3-5.
10.1007/s12020-013-0128-3
Maddaloni E, Pozzilli P(2014). Will we ever cure diabetes?. Diabetes Management vol. 4, (3) 219-221.
10.2217/dmt.14.6
Maddaloni E, Capolupo G, Palermo A, Manfrini S, Di Matteo FM, Grasso RF, Coppola R, Pozzilli P(2014). Continuous glucose monitoring and robot surgery of an insulinoma: a case report and review of the literature. Pancreas vol. 43, (3) 483-485.
10.1097/MPA.0000000000000040
Franciscus M, Nucci A, Bradley B, Suomalainen H, Greenberg E, Laforte D, Kleemola P, Hyytinen M et al.(2014). Recruitment and retention of participants for an international type 1 diabetes prevention trial: a coordinators' perspective. Clin Trials vol. 11, (2) 150-158.
10.1177/1740774513510070
Lehtonen E, Ormisson A, Nucci A, Cuthbertson D, Sorkio S, Hyytinen M, Alahuhta K, Berseth C et al.(2014). Use of vitamin D supplements during infancy in an international feeding trial. Public Health Nutr vol. 17, (4) 810-822.
10.1017/S1368980013001122
Barker A, Lauria A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M et al.(2014). Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study. Diabetes Obes Metab vol. 16, (3) 262-267.
10.1111/dom.12216
Soare A, Weiss EP, Pozzilli P(2014). Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk. Diabetes Metab Res Rev vol. 30 Suppl 1, 41-47.
10.1002/dmrr.2517
Pozzilli P, Fallucca F(2014). Diet and diabetes: a cornerstone for therapy INTRODUCTION. DIABETES-METABOLISM RESEARCH AND REVIEWS vol. 30, 1-3.
Pozzilli P, Fallucca F(2014). Diet and diabetes: a cornerstone for therapy. Diabetes Metab Res Rev vol. 30 Suppl 1, 1-3.
10.1002/dmrr.2512
Khazrai YM, Defeudis G, Pozzilli P(2014). Effect of diet on type 2 diabetes mellitus: a review. Diabetes Metab Res Rev vol. 30 Suppl 1, 24-33.
10.1002/dmrr.2515
Khazrai YM, Maddaloni E, Altomare M, Cacciapaglia F, Pozzilli P(2014). New technologies aiding dietary programmes for weight control: the oral glucose spray. Endocrine vol. 45, (2) 288-292.
10.1007/s12020-013-9987-x
Pozzilli P, Strollo R, Bonora E(2014). One size does not fit all glycemic targets for type 2 diabetes. JOURNAL OF DIABETES INVESTIGATION vol. 5, (2) 134-141.
10.1111/jdi.12206
Palermo A, Maggi D, Maurizi AR, Pozzilli P, Buzzetti R(2014). Prevention of type 2 diabetes mellitus: is it feasible?. Diabetes Metab Res Rev vol. 30 Suppl 1, 4-12.
10.1002/dmrr.2513
Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC et al.(2014). Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials. Diabetes Technology and Therapeutics vol. 16, (SUPPL. 1)
10.1089/dia.2014.1510
Suchkov S, Golubnitschaja O, von Herrath M, Pozzilli P, Paltsev M, Mkrtumyan A, Frank M, Marshall T et al.(2014). Predictive, preventive and personalized medicine (PPPM) as a strategic avenue and global tool for advancing T1D-related care: Fundamental, Applied and Affiliated Issues. EPMA Journal vol. 5, (Suppl 1)
10.1186/1878-5085-5-s1-a69
Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A et al.(2014). Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7 (Diabetes Care (2013) 36, (908-913)). Diabetes Care vol. 37, (5)
10.2337/dc14-er05
Maddaloni E, Pozzilli P(2014). Comment on: "Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results". Nutr Metab Cardiovasc Dis vol. 24, (1)
10.1016/j.numecd.2013.06.007
Pozzilli P, Raz I, Peled D, Elias D, Avron A, Tamir M, Eren R, Dagan S et al.(2014). Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal. Diabetes Care vol. 37, (5) 1384-1391.
10.2337/dc13-1392
Napoli N, Strollo R, Paladini A, Briganti SI, Pozzilli P, Epstein S(2014). The alliance of mesenchymal stem cells, bone, and diabetes. Int J Endocrinol vol. 2014,
10.1155/2014/690783
Soare A, Khazrai YM, Del Toro R, Roncella E, Fontana L, Fallucca S, Angeletti S, Formisano V et al.(2014). The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial. Nutr Metab (Lond) vol. 11,
10.1186/1743-7075-11-39
Raz I, Ziegler AG, Linn T, Schernthaner G, Bonnici F, Distiller LA, Giordano C, Giorgino F et al.(2014). Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial. Diabetes Care vol. 37, (5) 1392-1400.
10.2337/dc13-1391
Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Rossi FF, Antonelli-Incalzi R(2013). Bone health as a function of adipokines and vitamin D pattern in elderly patients. Rejuvenation Res vol. 16, (6) 467-474.
10.1089/rej.2013.1436
Pozzilli P, Lenzi A, Clarke BL, William F Young M(2013). Imaging in Endocrinology.
(2013). Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain. Diabetes/Metabolism Research and Reviews vol. 29, (8) 693-693.
10.1002/dmrr.2476
Levetan C, Pozzilli P, Jovanovic L, Schatz D(2013). Proposal for generating new beta cells in a muted immune environment for type 1 diabetes. Diabetes Metab Res Rev vol. 29, (8) 604-606.
10.1002/dmrr.2435
Mitrea A, Soare A, Popa SG, Tudor MN, Mota M, Pozzilli P(2013). Wrist circumference: An independent predictor of both insulin resistance and chronic kidney disease in an elderly population. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases vol. 20, (3) 323-329.
10.2478/rjdnmd-2013-0031
Mollo A, Hernandez M, Marsal JR, Esquerda A, Rius F, Blanco-Vaca F, Verdaguer J, Pozzilli P et al.(2013). Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain. Diabetes Metab Res Rev vol. 29, (6) 446-451.
10.1002/dmrr.2411
Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B (2013). Saxagliptin improves glycaemic control and is well tolerated in adult diabetes patients with glutamic acid decarboxylase antibodies. DIABETOLOGIA. vol. 56, S390-S390.
Pozzilli P, Raz I, Linn T, Bonnici F, Elias D, Avron A, Tamir M, Eren R et al. (2013). Subgroup analysis of DIA-AID 1, an immune intervention phase 3 study in newly diagnosed type 1 diabetes patients. DIABETOLOGIA. vol. 56, S230-S230.
Maurizi AR, Pozzilli P(2013). Do we need continuous glucose monitoring in type 2 diabetes?. Diabetes Metab Res Rev
10.1002/dmrr.2450
Mannucci E, Dicembrini I, Lauria A, Pozzilli P(2013). Is glucose control important for prevention of cardiovascular disease in diabetes?. Diabetes Care vol. 36 Suppl 2, S259-S263.
10.2337/dcS13-2018
Strollo R, Ponchel F, Malmström V, Rizzo P, Bombardieri M, Wenham CY, Landy R, Perret D et al.(2013). Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis. Arthritis Rheum vol. 65, (7) 1702-1712.
10.1002/art.37964
Khazrai YM, De Gara L, Iorio B, Pozzilli P (2013). Dietary Habits and Undiagnosed Diabetes in a Rural Population of Peru. DIABETES. vol. 62, A699-A699.
Dagan S, Avron A, Peled D, Elias D, Tamir M, Pozzilli P, Raz I, Harari G et al. (2013). Differences in Long-Term Changes in C-peptide Levels after Stimulation With Glucagon or a Mixed-Meal. DIABETES. vol. 62, A64-A64.
Pham TMN, Burkart V, Hawa MI, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum W et al. (2013). Higher Serum Concentrations of TGF beta 1 in Patients With Type 1 Diabetes than in Patients With Type 2 Diabetes or Latent Autoimmune Diabetes in Adults. DIABETES. vol. 62, A447-A447.
Maddaloni E, Sabatino F, Del Toro R, Grande S, Palermo A, Lauria A, Maurizi A, Manfrini S et al. (2013). In-Vivo Corneal Confocal Microscopy as a Novel Non-Invasive Tool to Study Autonomic Nerve Function in Type 1 Diabetes. DIABETES. vol. 62, A145-A146.
Briganti SI, Guglielmi C, Tomao E, Avallone V, Cataldo R, Manfrini S, Pozzilli P (2013). Obesity and Diabetes in Military and Civil Aviation Flying Personnel. DIABETES. vol. 62, A708-A709.
Pozzilli P, Buzzetti R, Frederich R, Iqbal N, Hirshberg B (2013). Saxagliptin Is Well Tolerated and Improves Glycemic Control in Adult Diabetes Patients With GAD Antibodies. DIABETES. vol. 62, A287-A287.
Pham TMN, Kolb H, Zivehe F, Battelino T, Ludvigsson J, Pozzilli P, Burkart V, Roden M et al. (2013). Serum Concentrations of Adiponectin Associated Positively With Proinflammatory Cytokines in Patients With Type 1 Diabetes. DIABETES. vol. 62, A64-A64.
Hessner M, Kaldunski M, Jia S, Wang X, Cheong S, Pickersgill L, De Koning E, Ziegler A-G et al. (2013). Serum Signature Analysis of Participants of the Anti-Interleukin-1 in Diabetes Action (AIDA) Trial. DIABETES. vol. 62, A63-A64.
Pozzilli P, Raz I, Linn T, Bonnici F, Elias D, Avron A, Tamir M, Eren R et al. (2013). Subgroup Analysis of DIA-AID 1, an Immune Intervention Phase III Study in Newly Diagnosed Type 1 Diabetes Patients. DIABETES. vol. 62, A64-A64.
Rizzo P, Pitocco D, Scavone G, Di Stasio E, Costantini F, Strollo R, Galli M, Pozzilli P et al. (2013). The Role of Collagen Neoepitopes Generated by Oxidative Stress in the Pathogenesis of Charcot Neuroarthropathy. DIABETES. vol. 62, A619-A619.
Bonafini B, Pozzilli P(2013). The Three Graces: canons of beauty or disease repulsion. Int J Cardiol vol. 166, (2) 283-285.
10.1016/j.ijcard.2013.01.174
Palermo A, Napoli N, Maddaloni E, Lauria A, Soare A, Manfrini S, Altomare M, Leotta S et al. (2013). Buccal spray insulin in subjects with impaired glucose tolerance: Improvement in HbA1c is lost after 6 months washout therapy. Diabetes Technology and Therapeutics. vol. 15,
10.1089/dia.2013.1514
Chon S, Lee YJ, Fraterrigo G, Pozzilli P, Choi MC, Kwon M-K, Chin SO, Rhee SY et al.(2013). Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus. Diabetes Technol Ther vol. 15, (6) 455-460.
10.1089/dia.2012.0315
Pham MN, Kolb H, Battelino T, Ludvigsson J, Pozzilli P, Zivehe F, Roden M, Mandrup-Poulsen T et al.(2013). Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes. Diabetologia vol. 56, (6) 1356-1363.
10.1007/s00125-013-2883-3
Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J, Kordonouri O, Otonkoski T et al.(2013). GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. Diabetes Technology and Therapeutics vol. 15, (SUPPL.1)
10.1089/dia.2013.1510
Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC et al.(2013). Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet vol. 381, (9881) 1905-1915.
10.1016/S0140-6736(13)60023-9
Guglielmi C, Pozzilli P(2013). L’immunoterapia del diabete di tipo 1. L'Endocrinologo vol. 14, (3) 111-114.
10.1007/bf03346065
Portuesi R, Cherubini C, Gizzi A, Buzzetti R, Pozzilli P, Filippi S(2013). A stochastic mathematical model to study the autoimmune progression towards type 1 diabetes. Diabetes Metab Res Rev vol. 29, (3) 194-203.
10.1002/dmrr.2382
Strollo R, Rizzo P, Spoletini M, Landy R, Hughes C, Ponchel F, Napoli N, Palermo A et al.(2013). HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus. Diabetologia vol. 56, (3) 563-572.
10.1007/s00125-012-2780-1
Pham MN, Kolb H, Mandrup-Poulsen T, Battelino T, Ludvigsson J, Pozzilli P, Roden M, Schloot NC et al.(2013). Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin. Diabetes Metab Res Rev vol. 29, (2) 166-170.
10.1002/dmrr.2378
Portuesi R, Pozzilli P, Boehm B, Buzzetti R, Filippi S(2013). Assessment of type 1 diabetes risk conferred by HLA-DRB1, INS-VNTR and PTPN22 genes using the Bayesian network approach. PLoS One vol. 8, (11)
10.1371/journal.pone.0079506
Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A et al.(2013). Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes. PLoS One vol. 8, (2)
10.1371/journal.pone.0056488
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5299
Dang MN, Buzzetti R, Pozzilli P(2013). Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diabetes Metab Res Rev vol. 29, (1) 8-18.
10.1002/dmrr.2375
Guglielmi C, Palermo A, Pozzilli P(2012). Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy. Diabetes Metab Res Rev vol. 28 Suppl 2, 40-46.
10.1002/dmrr.2345
Bodrova TA, Kostyushev DS, Antonova EN, Slavin S, Gnatenko DA, Bocharova MO, Legg M, Pozzilli P et al.(2012). Introduction into PPPM as a new paradigm of public health service: an integrative view. EPMA J vol. 3, (1)
10.1186/1878-5085-3-16
Vaccaro O, Masulli M, Bonora E, Del Prato S, Giorda CB, Maggioni AP, Mocarelli P, Nicolucci A et al.(2012). Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. Nutr Metab Cardiovasc Dis vol. 22, (11) 997-1006.
10.1016/j.numecd.2012.09.003
Cardwell CR, Stene LC, Ludvigsson J, Rosenbauer J, Cinek O, Svensson J, Perez-Bravo F, Memon A et al.(2012). Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care vol. 35, (11) 2215-2225.
10.2337/dc12-0438
Dagan S, Peled D, Elias D, Avron A, Eren R, Raz I, Pozzilli P (2012). Evaluation of treatment effect of a type 1 diabetes intervention therapy using GST versus MMTT. DIABETOLOGIA. vol. 55, S192-S192.
Raz I, Linn T, Ziegler A-G, Schernthaner G, Bonnici F, Eren R, Elias D, Dagan S et al. (2012). Recent data from DIA-AID 1, a global phase III clinical study using DiaPep277 (R) for the treatment of newly diagnosed type 1 diabetes patients. DIABETOLOGIA. vol. 55, S66-S66.
Khazrai YM, Cacciapaglia F, Palermo A, Pozzilli P(2012). The use of a glucose spray device to control progression towards hypoglycaemia. Endocrine vol. 42, (2) 442-444.
10.1007/s12020-012-9620-4
Pozzilli P, Strollo R(2012). Immunotherapy for Type 1 diabetes: getting beyond a negative first impression. Immunotherapy vol. 4, (7) 655-658.
10.2217/imt.12.54
Vesperini E, Maurizi AR, Pozzilli P, Salvinelli F(2012). Diabetes and Auditory Risk: the Recent Data. International Journal of Clinical Reviews
10.5275/ijcr.2012.06.07
Barker A, Lauria A, Schloot N, Hosszufalusi N, Panczel P, Ludvigsson J, Mathieu C, Mauricio D et al. (2012). BMI is the Major Driver of Beta Cell Loss in RecentOnset Type 1 Diabetes: a Multicentre, Longitudinal Study. DIABETES. vol. 61, A447-A447.
Palermo A, Maddaloni E, Pozzilli P(2012). Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?. Expert Opin Biol Ther vol. 12, (6) 767-772.
10.1517/14712598.2012.675324
Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A et al. (2012). Calcitriol and Bone Turnover in Type 1 Diabetic Adolescents. DIABETES. vol. 61, A331-A331.
Khazrai YM, Defeudis G, Cutolo S, Pasqualotto E, Pozzilli P, Manfrini S (2012). Conversation Maps: The Path Towards Self-Management. DIABETES. vol. 61, A179-A179.
Leslie RD, Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D et al. (2012). LADA is not a Distinct Form of Autoimmune Diabetes. DIABETES. vol. 61, A24-A25.
Dagan S, Ziegler AG, Pozzilli P, Linn T, Schernthaner G, Bonnici F, Elias D, Eren R et al. (2012). Recent Data from DIA-AID 1, a Global Phase III Clinical Study in Newly Diagnosed Type 1 Diabetes Patients. DIABETES. vol. 61, A76-A76.
Strom A, Menart B, Simon M-C, Pham MN, Kolb H, Roden M, Pozzilli P, Leslie RDG et al.(2012). Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6. Cytokine vol. 58, (2) 148-151.
10.1016/j.cyto.2012.01.002
Roth J, Pozzilli P(2012). Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012. Diabetes Metab Res Rev vol. 28, (4)
10.1002/dmrr.2267
Strom A, Menart B, Simon M, Pham M, Kolb H, Roden M, Pozzilli P, Leslie R et al.(2012). Zelluläre Interferon-γ und Interleukin-13 Immunantwort bei Typ 1, Typ 2 und Latentem Autoimmune Diabetes. Diabetologie und Stoffwechsel vol. 7, (S 01)
10.1055/s-0032-1314649
Pham MN, Hawa MI, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J et al.(2012). Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: action LADA 5. Diabet Med vol. 29, (4) 470-478.
10.1111/j.1464-5491.2011.03546.x
Bonafini B, Pozzilli P(2012). Scrotal asymmetry, varicocoele and the Riace Bronzes. Int J Androl vol. 35, (2) 181-182.
10.1111/j.1365-2605.2011.01181.x
Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J, Kordonouri O, Otonkoski T et al.(2012). Terapia antigenica con GAD65 nel diabete mellito di tipo 1 di recente diagnosi. L'Endocrinologo vol. 13, (2) 89-90.
10.1007/bf03344894
Bizzarri C, Pinto RM, Pitocco D, Astorri E, Cappa M, Hawa M, Giannone G, Palermo A et al.(2012). Diabetes-related autoantibodies in children with acute lymphoblastic leukemia. Diabetes Care vol. 35, (3)
10.2337/dc11-1946
https://qmro.qmul.ac.uk/xmlui/handle/123456789/19616
Robert JJ, Ludvigsson J, Krisky D, Casas R, Battelino T, Castano L, Greening J, Kordonouri O et al.(2012). Treatment with GAD65 antigen in type 1 diabetes diagnosed recently. DIABETES & METABOLISM vol. 38, A130-A130.
10.1016/S1262-3636(12)71523-9
Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J, Kordonouri O, Otonkoski T et al.(2012). GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med vol. 366, (5) 433-442.
10.1056/NEJMoa1107096
Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A et al.(2012). Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care
10.2337/dc12-0931
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18410
Napoli N, Zardi E, Strollo R, Arigliani M, Daverio A, Olearo F, Tosi D, Dicuonzo G et al.(2012). Increased carotid thickness in subjects with recently-diagnosed diabetes from rural Cameroon. PLoS One vol. 7, (8)
10.1371/journal.pone.0041316
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5339
VALORANI MG, Montelatici E, Germani A, Biddle A, D'Alessandro D, Strollo R, Patrizi MP, Lazzari L et al.(2012). Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potential. Cell Proliferation vol. 45, (3) 225-238.
10.1111/j.1365-2184.2012.00817
Pozzilli P(2011). Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy. Nat Rev Endocrinol vol. 8, (2) 78-80.
10.1038/nrendo.2011.228
Buzzetti R, Cernea S, Petrone A, Capizzi M, Spoletini M, Zampetti S, Guglielmi C, Venditti C et al.(2011). C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study. Diabetes vol. 60, (11) 3067-3072.
10.2337/db10-0560
Park Y, Kim K, Pozzilli P(2011). Preface. Diabetes Metab Res Rev vol. 27, (8)
10.1002/dmrr.1301
Morviducci L, Di Flaviani A, Lauria A, Pitocco D, Pozzilli P, Suraci C, Frontoni S, CSII Study Group Of Lazio Region, Italy(2011). Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit. Diabetes Technol Ther vol. 13, (10) 1071-1074.
10.1089/dia.2011.0056
Pham MN, Kolb H, Mandrup-Poulsen T, Battelino T, Ludvigsson J, Pozzilli P, Roden M, Schloot NC et al. (2011). Adiponectin levels negatively associate with beta cell function in type 1 diabetes, in contrast to leptin and resistin. DIABETOLOGIA. vol. 54, S304-S304.
Di Stasio E, Maggi D, Berardesca E, Marulli GC, Bizzarri C, Lauria A, Portuesi R, Cavallo MG et al.(2011). Blue eyes as a risk factor for type 1 diabetes. Diabetes Metab Res Rev vol. 27, (6) 609-613.
10.1002/dmrr.1214
Palermo A, Napoli N, Maddaloni E, Lauria A, Manfrini S, Maurizi A, Altomare M, Leotta S et al. (2011). Buccal spray insulin: a new tool to treat subjects with impaired glucose tolerance. DIABETOLOGIA. vol. 54, S52-S52.
Tuccinardi D, Fioriti E, Manfrini S, D'Amico E, Pozzilli P(2011). DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes. Expert Opin Biol Ther vol. 11, (9) 1233-1240.
10.1517/14712598.2011.599319
Pozzilli P, Schloot NC, Hosszufalusi N, Lauria A, Ludvigsson J, Mathieu C, Mauricio D, Rubinat E et al. (2011). Time dependent C-peptide decline in 4411 patients with recent onset type 1 diabetes followed for up to 10 years: a meta-analysis from 8 European centres. DIABETOLOGIA. vol. 54, S74-S74.
Napoli N, Pedone C, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Incalzi RA(2011). Effect of ghrelin on bone mass density: the InChianti study. Bone vol. 49, (2) 257-263.
10.1016/j.bone.2011.03.772
Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, Cavallo MG(2011). Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med vol. 9,
10.1186/1741-7015-9-85
Portuesi R, Cherubini C, Gizzi A, Valorani G, Buzzetti R, Filippi S, Pozzilli P (2011). A Mathematical Model To Study the Autoimmune Progression towards Type 1 Diabetes. DIABETES. vol. 60, A668-A668.
Maurizi AR, Napoli N, Strollo R, Lauria A, Manfrini S, Schwatz A, Pozzilli P (2011). Osteocalcin and Residual beta-Cell Function in Type 1 Diabetes. DIABETES. vol. 60, A485-A485.
Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA et al.(2011). Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia vol. 54, (7) 1630-1638.
10.1007/s00125-011-2088-6
Pham M-N, Hawa M, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum W, Seissler J et al. (2011). Similar Circulating Concentrations of Adhesion Molecules between Type 1 Diabetes and LADA Patients: Results from the Action LADA Study. DIABETES. vol. 60, A144-A144.
Palermo A, Napoli N, Maddaloni E, Lauria A, Manfrini S, Altomare M, Leotta S, Pozzilli P (2011). Treatment of Impaired Glucose Tolerance with Buccal Spray Insulin: A 6 Months Randomised Controlled Trial. DIABETES. vol. 60, A592-A593.
Vadacca M, Valorani MG, von Hofe E, Kallinteris NL, Buzzetti R, Pozzilli P(2011). Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes. Horm Metab Res vol. 43, (7) 483-488.
10.1055/s-0031-1275705
Pham M, Hawa M, Roden M, Schernthaner G, Pozzilli P, Scherbaum W, Seissler J, Hunter S et al.(2011). Erhöhte systemische Konzentrationen der Adhäsionsmoleküle sICAM-1, sVCAM-1 und sE-Selectin bei Typ 2 Diabetes verglichen mit LADA und Typ 1 Diabetes in der Action LADA Kohorte. Diabetologie und Stoffwechsel vol. 6, (S 01)
10.1055/s-0031-1277515
Pozzilli P, Guglielmi C, Caprio S, Buzzetti R(2011). Obesity, autoimmunity, and double diabetes in youth. Diabetes Care vol. 34 Suppl 2, S166-S170.
10.2337/dc11-s213
Maurizi AR, Lauria A, Maggi D, Palermo A, Fioriti E, Manfrini S, Pozzilli P(2011). A Novel Insulin Unit Calculator for the Management of Type 1 Diabetes. DIABETES TECHNOL THE vol. 13, (4) 425-428.
10.1089/dia.2010.0190
Nesbitt A, Fossati G, Whittall CE, Askari A, Middleton J, Astorri E, Bombardi M, Peakman M et al.(2011). Cytokines and inflammatory mediators25. Certolizumab Pegol has a Different Profile from the other Anti-TNFS, Including Golimumab, in a Variety of in Vitro Assays. Rheumatology vol. 50, (suppl_3) iii52-iii55.
10.1093/rheumatology/ker035
Pedone C, Napoli N, Pozzilli P, Rossi FF, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R(2011). Dietary pattern and bone density changes in elderly women: a longitudinal study. J Am Coll Nutr vol. 30, (2) 149-154.
10.1080/07315724.2011.10719954
Astorri E, Bombardi M, Peakman M, Pozzilli P, Pitzalis C (2011). EVOLUTION OF ECTOPIC LYMPHOID NEOGENESIS AND IN SITU AUTOANTIBODY PRODUCTION IN AUTOIMMUNE DIABETIC NOD MICE: CELLULAR AND MOLECULAR CHARACTERIZATION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC ISLETS. RHEUMATOLOGY. vol. 50, 52-53.
Guglielmi C, Pozzilli P(2011). Early Diagnosis of Type 1 Diabetes: Useful or a Phyrrhic Victory?. Clinical Dilemmas in Diabetes,
Napoli N, Costanza F, Di Stasio E, Strollo R, Manfrini S, Cipponeri E, Picardi A, Carrano F et al.(2011). Blood glucose monitoring in the normal population: the PREDICA study. Acta Diabetol vol. 48, (1) 29-34.
10.1007/s00592-010-0212-6
Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C (2011). EVOLUTION OF ECTOPIC LYMPHOID NEOGENESIS AND IN SITU AUTOANTIBODIES PRODUCTION IN AUTOIMMUNE DIABETIC NOD MICE: CELLULAR AND MOLECULAR CHARACTERISATION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC ISLETS. ANNALS OF THE RHEUMATIC DISEASES. vol. 70,
10.1136/ard.2010.148999.2
Pozzilli P, Maurizi AR(2011). Quale terapia precoce per il diabete autoimmune dell’adulto?. L'Endocrinologo vol. 12, (1) 2-7.
10.1007/bf03344774
Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R(2011). Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women. Bone vol. 48, (2)
10.1016/j.bone.2010.09.004
Bonafini BA, Pozzilli P(2011). Body weight and beauty: the changing face of the ideal female body weight. Obes Rev vol. 12, (1) 62-65.
10.1111/j.1467-789X.2010.00754.x
Palermo A, Napoli N, Manfrini S, Lauria A, Strollo R, Pozzilli P(2011). Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study. Diabetes Obes Metab vol. 13, (1) 42-46.
10.1111/j.1463-1326.2010.01312.x
Pozzilli P, Guglielmi C, Maggi D, Carlone A, Buzzetti R, Manfrini S(2011). Clinical update on the use of immuno modulators (antiCD3, GAD, Diapep277, anti-IL1) in type 1 diabetes. Curr Pharm Des vol. 17, (29) 3224-3228.
10.2174/138161211798157531
Pozzilli P, Strollo R, Napoli N(2011). Drug-Induced Endocrine Autoimmunity. Immunoendocrinology: Scientific and Clinical Aspects,
POZZILLI P, STROLLO, R, NAPOLI, N(2010). Iatrogenic immunoendocrinopathy. Immunoendocrinology: Scientific and Clinical Aspects, Editors: Eisenbarth, GS, Humana Pr Inc
Napoli N, Pedone C, Pozzilli P, Lauretani F, Ferrucci L, Incalzi RA(2010). Adiponectin and bone mass density: The InCHIANTI study. Bone vol. 47, (6) 1001-1005.
10.1016/j.bone.2010.08.010
Astorri E, Guglielmi C, Bombardieri M, Alessandri C, Buzzetti R, Maggi D, Valesini G, Pitzalis C et al.(2010). Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes. Horm Metab Res vol. 42, (13) 955-960.
10.1055/s-0030-1267206
Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C (2010). Evolution of ectopic lymphoid neogenesis and in-situ autoantibodies production in autoimmune diabetic NOD mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islet. IMMUNOLOGY. vol. 131, 63-63.
Pozzilli P, Guglielmi C(2010). Prevention of type 1 diabetes mellitus. Principles of Diabetes Mellitus,
Bizzarri C, Patera PI, Arnaldi C, Petrucci S, Bitti MLM, Scrocca R, Manfrini S, Portuesi R et al.(2010). Incidence of type 1 diabetes has doubled in Rome and the Lazio region in the 0- to 14-year age-group: a 6-year prospective study (2004-2009). Diabetes Care vol. 33, (11)
10.2337/dc10-1168
Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C(2010). Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J Immunol vol. 185, (6) 3359-3368.
10.4049/jimmunol.1001836
Maurizi A, Palermo A, Anguissola GB, Benevento D, Lauria A, Cipponeri H, Tuccinardi D, Manfrini S et al. (2010). A pocket instrument for calculating insulin need in the management of type 1 diabetes. DIABETOLOGIA. vol. 53,
Bruno G, Maule M, Merletti F, Novelli G, Falorni A, Iannilli A, Iughetti L, Altobelli E et al.(2010). Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes vol. 59, (9) 2281-2287.
10.2337/db10-0151
Pozzilli P, Ghirlanda G, Brennan AM, Belanger B, Mckee CM (2010). Fasting and stimulated C-peptide at aseline in DEFEND-1, a phase 3 study of otelixizumab in new onset type 1 diabetes. DIABETOLOGIA. vol. 53, S189-S190.
Portuesi R, Bohm BO, Julier C, Pozzilli P (2010). HLA and insulin genes: Bayesian networks confirm interaction between the two most important susceptibility genes in type 1 diabetes in a French caucasian population. DIABETOLOGIA. vol. 53, S77-S78.
Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG et al.(2010). No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care vol. 33, (9) 1962-1963.
10.2337/dc10-0814
Napoli N, Bizzarri C, Pitocco D, Suraci C, Altomare M, Sacchetti E, Valente L, Pozzilli P (2010). Osteocalcin and its effect on metabolic control in type 1 diabetes. DIABETOLOGIA. vol. 53,
Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Seissler J et al. (2010). Proinflammatory and regulatory cytokines are similar in type 1 diabetes (T1D) and LADA and lower compared to type 2 diabetes (T2D) patients: results from Action LADA Study. DIABETOLOGIA. vol. 53, S184-S185.
Hilner JE, Perdue LH, Sides EG, Pierce JJ, Wägner AM, Aldrich A, Loth A, Albret L et al.(2010). Designing and implementing sample and data collection for an international genetics study: The Type 1 Diabetes Genetics Consortium (T1DGC). Clinical Trials vol. 7, (1_suppl) S5-S32.
10.1177/1740774510373497
Occhicone F, Quattrocchi CC, Napoli N, Dell'Aia P, D'Agostino F, Pozzilli P, Beomonte Zobel B(2010). Incidence of new fractures in women with osteoporosis-induced vertebral fractures detected on routine lateral chest radiographs. Radiol Med vol. 115, (5) 815-825.
10.1007/s11547-010-0564-6
Valorani MG, Germani A, Otto WR, Harper L, Biddle A, Khoo CP, Lin WR, Hawa MI et al.(2010). Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential. Cell Tissue Res vol. 341, (1) 111-120.
10.1007/s00441-010-0982-8
Bizzarri C, Pitocco D, Napoli N, Maggi D, Suraci C, Di Stasio E, Anguissola GB, Pozzilli P et al. (2010). A Double-Blind Trial with Calcitriol in Recent Onset Type 1 Diabetes (IMDIAB XIII). DIABETES. vol. 59, A88-A88.
Maurizi AR, Palermo A, Anguissola GB, Benevento D, Pantano AL, Cipponeri E, Tuccinardi D, Manfrini S et al. (2010). A Novel Insulin Unit Calculator for the Management of Type 1 Diabetes. DIABETES. vol. 59, A539-A539.
10.1089/dia.2010.0190
Zampetti S, Spoletini M, Petrone A, Capizzi M, Arpi ML, Tiberti C, Di Pietro S, Bosi E et al.(2010). Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). Diabet Med vol. 27, (6) 701-704.
10.1111/j.1464-5491.2010.02997.x
Benevento D, Bizzarri C, Pitocco D, Crinò A, Moretti C, Spera S, Tubili C, Costanza F et al.(2010). Computer use, free time activities and metabolic control in patients with type 1 diabetes. Diabetes Res Clin Pract vol. 88, (3) e32-e34.
10.1016/j.diabres.2010.03.016
Khazrai YM, Cacciapaglia F, Sellaci T, Benevento D, Fioriti E, Manfrini S, Pozzilli P (2010). Dietary and Lifestyle Differences between an Urban and a Rural Population in Central Italy. DIABETES. vol. 59, A679-A679.
Maggi D, Camera E, Abril E, Picardo M, Maurizi AR, Manfrini S, Pozzilli P (2010). Effects of a Loofa Scrub Soap Prepared from Dead Sea for Care of Diabetic Foot. DIABETES. vol. 59, A628-A629.
Khazrai YM, Cacciapaglia F, Manfrini S, Bodoni G, Gillanti G, Lorubbio A, Leto G, Buzzetti R et al. (2010). Empowering People with Diabetes Is a Key for Optimal Disease Management. DIABETES. vol. 59, A602-A602.
Spoletini M, Maggi D, Zampetti S, Astorri E, Buzzetti R, Pozzilli P, Imdiab Grp (2010). OCA2 Gene Polymorphisms Are Associated with Specific Eye Colour and Skin Phenotype in Type 1 Diabetes. DIABETES. vol. 59, A330-A331.
Napoli N, Zardi E, Strollo R, Arigliani M, Guglielmi C, Tosi D, Daverio A, Scarpa F et al. (2010). The Effect of a Dietary Education Program in a Diabetic Population from Sub-Saharian Africa. DIABETES. vol. 59, A275-A275.
Napoli N, Strollo R, Pozzilli P (2010). CALCITIOL ADMINISTRATION IN TYPE 1 DIABETIC ADOLESCENTS: DOES IT IMPROVE OR IMPAIR BONE HEALTH?. OSTEOPOROSIS INTERNATIONAL. vol. 21, 309-309.
Pozzilli P, Leslie RD, Chan J, De Fronzo R, Monnier L, Raz I, Del Prato S(2010). The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach. Diabetes Metab Res Rev vol. 26, (4) 239-244.
10.1002/dmrr.1092
Cardwell CR, Stene LC, Joner G, Davis EA, Cinek O, Rosenbauer J, Ludvigsson J, Castell C et al.(2010). Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Diabetologia vol. 53, (4) 641-651.
10.1007/s00125-009-1648-5
Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R(2010). Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women. Bone vol. 46, (4) 1063-1067.
10.1016/j.bone.2009.11.031
Napoli N, Strollo R, Tosi D, Daverio A, Arigliani M, Mottini G, Pozzilli P(2010). The effect of dietary education on metabolic control and vascular impairment in a diabetic population from sub-saharian Africa. ENDOCR J vol. 57, S358-S359.
Cardwell CR, Stene LC, Joner G, Bulsara MK, Cinek O, Rosenbauer J, Ludvigsson J, Jané M et al.(2010). Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies. Diabetes vol. 59, (2) 486-494.
10.2337/db09-1166
Pozzilli P, Raskin P, Parkin CG(2010). Review of clinical trials: update on oral insulin spray formulation. Diabetes Obes Metab vol. 12, (2) 91-96.
10.1111/j.1463-1326.2009.01127.x
Pozzilli P(2010). NEW CURATIVE TREATMENT FOR TYPE 1 DIABETES. CHILD CARE HLTH DEV vol. 36, 14-14.
Pozzilli P, Guglielmi C(2010). Prevention of Type 1 Diabetes Mellitus. Principles of Diabetes Mellitus,
Napoli N, Mottini G, Arigliani M, Creta A, Giua R, Incammisa A, Carotti S, Sihom F et al.(2010). Unexpectedly high rates of obesity and dysglycemia among villagers in Cameroon. Diabetes Metab Res Rev vol. 26, (1) 10-12.
10.1002/dmrr.1036
Pozzilli P, Strollo R, Barchetta I(2009). Natural history and immunopathogenesis of type 1 diabetes. Endocrinol Nutr vol. 56 Suppl 4, 50-52.
10.1016/s1575-0922(09)73519-3
Cernea S, Buzzetti R, Pozzilli P (2009). Beta-cell protection and therapy for latent autoimmune diabetes in adults. Diabetes Care. vol. 32 Suppl 2, S246-S252.
10.2337/dc09-S317
Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P et al.(2009). Challenges in developing endpoints for type 1 diabetes intervention studies. Diabetes Metab Res Rev vol. 25, (8) 694-704.
10.1002/dmrr.1002
Barchetta I, Cavallo MG, Angelico F, Del Ben M, Fraioli A, Morini S, Pozzilli P (2009). HYPOVITAMINOSIS D IS ASSOCIATED WITH MILD NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME'S COMPONENTS IN DYS-METABOLIC ADULT PATIENTS. HEPATOLOGY. vol. 50, 797A-797A.
Buzzetti R, Cernea S, Petrone A, Spoletini M, Zampetti S, Guglielmi C, Venditti C, Pozzilli P (2009). C-Peptide response and HLA genotypes in subjects with recent onset type 1 diabetes following immunotherapy with diapep277. DIABETOLOGIA. vol. 52, S192-S193.
Napoli N, Pitocco D, Di Stasio E, Bizzarri C, Maggi D, Strollo R, Barchetta I, Suraci C et al. (2009). Calcitriol administration in the youth reduces bone turnover and may prevent bone loss in type 1 diabetes. DIABETOLOGIA. vol. 52, S347-S347.
Di Gialleonardo V, de Vries EFJ, Chianelli M, Wolffenbuttel BHR, De Vos P, Pozzilli P, Dierckx RA, Signore A (2009). F-18-Interleukin-2, a novel radioactive probe for insulitis imaging by PET. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. vol. 36, S211-S211.
Palermo A, Napoli N, Costanza F, Beretta G, Manfrini S, Pozzilli P (2009). Management of impaired glucose tolerance using buccal spray insulin. DIABETOLOGIA. vol. 52, S373-S373.
Fallucca F, Pozzilli P(2009). Physical exercise, public health and quality of life in diabetes. Diabetes Metab Res Rev vol. 25 Suppl 1, S1-S3.
10.1002/dmrr.990
Pronina E, Guglielmi C, Petraikina H, Antsiferov M, Duchareva O, Pozzilli P (2009). Rapid GlucoseSpray: an innovative tool to control hypoglycaemia and improve HbA(1c) in children with type 1 diabetes. DIABETOLOGIA. vol. 52, S346-S346.
Pozzilli P, Spoletini M, Zampetti S, Capizzi M, Kyanvash S, Venditti C, Buzzetti R, IMDIAB Grp (2009). Similar frequencies of HLA risk genotypes in type 1 diabetes over the past six decades in a southern European Caucasian population. DIABETOLOGIA. vol. 52, S120-S120.
Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G et al.(2009). Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nature Genetics vol. 41, (6) 703-707.
10.1038/ng.381
Napoli N, Pozzilli P, Rini GB, Armamento-Villareal R(2009). HIGH PREVALENCE OF LOW VITAMIN D AND MUSCULOSKELETAL COMPLAINTS IN WOMEN WITH BREAST CANCER: THE IMPLICATIONS FOR AROMATASE INHIBITOR THERAPY. Maturitas vol. 63,
10.1016/s0378-5122(09)70364-0
Napoli N, Rini GB, Pozzilli P, Armamento-Villareal R(2009). THE A ALLELE AT VALINE80 OF THE CYP19 GENE IS A RISK FACTOR FOR AROMATASE INHIBITORS ASSOCIATED BONE LOSS. Maturitas vol. 63,
10.1016/s0378-5122(09)70098-2
Beyan H, Buckley LR, Bustin SA, Yousaf N, Pozzilli P, Leslie RD(2009). Altered monocyte cyclo-oxygenase response in non-obese diabetic mice. Clin Exp Immunol vol. 155, (2) 304-310.
10.1111/j.1365-2249.2008.03825.x
Khoo CP, Valorani MG, Brittan M, Alison MR, Warnes G, Johansson U, Hawa M, Pozzilli P(2009). Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies. Diabetes Metab Res Rev vol. 25, (1) 89-93.
10.1002/dmrr.898
Pozzilli P, Guglielmi C(2009). Double diabetes: a mixture of type 1 and type 2 diabetes in youth. Endocr Dev vol. 14, 151-166.
10.1159/000207484
Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R et al.(2009). Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care vol. 32, (1) 160-164.
10.2337/dc08-1419
https://qmro.qmul.ac.uk/xmlui/handle/123456789/19764
Khoo CP, Pozzilli P, Alison MR(2008). Endothelial progenitor cells and their potential therapeutic applications. Regen Med vol. 3, (6) 863-876.
10.2217/17460751.3.6.863
Picardi A, Cipponeri E, Bizzarri C, Fallucca S, Guglielmi C, Pozzilli P(2008). Menarche in type 1 diabetes is still delayed despite good metabolic control. Fertil Steril vol. 90, (5) 1875-1877.
10.1016/j.fertnstert.2007.09.035
Cernea S, Pozzilli P(2008). New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes. Diabet Med vol. 25, (11) 1259-1267.
10.1111/j.1464-5491.2008.02556.x
Leslie RDG, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C et al.(2008). Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev vol. 24, (7) 511-519.
10.1002/dmrr.877
Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM et al.(2008). Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care vol. 31, (10) 1966-1971.
10.2337/dc07-2451
Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N et al.(2008). on behalf of the Action LADA Group: Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. (vol 31, pg 439, 2008). DIABETES CARE vol. 31, (10) 2077-2077.
Guglielmi C, Astorri E, Portuesi R, Bombardieri M, Valorani M, Pozzilli P(2008). A diet rich in protein and poor in starch with reduced food intake prevents diabetes in the NOD moose: the significance of Reg gene expression in the pancreas. DIABETOLOGIA vol. 51, S229-S229.
Astorri E, Bombardieri M, Guglielmi C, Pitzalis C, Pozzilli P(2008). Beta cell regeneration in type 1 diabetes: the role of Reg genes in NOD mice. DIABETOLOGIA vol. 51, S186-S186.
Bizzarri C, Benevento D, Pitocco D, Crino A, Spera S, Tubili C, Costanza F, Maurizi A et al.(2008). Free time activities and blood glucose control in patients with type 1 diabetes. DIABETOLOGIA vol. 51, S419-S419.
Pronina E, Petraikina H, Antsiferov M, Duchareva O, Guglielmi C, Khazrai M, Pozzilli P (2008). Glucose RapidSpray (TM) for a new management of hypoglycaemia in children up to 5 years of age with type 1 diabetes. DIABETOLOGIA. vol. 51, S383-S383.
Khoo CP, Hill N, Valorani MG, Signore A, Pozzilli P(2008). Intracellular inhibition of JNK kinase reduces lymphocyte homing into endocrine pancreas of non obese diabetic (NOD) mouse. DIABETOLOGIA vol. 51, S228-S229.
Schloot NC, Hawa MI, Scherbaum WA, Pozzilli P, Leslie R, Seissler J, Action LADA Consortium(2008). Organ specific autoantibodies in patients with type 1 diabetes, LADA and type 2 diabetes. DIABETOLOGIA vol. 51, S235-S235.
Petrone A, Park Y, Genovese S, Woo JT, Giordano C, Lee KW, Pontiroli AE, Paik SH et al.(2008). Similarities and differences between Caucasian and Asian LADA. DIABETOLOGIA vol. 51, S155-S156.
Cernea S, Moretti C, Tubili C, Suraci C, Pitocco D, Barchetta I, Manfrini S, Napoli N et al.(2008). The natural history of residual beta cell function in patients with type 1 diabetes under continuous subcutaneous insulin infusion therapy. DIABETOLOGIA vol. 51, S397-S397.
Hawa MI, Cipponeri E, Collier D, Loh Y, Pozzilli P, Brophy S, Hunter S, Thivolet C et al.(2008). The prevalence of metabolic syndrome is much less in LADA and type 1 diabetes than type 2 diabetes: ACTION LADA 3. DIABETOLOGIA vol. 51, S155-S155.
Pronina EA, Petraikina EE, Antsiferov MB, Duchareva OV, Petrone A, Buzzetti R, Pozzilli P(2008). A 10-year (1996-2005) prospective study of the incidence of Type 1 diabetes in Moscow in the age group 0-14 years. Diabet Med vol. 25, (8) 956-959.
10.1111/j.1464-5491.2008.02508.x
Cavallo MG, Pozzilli P, Misiti S, Baroni MG(2008). Insulinoma CM cell line as in vitro model for beta-cell. J Cell Physiol vol. 216, (2)
10.1002/jcp.21409
Cacciapaglia F, Arcarese L, Rigon A, Vadacca M, Valorani MG, Pozzilli P, Afeltra A(2008). Antinuclear antibodies prevalence in Filipinos migrated to Italy. Eur Rev Med Pharmacol Sci vol. 12, (4) 267-270.
Gentilucci UV, Picardi A, Manfrini S, Khazrai YM, Fioriti E, Altomare M, Guglielmi C, Di Stasio E et al.(2008). Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension. Diabetes Metab Res Rev vol. 24, (5) 364-370.
10.1002/dmrr.807
Vadacca M, Valorani MG, Humphreys R, Kallinteris N, Valente L, Pozzilli P (2008). Detection of T cell response to insulin and GAD in Type 1 diabetes using the Ii-Key-hybrid technique. DIABETES. vol. 57, A18-A18.
Guglielmi C, Astorri E, Bizzarri C, Suraci C, Pitocco D, Morviducci L, Buzzetti R, Pozzilli P et al. (2008). High prevalence of double diabetes in a Caucasian population. DIABETES. vol. 57, A273-A274.
Picardi A, Costanza F, Di Stasio E, Napoli N, Carrano F, Dell'Anna V, Macin W, Pozzilli P (2008). The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population. DIABETES. vol. 57, A674-A675.
Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R et al.(2008). The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control. Diabetes Care vol. 31, (6) 1214-1218.
10.2337/dc07-1158
Khazrai M, Cacciapaglia F, Picardi A, Anguissola GB, Guglielmi C, Manfrini S, Pozzilli P (2008). Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia. DIABETES. vol. 57, A564-A564.
Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, Parslow RC, Pozzilli P et al.(2008). Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia vol. 51, (5) 726-735.
10.1007/s00125-008-0941-z
Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A, Lorini R, Pozzilli P et al.(2008). Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum Immunol vol. 69, (4-5) 291-300.
10.1016/j.humimm.2008.02.003
Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P et al.(2008). The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care vol. 31, (3) 534-538.
10.2337/dc07-1457
Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N et al.(2008). Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care vol. 31, (3) 439-441.
10.2337/dc07-1308
Chianelli M, Parisella MG, Visalli N, Mather SJ, D'Alessandria C, Pozzilli P, Signore A, IMDIAB study group(2008). Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy. Diabetes Metab Res Rev vol. 24, (2) 115-122.
10.1002/dmrr.767
Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC et al.(2008). Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function. Horm Metab Res vol. 40, (1) 66-68.
10.1055/s-2007-993217
Brophy S, Yderstræde K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schoot N et al.(2008). Errata. Diabetes Care vol. 31, (10)
10.2337/dc08-er10
Pronina E, Petraikina H, Antsiferov M, Duchareva O, Guglielmi C, Merola MY, Pozzilli P(2008). Treatment of Hypoglycaemia in Very Young Children (< 5 Years of Age) with Type 1 Diabetes Using the Glucose RapidSpray™. Canadian Journal of Diabetes vol. 32, (4)
10.1016/s1499-2671(08)24225-5
Merriman T, Twells R, Merriman M, Eaves I, Cox R, Cucca F, McKinney P, Shield J et al.(2007). Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21 (vol 6, pg 1003, 1997). HUM MOL GENET vol. 16, (24) 3197-3197.
10.1093/hmg/ddm307
Pozzilli P, Guglielmi C, Pronina E, Petraikina E(2007). Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths. Pediatr Diabetes vol. 8 Suppl 9, 88-95.
10.1111/j.1399-5448.2007.00338.x
Spoletini M, Petrone A, Zampetti S, Capizzi M, Zavarella S, Osborn J, Foffi C, Tuccinardi D et al.(2007). Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis. Diabet Med vol. 24, (12) 1487-1490.
10.1111/j.1464-5491.2007.02292.x
Guglielmi C, Battistoni F, Valente L, Astorri E, Valorani MG, Pitocco D, Pozzilli P, IMDIAB Grp(2007). Circulating Reg1-alpha plasma levels as potential marker of beta cell regeneration in type 1 diabetes. ACTA DIABETOL vol. 44, S18-S19.
Vadacca M, Valorani G, Humphreys R, Kallinteris N, Valente L, D'Agostino G, Pozzilli P, IMDIAB Grp (2007). Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes. DIABETOLOGIA. vol. 50, S30-S30.
Khoo CP, Valorani MG, Brittan M, Alison MR, Guglielmi C, Warnes G, Johansson U, Hawa MI et al. (2007). Isolation, characterisation and prospects of endothelial progenitor cells to aid pancreatic beta cell regeneration. DIABETOLOGIA. vol. 50, S221-S222.
Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, Francesconi A, Calatola P et al. (2007). Italian experience trial for the implementation of insulin glargine in basal-bolus regimen in patients with type 1 diabetes. DIABETOLOGIA. vol. 50, S394-S394.
Spoletini M, Petrone A, Capizzi M, Zavarella S, Zampetti S, Leto G, Alemanno I, Pozzilli P et al. (2007). Low risk HLA genotype is associated with less destruction of beta cells persisting 12 months after diagnosis. DIABETOLOGIA. vol. 50, S133-S133.
Petrone A, Spoletini M, Capizzi M, Zampetti S, Zavarella S, Venditti C, Foffi C, Alemanno I et al. (2007). The PTPN22 1858T gene variant is associated with reduced residual insulin secretion and worst metabolic control in type 1 diabetes. DIABETOLOGIA. vol. 50, S113-S113.
Locatelli M, Buzzetti R, Galgani A, Montemari AL, Khazrai M, Petrone A, Visalli N, Meschi F et al.(2007). Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). Diabet Med vol. 24, (8) 916-919.
10.1111/j.1464-5491.2007.02192.x
Maggi D, Berardesca E, Marulli G, Manfrini S, Bizzarri C, Lauria A, Pitocco D, Pozzilli P (2007). Blue eyes and fair skin are risk factors for type 1 diabetes in the Mediterranean region. DIABETES. vol. 56, A267-A267.
Khazrai YM, Manfrini S, Cacciapaglia F, Spallina F, Picardi A, Spera S, Benevento D, Pozzilli P (2007). Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes. DIABETES. vol. 56, A41-A41.
Picardi A, Merola YM, Altomare M, Visalli N, Cipponeri E, Pozzilli P (2007). Glucose rapidspray, a new tool to control progression towards hypoglycaemia. DIABETES. vol. 56, A128-A128.
Napoli N, Arigliani M, Creta A, Giua R, Incam-Misa A, Mottini G, Carotti C, Sihom F et al. (2007). High prevalence of diabetes, impaired glucose tolerance and increased body weight in a rural population of sub-Saharian Africa despite lack of known risk factors. DIABETES. vol. 56, A632-A632.
Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, Francesconi A, Calatola P et al. (2007). Italian experience trial for the implementation of LANTUS in basal-bolus regimen in patients with type 1 diabetes. DIABETES. vol. 56, A558-A558.
Pozzilli P, Lauria A(2007). Quali fattori aumentano l’incidenza del diabete di tipo 1 in Italia. L'Endocrinologo vol. 8, (2) 80-84.
10.1007/bf03344567
Guglielmi C, Battistoni F, Valente L, Astorri E, Valorani MG, Pozzilli P, Imdiab G (2007). Raised levels of reg1-alpha in sera of subjects with type I diabetes: Evidence for beta cell regeneration. DIABETES. vol. 56, A323-A323.
Khazrai YM, Altomare M, Visalli N, Cipolloni L, Maurizi AM, Pozzilli P (2007). Reduction of body weight through diet and the use of glucose rapidspray. DIABETES. vol. 56, A463-A463.
Åkerblom HK, Knip M, Becker D, Dosch HM, Dupré J, Ilonen J, Kriseher JP, Craig MM et al.(2007). The TRIGR trial: Testing the potential link between weaning diet and type 1 diabetes. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry vol. 7, (3) 251-263.
10.2174/187152207780832315
Pozzilli P(2007). Immuno-intervention and preservation of beta-cell function in type 1 diabetes. Diabetes Metab Res Rev vol. 23, (4) 255-256.
10.1002/dmrr.746
Pozzilli P, Buzzetti R(2007). A new expression of diabetes: double diabetes. Trends Endocrinol Metab vol. 18, (2) 52-57.
10.1016/j.tem.2006.12.003
Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P et al.(2007). Raised C-reactive protein levels in patients with recent onset type 1 diabetes. Diabetes Metab Res Rev vol. 23, (3) 211-214.
10.1002/dmrr.671
Pitocco D, Pozzilli P(2007). Authors' response [4]. Diabetic Medicine vol. 24, (2) 219-220.
10.1111/j.1464-5491.2007.2065_1.x
Pitocco D, Pozzilli P(2007). Authors’ response. Diabetic Medicine vol. 24, (2) 220-220.
10.1111/j.1464-5491.2007.2065_2.x
Pitocco D, Pozzilli P, IMDIAB Grp(2007). The effects of calcitriol and nicotinamide on residual pancreatic beta-cell funtion in patients with recent-onset Type 1 diabetes (IMDIAB XI) - Response. DIABETIC MED vol. 24, (2) 219-220.
10.1111/j.1464-5491.2007.2065_1.x
Papavramidou N, Christopoulou-Aletra H, Pozzilli P(2007). Endocrinology and art. J ENDOCRINOL INVEST vol. 30, (1) 83-83.
10.1007/BF03347401
Christopoulou-Aletra H, Papavramidou N, Pozzilli P(2007). Goitrous beauty in Artemisia Gentileschi's Judith and her Maidservant. Thyroid vol. 17, (1) 37-38.
10.1089/thy.2006.0223
Gentilucci UV, Picardi A, Pozzilli P(2006). Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis: response to Lecube et al. Diabetes Care vol. 29, (11) 2558-2559.
10.2337/dc06-1374
Pozzilli P, Guglielmi C (2006). Immunomodulation for the prevention of SPIDDM and LADA. Ann N Y Acad Sci. vol. 1079, 90-98.
10.1196/annals.1375.012
Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C et al.(2006). Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes. Horm Metab Res vol. 38, (10) 668-672.
10.1055/s-2006-954586
Manfrini S, Bruni R, Terminio N, Khazrai M, Sandri G, Benevento D, Spera S, Ganz M et al. (2006). Alexithymia in type 1 diabetes and coeliac disease. DIABETOLOGIA. vol. 49, 531-532.
Vadacca M, Valorani G, Humphreys RE, Kallinteris N, Valente L, Pozzilli P, Group I (2006). Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes. DIABETOLOGIA. vol. 49, 165-166.
Spoletini M, Petrone A, Zampetti S, Alemanno I, Capizzi M, Zavarella S, Bizzarri C, Pozzilli P et al. (2006). Preservation of beta cell secretion in T1DM subjects with low risk HLA genotype. DIABETOLOGIA. vol. 49, 444-445.
Mandrup-Poulsen TR, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lalic NM, Martinez-Larrad MT, Mauricio D et al. (2006). The European C-Peptide Trial CPT: comparison of liquid mixed meal and glucagon stimulation assays for the analysis of residual beta cell function in type 1 diabetes. DIABETOLOGIA. vol. 49, 375-376.
Petrone A, Capizzi M, Giaccari A, Bosi E, Cucinotta D, Cossu E, Suraci C, Falorni A et al. (2006). The Protein Tyrosine Phosphatase Non receptor (PTPN22) is associated with high GAD antibody titre in adult-onset autoimmune diabetes (The NIRAD Study). DIABETOLOGIA. vol. 49, 183-184.
Prisco F, Picardi A, Iafusco D, Lorini R, Minicucci L, Martinucci ME, Toni S, Cerutti F et al.(2006). Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Pediatr Diabetes vol. 7, (4) 223-228.
10.1111/j.1399-5448.2006.00187.x
Bessaoud K, Boudraa G, de Ropolo MM, de Sereday M, Marti ML, Moser M, Lapertosa S, Damiano M et al.(2006). Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. DIABETIC MED vol. 23, (8) 857-866.
10.1111/j.1464-5491.2006.01925.x
Christopoulou-Aletra H, Papavramidou N, Pozzilli P(2006). Obesity in the Neolithic era: a Greek female figurine. Obes Surg vol. 16, (8) 1112-1114.
10.1381/096089206778026334
Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N et al.(2006). The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med vol. 23, (8) 920-923.
10.1111/j.1464-5491.2006.01921.x
Pozzilli P, Astorri E, Bizzari C, Cappa M, De Rossi G, Leslie RDG, Hawa M, Spoletini ML et al. (2006). GAD, IA2 and insulin autoantibodies in children diagnosed with acute lymphoblastic leukaemia: Relevance for type 1 diabetes. DIABETES. vol. 55, A412-A412.
Vadacca M, Valeri C, Gigante A, Guglielmi C, Pozzilli P, Action LADA Grp (2006). Gender differences and the metabolic syndrome in patients with type 2 diabetes with or without auioantibodies to glutamic acid decarboxilase (GAD). DIABETES. vol. 55, A283-A283.
Vadacca M, Humphreys RE, Kallinteris NL, Valente L, Valorani G, Pozzilli P, IMDIAB Grp (2006). Ii-key/insulin MHC class-II antigenic epitope peptides in type 1 diabetes. DIABETES. vol. 55, A88-A88.
Yeganeh MK, Cacciapaglia F, Beretta G, Altomare M, Cherubini V, Suraci C, Pozzilli P, Trigr Study Grp (2006). Pregnancy and offspring outcomes in families with one parent affected by type 1 diabetes. DIABETES. vol. 55, A607-A607.
Pozzilli P, Palermo A, Manfrini S, Fioriti E, Visalli N, Suraci C, Picardi A, IMDIAB Grp (2006). Prevalence of the metabolic syndrome in type 1 diabetes. DIABETES. vol. 55, A233-A233.
Leslie RDG, Williams R, Pozzilli P(2006). Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab vol. 91, (5) 1654-1659.
10.1210/jc.2005-1623
Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RFL, Chen L, Warnock GL(2006). Suppression of Human T-Cell Responses to β-Cells by Activation of B7-H4 Pathway. Cell Transplant vol. 15, (5) 399-410.
10.3727/000000006783981837
Genovese S, Bazzigaluppi E, Gonçalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM et al.(2006). Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol vol. 154, (3) 441-447.
10.1530/eje.1.02115
Hawa MI, Picardi A, Costanza F, D'Avola D, Beretta Anguissola G, Guglielmi C, Mottini G, Fezeu L et al.(2006). Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon. Clin Immunol vol. 118, (2-3) 229-232.
10.1016/j.clim.2005.09.016
Pozzilli P, Valeri C, Gigante A, Group TI(2006). Gender related differences in patients with type 2 diabetes with or without autoantibodies to glutamic acid decarboxilase (GAD). Gender Medicine vol. 3,
10.1016/s1550-8579(06)80143-9
Pozzilli P(2006). Prevention of diabetes in children. HORM RES vol. 65, 9-9.
Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RFL, Chen L, Warnock GL(2006). Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant vol. 15, (5) 399-410.
10.3727/000000006783981837
Pozzilli P, Manfrini S, Crinò A, Picardi A, Leomanni C, Cherubini V, Valente L, Khazrai M et al.(2005). Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res vol. 37, (11) 680-683.
10.1055/s-2005-870578
Crinó A, Schiaffini R, Ciampalini P, Suraci MC, Manfrini S, Visalli N, Matteoli MC, Patera P et al.(2005). A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus. J Pediatr Endocrinol Metab vol. 18, (8) 749-754.
10.1515/jpem.2005.18.8.749
Pozzilli P, Manfrini S, Costanza F, Coppolino G, Cavallo MG, Fioriti E, Modi P(2005). Biokinetics of buccal spray insulin in patients with type 1 diabetes. Metabolism vol. 54, (7) 930-934.
10.1016/j.metabol.2005.02.008
Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RFL et al.(2005). Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB. Hum Immunol vol. 66, (7) 799-809.
10.1016/j.humimm.2005.03.009
Pozzilli P(2005). Genetic Screening and Prevention of Type 2 Diabetes. Prevention of Type 2 Diabetes,
Pozzilli P, Manfrini S, Buzzetti R, Lampeter E, Leeuw ID, Iafusco D, Prisco M, Ionescu-Tirgoviste C et al.(2005). Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study. Diabetes Res Clin Pract vol. 68, (3) 258-264.
10.1016/j.diabres.2004.10.001
Petrone A, Galgani A, Spoletini M, Alemanno I, Di Cola S, Bassotti G, Picardi A, Manfrini S et al.(2005). Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype. Diabetes Metab Res Rev vol. 21, (3) 271-275.
10.1002/dmrr.549
Ou D, Wang X, Metzger DL, James RFL, Pozzilli P, Plesner A, Korneluk RG, Verchere CB et al.(2005). Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis. Hum Immunol vol. 66, (3) 274-284.
10.1016/j.humimm.2004.12.002
Pozzilli P, Khazrai YM(2005). "La Monstrua Vestida", a case of Prader-Willi syndrome. J Endocrinol Invest vol. 28, (2)
10.1007/BF03345368
Vadacca M, Valorani MG, Valente L, Humpreys RE, Pozzilli P (2005). A novel approach to study T cell response to Ii-KEY/MHC class II epitope hybrid peptides in type 1 diabetes. DIABETOLOGIA. vol. 48, A99-A99.
Manfrini S, Bruni R, Terminio N, Poterzio F, Ricci S, Sforza S, Pantano AL, Costanza E et al. (2005). Alexithymia in subjects with type 1 diabetes. DIABETOLOGIA. vol. 48, A323-A324.
Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, Chen L, Warnock GL (2005). B7-H4.Ig inhibits human beta-cell destruction mediated by beta cell-specific cytotoxic T cells derived from patients with type 1 diabetes. DIABETES. vol. 54, A311-A311.
POZZILLI P, Warnock G, Ou D, Chen L, Ao Z, Metzger DL, Wang X, James RFL(2005). Induction of human T-cell tolerance to B cells by activation of B7-H4 pathway. Human Immunology
Spoletini ML, Petrone A, Galgani A, Di Cola S, Guglielmi C, Picardi A, Manfrini S, Pozzilli P et al. (2005). Insulin secretion at diagnosis of type 1 diabetes is associated with both age of onset and HLA class II. DIABETES. vol. 54, A276-A276.
Locatelli M, Buzzetti R, Galgani A, Montemari A, Lorini R, Meschi F, Bottazzo G, Pozzilli P (2005). Investigation of risk factors associated with different HLA genotypes of susceptibility to type 1 diabetes. DIABETES. vol. 54, A276-A277.
Valiante S, Barchetta I, Calabria M, Leomanni C, Manfrini S, Hawa M, Leslie D, Pozzilli P et al. (2005). Prevalence of GAD antibodies in diabetic patients with or without the metabolic syndrome. DIABETES. vol. 54, A310-A310.
Picardi A, Valorani MG, Cio-Fini O, Manfrini S, D'Avola D, Valente L, Cappa M, Pozzilli P et al. (2005). Raised C-reactive protein in recent onset type 1 diabetes. DIABETES. vol. 54, A176-A176.
Lorini R, Minicucci L, Napoli F, Padovani P, Bazzigaluppi E, Tortoioli C, Cherubini V, Bottazzo G et al.(2005). Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefin Italy)--preliminary data. Acta Biomed vol. 76 Suppl 3, 31-35.
Carle F, Gesuita R, Bruno G, Coppa GV, Falorni A, Lorini R, Martinucci ME, Pozzilli P et al.(2004). Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. Diabetes Care vol. 27, (12) 2790-2796.
10.2337/diacare.27.12.2790
Valeri C, Pozzilli P, Leslie D(2004). Glucose control in diabetes. Diabetes Metab Res Rev vol. 20 Suppl 2, S1-S8.
10.1002/dmrr.512
Monetini L, Cavallo MG, Sarugeri E, Sentinelli F, Stefanini L, Bosi E, Thorpe R, Pozzilli P et al.(2004). Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin. Diabetologia vol. 47, (10) 1795-1802.
10.1007/s00125-004-1521-5
Khazrai Y, Manfrini S, Pozzilli P(2004). Diet and diabetes. Functional Foods, Cardiovascular Disease and Diabetes,
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S et al.(2004). A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes (vol 36, pg 837, 2004). NAT GENET vol. 36, (9) 1024-1024.
10.1038/ng0904-1024b
Hawa MI, Valorani MG, Buckley LR, Beales PE, Afeltra A, Cacciapaglia F, Leslie RD, Pozzilli P(2004). Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse. Horm Metab Res vol. 36, (9) 620-624.
10.1055/s-2004-825926
Valorani MG, Hawa MI, Buckley LR, Afeltra A, Cacciapaglia F, Pozzilli P(2004). The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans. Diabetes Metab Res Rev vol. 20, (5) 394-398.
10.1002/dmrr.463
(2004). 40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004. Diabetologia vol. 47, (Suppl 1) A1-A464.
10.1007/BF03375463
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S et al.(2004). A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet vol. 36, (8) 837-841.
10.1038/ng1391
Beyan H, Valorani GM, Imdiab G, Pozzilli P, Leslie RDG (2004). Abnormalities in plasma 1,25-dihydroxyvitamin D3, and cellular 1-alpha hydroxylase and Cyclooxygenase-2 mRNA levels in recent-onset type 1 diabetes. DIABETOLOGIA. vol. 47, A188-A188.
Ola TO, Hawa MI, Beck-Nielsen H, Buzzetti R, Scherbaum W, Kolb H, Tuomilehto J, Thivolet C et al. (2004). Action LADA a multinational European project in latent autoimmune diabetes in adults. DIABETOLOGIA. vol. 47, A113-A113.
Pozzilli P, Pitocco D, Visalli N, Spera S, Corbi S, Suraci C, Crino A, Patera P et al. (2004). C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age at onset of Type 1 diabetes. DIABETOLOGIA. vol. 47, A299-A299.
Pitocco D, Visalli N, Crino A, Costantino F, Manfrini S, Spera S, Suraci C, Patera P et al. (2004). Calcitriol versus nicotinamide in patients with recent onset Type 1 diabetes: IMDIAB XI randomised trial. DIABETOLOGIA. vol. 47, A185-A186.
Anguissola GB, Totonelli A, D'Avola D, Longhitano S, Costanza F, Fioriti E, Agro F, Pozzilli P (2004). Continuous glucose monitoring for the evaluation of peri-operative stress in patients with Type 2 diabetes, impaired glucose tollerance and normal subjects. DIABETOLOGIA. vol. 47, A309-A309.
Khazrai YM, Manfrini S, Pozzilli P(2004). Diet and diabetes: Prevention and control. Functional Foods, Cardiovascular Disease and Diabetes,
Guglielmi C, Galgani A, Anguissola GB, D'Avola D, Pozzilli P (2004). Different HLA pattern in patients affected by LADA in Congo, central Africa. DIABETOLOGIA. vol. 47, A130-A130.
Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS et al.(2004). C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop (vol 53, pg 250, 2004). DIABETES vol. 53, (7) 1934-1934.
Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS et al.(2004). Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)). Diabetes vol. 53, (7)
10.2337/diabetes.53.7.1934
Pozzilli P, Visalli N, Picardi A, Manfrini S, Crino A, Suraci C, Pitocco D, Ghirlanda G et al. (2004). C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age of onset of type 1 diabetes. DIABETES. vol. 53, A603-A603.
Ou DW, Wang XJ, Metzger DL, James RFL, Pozzilli P, Plesner A, Korneluk RG, Verchere CB et al. (2004). Cytoprotection of pancreatic beta cells by co-overexpression of Bcl-2 and XIAP genes blocking TRAIL-mediated death-signal transduction pathways. DIABETES. vol. 53, A444-A444.
Gugielmi C, Galgani A, Beretta G, Davola D, Tshilolo L, Mottini G, Caro A, Spoletini M et al. (2004). Different HLA pattern in patients affected by LADA in Congo, central Africa. DIABETES. vol. 53, A536-A536.
Noble JA, Valdes AM, McGrue Q, Martin A, Galgani A, Di Cola S, Petrone A, Erlich HA et al. (2004). Genetics of type 1 diabetes in Italy: Variation among populations. DIABETES. vol. 53, A536-A536.
Lorini R, Minicucci L, Napoli F, Padovani P, Bazzigaluppi E, Cherubini V, Bottazzo G, Pozzilli P et al. (2004). HLA screening for type 1 diabetes at birth in the general population in Italy and implementation of a primary prevention trial with vitamin D and cow's milk hydrolysate. (The PREVEFIN trial). DIABETES. vol. 53, A299-A299.
Beyan H, Valorani MG, Valente L, Pozzilli P, Leslie RDG (2004). Plasma 1,25-dihydroxyvitamin D3,one-alpha hydroxylase and vitamin D receptor mRNA in patients with recent-onset type I diabetes. DIABETES. vol. 53, A296-A296.
Crinò A, Schiaffini R, Manfrini S, Mesturino C, Visalli N, Beretta Anguissola G, Suraci C, Pitocco D et al.(2004). A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX). Eur J Endocrinol vol. 150, (5) 719-724.
10.1530/eje.0.1500719
Pozzilli P(2004). Umberto Di Mario, 1948-2004, professor of Endocrinology at the University of Rome, La Sapienza, Co-editor of 'Diabetes and metabolism research and reviews', president of the Italian Society of Diabetes. DIABETES-METAB RES vol. 20, (3) 177-177.
10.1002/dmrr.484
Gentilucci UV, Picardi A, Manfiini S, D'Avola D, Costantino S, Pozzilli P(2004). Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis. Acta Biomed vol. 75, (1) 69-73.
Gale EAM, Bingley PJ, Knip M, Emmett CL, Swankie H, Fewell S, Kearsey P, Schober E et al.(2004). European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. LANCET vol. 363, (9413) 925-931.
10.1016/S0140-6736(04)15786-3
Buzzetti R, Galgani A, Petrone A, Del Buono ML, Erlich HA, Bugawan TL, Lorini R, Meschi F et al.(2004). Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study). Diabetes Metab Res Rev vol. 20, (2) 137-143.
10.1002/dmrr.426
Khazrai YM, Manfrini S, Pozzilli P(2004). 7 Diet and diabetes: prevention and control. Functional Foods, Cardiovascular Disease and Diabetes,
Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS et al.(2004). C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes vol. 53, (1) 250-264.
10.2337/diabetes.53.1.250
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S et al.(2004). Erratum: A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes (Nature Genetics (2004) 36 (837-841)). Nature Genetics vol. 36, (9)
10.1038/ng0904-1024b
Pozzilli P, Leomanni C, Merola KYM (2004). Immunointervention in Type 1 diabetes. PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY. 327-334.
Pozzilli P, Leslie RDG(2003). Infections, Immunity, and Diabetes. International Textbook of Diabetes Mellitus,
Noble JA, Valdes AM, McGrue Q, Galgani A, Petrone A, Di Cola S, Erlich HA, Pozzilli P et al. (2003). A study of DR-DQ matched T1D cases and controls in a continental Italian population reveals susceptibility effects of DPB1 and HLA-A alleles. AMERICAN JOURNAL OF HUMAN GENETICS. vol. 73, 523-523.
Pozzilli P, Manfrini S, Picardi A(2003). Cow's milk and trials for prevention of Type 1 diabetes. Diabet Med vol. 20, (11) 871-872.
10.1046/j.1464-5491.2003.01080.x
Signore A, Annovazzi A, Giacalone P, Beales PE, Valorani MG, Vestri AR, Ruberti G, Manfrini S et al.(2003). Reduced cumulative incidence of diabetes but not insulitis following administration of chimeric human IL-15-murine IgG2b in NOD mice. Diabetes Metab Res Rev vol. 19, (6) 464-468.
10.1002/dmrr.400
Pozzilli P, Leslie D(2003). Endocrinology and Art. Louise ou la Servante Bretonne. J Endocrinol Invest vol. 26, (10)
10.1007/BF03348207
Pozzilli P(2003). Blessed with exophthalmos in Michelangelo's Last judgment. QJM vol. 96, (9) 688-690.
10.1093/qjmed/hcg095
Mottini G, D'Avola D, Dimbelolo JC, Lumu R, Gallizioli E, Nisita J, Manfrini S, De Clerck M et al.(2003). A hospital survey of the clinical features of diabetes in Congo. Diabetes Nutr Metab vol. 16, (4) 236-242.
Buckley LR, Hawa MI, Beyan H, Valorani MG, Pozzilli P, Leslie RDG (2003). Altered monocyte cyclooygenase expression in non-obese diabetic mice. DIABETOLOGIA. vol. 46, A180-A180.
Visalli N, Sebastiani L, Adorisio E, Conte A, De Cicco AL, D'Elia R, Manfrini S, Pozzilli P et al.(2003). Environmental risk factors for type 1 diabetes in Rome and province. Arch Dis Child vol. 88, (8) 695-698.
10.1136/adc.88.8.695
Valdes A, Buzzetti R, Galgani A, Visalli N, Montemari AL, Bosi E, Meschi F, Lorini R et al. (2003). Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). DIABETOLOGIA. vol. 46, A113-A113.
Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA(2003). Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am J Hum Genet vol. 72, (6) 1505-1514.
10.1086/375655
Pozzilli P, Marchini F(2003). Puppet with a voluminous goiter. J Endocrinol Invest vol. 26, (6)
10.1007/BF03345226
Ou DW, Wang XJ, Metzger D, Jobin C, Chantler J, James R, Pozzilli P, Tingle A (2003). Regulation of TRAIL-mediated human beta-cells destruction by FADD and NF-kappa B. DIABETES. vol. 52, A423-A423.
Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B(2003). The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes. Eur J Immunogenet vol. 30, (3) 223-227.
10.1046/j.1365-2370.2003.00395.x
Visalli N, Crino A, Spera S, Costanza F, Fioriti E, Corbi S, Beretta G, Pozzilli P et al. (2003). The natural history of C-peptide secretion in the first year of type 1 diabetes. DIABETES. vol. 52, A277-A277.
Prisco F, Iafusco D, Lorini R, Minicucci L, Martinucci M, Toni S, Cerrutti F, Rabbone I et al. (2003). Usefulness of blood ketone bodies for monitoring insulin therapy in patients with recent onset type 1 diabetes (a multicenter study). DIABETES. vol. 52, A131-A131.
Pozzilli P, Crino A, Costantino F, Manfrini S, Spera S, Suraci C, Pitocco D, Patera P et al. (2003). Vitamin D supplementation in patients with recent onset type I diabetes: IMDIAB XI trial. DIABETES. vol. 52, A44-A44.
Picardi A, Gentilucci UV, Zardi EM, Caccavo D, Petitti T, Manfrini S, Pozzilli P, Afeltra A(2003). TNF-alpha and growth hormone resistance in patients with chronic liver disease. J Interferon Cytokine Res vol. 23, (5) 229-235.
10.1089/107999003321829944
Picardi A, Gentilucci UV, Zardi EM, Manfrini S, Afeltra A, Pozzilli P (2003). GH-resistance in different stages of chronic liver disease. JOURNAL OF HEPATOLOGY. vol. 38, 67-68.
10.1016/s0168-8278(03)80286-6
Picardi A, Gentilucci UV, Zardi EM, Intelligente F, Manfrini S, Afeltra A, Pozzilli P (2003). Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease. JOURNAL OF HEPATOLOGY. vol. 38, 68-68.
10.1016/s0168-8278(03)80287-8
Pozzilli P, Adorini L(2003). Prevention of type 1 diabetes: where do we start?. J Endocrinol Invest vol. 26, (4) 292-293.
10.1007/BF03345174
Signore A, Picarelli A, Annovazzi A, Britton KE, Grossman AB, Bonanno E, Maras B, Barra D et al.(2003). 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases. Nucl Med Commun vol. 24, (3) 305-316.
10.1097/00006231-200303000-00011
Flohé SB, Wasmuth HE, Kerad JB, Beales PE, Pozzilli P, Elliott RB, Hill JP, Scott FW et al.(2003). A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice. Cytokine vol. 21, (3) 149-154.
10.1016/s1043-4666(02)00486-6
Beyan H, Valorani MG, Pozzilli P(2003). --to: Gale EAM (2002) A missing link in the hygiene hypothesis? Diabetologia 45:588-592. Diabetologia vol. 46, (2) 301-302.
10.1007/s00125-002-1019-y
Pozzilli P, Crinò A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N et al.(2003). A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). Diabetes Technol Ther vol. 5, (6) 965-974.
10.1089/152091503322641006
POZZILLI P, Valdes AM, Noble JA, McGrue Q, Galgani A, Cola SD, Erlich HA, Buzzetti R(2003). A study of DR-DQ matched T1D cases and controls in a continental Italian population reveals susceptibility effects of DPB1 and HLA-A alleles. Hum. Immunol. vol. 64, S143-S143.
10.1016/j.humimm.2003.08.270
Picardi A, Pozzilli P(2003). Dynamic tests in the clinical management of diabetes. J Endocrinol Invest vol. 26, (7 Suppl) 99-106.
Monetini L, Barone F, Stefanini L, Petrone A, Walk T, Jung G, Thorpe R, Pozzilli P et al.(2003). Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes. J Endocrinol vol. 176, (1) 143-150.
10.1677/joe.0.1760143
Buzzetti R, Pozzilli P, Di Mario U, Ballerini C, Massacesi L(2002). Multiple sclerosis and Type I diabetes. Diabetologia vol. 45, (12) 1735-1736.
10.1007/s00125-002-0967-6
Ou D, Metzger DL, Wang X, Huang J, Pozzilli P, Tingle AJ(2002). TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction. Diabetologia vol. 45, (12) 1678-1688.
10.1007/s00125-002-0926-2
Beales PE, Elliott RB, Flohé S, Hill JP, Kolb H, Pozzilli P, Wang G-S, Wasmuth H et al.(2002). A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes. Diabetologia vol. 45, (9) 1240-1246.
10.1007/s00125-002-0898-2
Dorff G, Meyer G, Krone D, Pozzilli P, Zühlke H(2002). Neuronal NO synthase and its inhibitor PIN are present and influenced by glucose in the human beta-cell line CM and in rat INS-1 cells. Biol Chem vol. 383, (9) 1357-1361.
10.1515/BC.2002.154
Petrone A, Battelino T, Krzisnik C, Bugawan T, Erlich H, Di Mario U, Pozzilli P, Buzzetti R(2002). Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens vol. 60, (3) 244-253.
10.1034/j.1399-0039.2002.600306.x
Beales PE, Castri F, Valiant A, Rosignoli G, Buckley L, Pozzilli P(2002). Adrenalitis in the non-obese diabetic mouse. Autoimmunity vol. 35, (5) 329-333.
10.1080/0891693021000003189
Monetini L, Cavallo MG, Manfrini S, Stefanini L, Picarelli A, Di Tola M, Petrone A, Bianchi M et al.(2002). Antibodies to bovine beta-casein in diabetes and other autoimmune diseases. Horm Metab Res vol. 34, (8) 455-459.
10.1055/s-2002-33595
Klitz W, Bugawan TL, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P, Steiner L, Alejandrino M et al.(2002). Association of CTLA-4 variation with type I diabetes in Filipinos. Immunogenetics vol. 54, (5) 310-313.
10.1007/s00251-002-0471-7
Manfrini S, Coppolino G, Costanza F, Modi P, Montemari A, Pozzilli P (2002). Biokinetics of oral spray insulin: comparison with regular and lispro insulin in patients with Type 1 diabetes. DIABETOLOGIA. vol. 45, A262-A262.
Visalli N, Crino A, Schiaffini R, Matteoli M, Patera P, Pitocco D, Ghirlanda G, Manfrini S et al. (2002). C-peptide two years after diagnosis of Type 1 diabetes: the effect of nicotinamide and intensive insulin therapy. DIABETOLOGIA. vol. 45, A119-A119.
Coppolino G, Manfrini S, Schiaffini R, Crino A, Merola MK, Valente L, Visalli N, Pozzilli P et al. (2002). Leptin levels in the early phases of Type 1 diabetes could explain insulin resistance in the early stages of the disease in female patients. DIABETOLOGIA. vol. 45, A208-A209.
Buzzetti R, Galgani A, Petrone A, Di Mario U, Multari G, Lorini R, Bosi E, Cristaldi A et al. (2002). Newborn screening for prediction of Type 1 diabetes genetic risk in continental Italy (Diabfln Study). DIABETOLOGIA. vol. 45, A49-A49.
Buckley LR, Hawa MI, Beyan H, Pozzilli P, Leslie RDG (2002). Role of monocyte cyclooxygenase-2 in Non-Obese Diabetic mice. DIABETOLOGIA. vol. 45, A116-A116.
Pozzilli P(2002). The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention. Diabetes Metab Res Rev vol. 18, (4) 257-259.
10.1002/dmrr.316
Manfrini S, Crino A, Fredrickson L, Pozzilli P, IMDIAB Grp(2002). CSII versus intensive insulin therapy at onset of type 1 diabetes: The IMDIAB 8 two-year randomised trial. DIABETES vol. 51, A4-A4.
Manfrini S, Modi P, Fioriti E, Coppolino G, Costanza F, Pozzilli P(2002). Evaluation of the compliance in the use of oral spray insulin in patients with Type-1 diabetes. DIABETES vol. 51, A440-A440.
Pozzilli P, Cherubini V, Pinelli A, Valente L, Suraci C(2002). Low levels of 1,25-dihydroxyvitamin D3 in patients with recent onset type 1 diabetes living in a Mediterranean country. DIABETES vol. 51, A289-A289.
Pozzilli P, Modi P, Manfrini S, Coppolino G, Costanza F, Fioriti E(2002). Pharmacokinetics of oral spray insulin vs. regular insulin and lispro insulin in Type-1 diabetes. DIABETES vol. 51, A48-A48.
Visalli N, Suraci C, Leotta S, Pozzilli P, Imdiab Group(2002). Residual beta cell function as assessed by baseline C-peptide is an independent factor from glucose levels at the time of blood sampling. DIABETES vol. 51, A427-A428.
Ou DW, Wang XJ, Metzger D, Huang JQ, Pozzilli P, Tingle A(2002). TRAIL death signal transduction pathway mediated human beta-cell destruction. DIABETES vol. 51, A453-A453.
Bugawan TL, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM, Petrone A, Buzzetti R et al.(2002). The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens vol. 59, (6) 452-469.
10.1034/j.1399-0039.2002.590602.x
Nisticò L, Giorgi G, Giordano M, Galgani A, Petrone A, D'Alfonso S, Federici M, Di Mario U et al.(2002). IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study. Diabetes vol. 51, (5) 1649-1650.
10.2337/diabetes.51.5.1649
Bottini N, Meloni GF, Borgiani P, Giorgini A, Buzzetti R, Pozzilli P, Lucarelli P, Gloria-Bottini F(2002). Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner. Metabolism vol. 51, (4) 419-422.
10.1053/meta.2002.31317
Ou D, Metzger DL, Wang X, Pozzilli P, Tingle AJ(2002). beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathways. Hum Immunol vol. 63, (4) 256-270.
10.1016/s0198-8859(02)00372-5
Beales PE, Pozzilli P(2002). Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev vol. 18, (2) 114-117.
10.1002/dmrr.262
Misani P, Pozzilli P(2002). Bather. Fernando Botero--Medellín 1932. J Endocrinol Invest vol. 25, (2)
10.1007/BF03343988
Leslie RDG, Pozzilli P (2002). An introduction to new advances in diabetes. Diabetes Metab Res Rev. vol. 18 Suppl 1, S1-S6.
10.1002/dmrr.203
Bugawan TL, Alejandrino M, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P, Mirel D, Reynolds R et al.(2002). Genetics of type 1 diabetes among flipinos: Association studies of HLA and non-HLA candidate genes. TISSUE ANTIGENS vol. 59, 53-54.
Bugawan TL, Alejandrino M, Ching J, Klitz W, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P et al.(2001). Analysis of the HLA class I and class II susceptibility to type 1 diabetes in filipinos using the PCR-SSOP reverse line blot method. European Journal of Immunogenetics vol. 28, (2)
Pozzilli P, Mesturino CA, Crino A, Gross TM, Jeng LM, Visalli N, IMDIAB Group(2001). Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males?. Eur J Endocrinol vol. 145, (6) 757-761.
10.1530/eje.0.1450757
Sebastiani L, Visalli N, Adorisio E, D'Elia R, Conte A, Pozzilli P(2001). [Type 1 diabetes in Lazio. Note 2 -- case control study of risk factors]. Ann Ig vol. 13, (6) 523-530.
Bugawan TL, Alejandrino M, Mirel DB, Panelo A, Solfelix CM, Pozzilli P, Buzzetti R, Reynolds RL et al.(2001). Association of specific IL4 receptor SNPs with type 1 diabetes in Filipinos. AM J HUM GENET vol. 69, (4) 403-403.
Mango R, Guarino S, D'Apice R, Amati F, Sangiuolo F, Pozzilli P, Bottazzo G, Crino A et al.(2001). Mutational analysis of AIRE gene in APS2 patients. AM J HUM GENET vol. 69, (4) 580-580.
Sebastiani L, Adorisio E, Visalli N, Conte A, D'Elia R, Pozzilli P(2001). [Type I diabetes in Lazio. Note 1: incidence in 1989-1998]. Ann Ig vol. 13, (5) 393-398.
Beales PE, Rosignoli G, Buckley LR, Pozzilli P(2001). Admistration of vitamin D3 during pregnancy and early life did not reduce diabetes incidence in NOD/Ba mice. DIABETOLOGIA vol. 44, A100-A100.
Pozzilli P, Di Mario U(2001). Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care vol. 24, (8) 1460-1467.
10.2337/diacare.24.8.1460
Monetini L, Cavallo MG, Sentinelli F, Stefanini L, Bonifacio E, Sarugeri E, Bosi E, Pozzilli P et al.(2001). Cytokine profiles and IgG-IA subclasses response in type 1 diabetic patients treated with oral insulin. DIABETOLOGIA vol. 44, A151-A151.
Cavallo MG, Coppolino G, Romeo S, Manfrini S, Modi P, Pozzilli P(2001). Oral spray insulin in patients with Type 1 diabetes: Comparison with regular insulin. DIABETOLOGIA vol. 44, A213-A213.
Chan NN, Baldeweg S, Tan TMM, Hurel SI, Nagaoka T, Miyakoshi H, Baker EH, Philips BJ et al.(2001). Inhaled insulin in type 1 diabetes [7] (multiple letters). Lancet vol. 357, (9272) 1979-1980.
10.1016/s0140-6736(00)05050-9
Cavallo MG, Coppolino G, Romeo S, Pozzilli P(2001). Inhaled insulin in type 1 diabetes. Lancet vol. 357, (9272)
10.1016/s0140-6736(00)05051-0
Pozzilli P, Mesturino CA, Crino A, Ciampalini P, Cervoni M, Coppolino G, Manfrini S, Suraci MC et al.(2001). Nicotinamide and vitamin E versus Nicotinamide alone as adyuvant therapy at onset of Type 1 diabetes (IMDIAB IX trial). DIABETES vol. 50, A71-A71.
Cavallo MG, Romeo S, Coppolino G, Modi P, Pozzilli P(2001). Oral spray insulin in patients with Type 1 diabetes and residual beta cell function. DIABETES vol. 50, A108-A108.
Genovese S, Goncalves D, Cavallo GM, Purrello F, Anello L, Rotella CM, Bardini G, Riccardi G et al.(2001). Prevalence and clinical characteristics of adult onset diabetes associated with GAD65 autoantibodies. Screening of a large sample of patients attending diabetic clinics in Italy. DIABETES vol. 50, A94-A94.
Ou DW, Metzger D, Wang XJ, Pozzilli P, Tingle A(2001). beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetes patients: Autoaggressive effector T cells damage human CD56+p cells by HLA-Restricted and Non-HLA-Restricted pathways. DIABETES vol. 50, A264-A264.
Crinò A, Cavallo MG, Corbi S, Mesturino CA, Ferrazzoli F, Coppolino G, Bizzarri C, Cervoni M et al.(2001). Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes. Clin Exp Immunol vol. 123, (3) 382-386.
10.1046/j.1365-2249.2001.01480.x
Pozzilli P(2001). A ferocious cretin with voluminous goiter. J ENDOCRINOL INVEST vol. 24, (2) 137-137.
10.1007/bf03343829
Cavallo MG, Romeo S, Coppolino G, Pozzilli P(2001). Continuous glucose monitoring during the European Soccer cup semifinal, Italy against Holland. Diabetologia vol. 44, (2)
10.1007/s001250051611
Pozzilli P(2001). Endocrinology and art. "A ferocious cretin with voluminous goiter". Morazzone, circa 1600. J Endocrinol Invest vol. 24, (2)
10.1007/BF03343829
Multari G, Werner B, Cervoni M, Lubrano R, Costantino F, Demiraj V, Pozzilli P(2001). Peritoneal dialysis in an infant with type 1 diabetes and hyperosmolar coma. J Endocrinol Invest vol. 24, (2) 104-106.
10.1007/BF03343822
Pozzilli P, Manfrini S, Monetini L(2001). Biochemical markers of type 1 diabetes: clinical use. Scand J Clin Lab Invest Suppl vol. 235, 38-44.
10.1080/003655101753352031
Monetini L, Cavallo MG, Stefanini L, Ferrazzoli F, Bizzarri C, Marietti G, Curro V, Cervoni M et al.(2001). Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes. Diabetes Metab Res Rev vol. 17, (1) 51-54.
10.1002/1520-7560(2000)9999:9999<::aid-dmrr156>3.0.co;2-h
Pozzilli P, Coppolino G, Monetini L, Nisticò L(2001). Type 1 Diabetes and Multiple Sclerosis: Similarities and Dissimilarities. New Concepts in Pathology and Treatment of Autoimmune Disorders,
Pozzilli P, Cavallo MG(2000). Oral insulin and the induction of tolerance in man: Reality or fantasy?. Diabetes/Metabolism Research and Reviews vol. 16, (5) 306-307.
10.1002/1520-7560(200009/10)16:5<306::AID-DMRR150>3.0.CO;2-J
Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crinò A, Spera S, Suraci C et al.(2000). No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII). Diabetologia vol. 43, (8) 1000-1004.
10.1007/s001250051482
Beales PE, Rosignoli G, Batchelor K, Pozzilli P(2000). The prevention of diabetes using rosiglitazone in the non-obese diabetic mouse. Diabetes Research and Clinical Practice vol. 50,
10.1016/s0168-8227(00)81324-8
Visalli N, Sebastiani L, Adorisio E, Castelli MD, Coppolino G, Marietti G, Pozzilli P, Group IMDIAB (2000). Caesarean section delivery and vitamin D supplement: Risk and protective factors for Type 1 diabetes. DIABETOLOGIA. vol. 43, A94-A94.
Beales PE, Liddi R, Rosignoli G, Hill J, Pozzilli P (2000). Diet and its effect on diabetes incidence in the NOD/Ba mouse. DIABETOLOGIA. vol. 43, A3-A3.
Monetini L, Cavallo MG, Stefanini L, Coppolino G, Walk T, Jung G, Pozzilli P (2000). Isolation of specific bovine beta-casein T cell lines in Type 1 diabetes. DIABETOLOGIA. vol. 43, A104-A104.
Pozzilli P, Visalli N, Coppolino G, Leslie D, Grp IMDIAB (2000). No evidence of rapid onset "Japanese" Type 1 diabetes in Caucasian patients. DIABETOLOGIA. vol. 43, A103-A103.
Salvetti M, Ristori G, Bomprezzi R, Pozzilli P, Leslie RDG(2000). Twins: Mirrors of the immune system. Immunology Today vol. 21, (7) 342-347.
10.1016/S0167-5699(00)01658-3
Burkart V, Liu H, Bellmann K, Wissing D, Jäättelä M, Cavallo MG, Pozzilli P, Briviba K et al.(2000). Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70. Journal of Biological Chemistry vol. 275, (26) 19521-19528.
10.1074/jbc.M002265200
Chianelli M, Parisella MG, Mather SJ, Visalli N, Annovazzi A, Giacalone P, Capriotti G, Corsetti F et al.(2000). 99mTc-IL2 detects insulitis in the pancreas of newly diagnosed type 1 diabetes patients and predicts response to immunotherapy. Nuclear Medicine Communications vol. 21, (6)
10.1097/00006231-200006000-00035
Pozzilli P, Visalli N, Coppolino G, Classen DC, Classen JB, Grp IMDIAB (2000). Hepatitis B vaccine associated with an increased risk of type 1 diabetes in Italy. DIABETES. vol. 49, A67-A67.
Pugliese G, Buzzetti R, Mellozzi M, Galante V, Parravano C, Pala L, Rotella CM, Di Mario U et al. (2000). Low prevalence of diabetic nephropathy in Type 1 diabetes from central Italy. DIABETES. vol. 49, A158-A158.
Monetini L, Cavallo MG, Stefanini L, Coppolino G, Walk T, Jung G, Pozzilli P (2000). T cell lines to bovine beta-casein in Type 1 diabetes. DIABETES. vol. 49, A323-A323.
(2000). Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet vol. 355, (9207) 873-876.
10.1016/s0140-6736(99)07125-1
Signore A, Chianelli M, Annovazzi A, Bonanno E, Spagnoli LG, Pozzilli P, Pallone F, Biancone L(2000). <sup>123</sup>I-Interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease. Journal of Nuclear Medicine vol. 41, (2) 242-249.
Liddi R, Beales PE, Rosignoli G, Pozzilli P(2000). Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse. Hormone and Metabolic Research vol. 32, (6) 201-206.
10.1055/s-2007-978622
Beales PE, Liddi R, Endl J, Kientsch-Engel R, Pozzilli P(2000). Intradermal administration of GAD and evaluation of diabetes incidence in mice: Possible relevance for skin tests in humans. Autoimmunity vol. 32, (2) 109-113.
10.3109/08916930008994080
Pozzilli P, Visalli N, Leslie D(2000). No evidence of rapid onset (Japanese) Type I diabetes in Caucasian patients [3]. Diabetologia vol. 43, (10)
10.1007/pl00022647
Merriman T, Corradu F, Cucca F, Broadley S, Sawcer S, Compston A, Wordsworth P, Bain S et al. (1999). Human chromosome 18q12-q21 and distal rodent chromosome 18 are associated with multiple autoimmune phenotypes. AMERICAN JOURNAL OF HUMAN GENETICS. vol. 65, A59-A59.
Medici F, Hawa MI, Giorgini A, Panelo A, Solfelix CM, Leslie RDG, Pozzilli P(1999). Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type I diabetic patients. Diabetes Care vol. 22, (9) 1458-1461.
10.2337/diacare.22.9.1458
(1999). 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999. Diabetologia vol. 42, (Suppl 1) A1-A330.
10.1007/BF03375458
Pitocco D, Visalli N, Cavallo MG, Bitti MLM, Suraci C, Crino A, Giordano C, Cervoni M et al. (1999). Double blind trial of oral insulin in recent onset type 1 diabetes. DIABETOLOGIA. vol. 42, A92-A92.
Monetini L, Cavallo MG, Valente L, Coppolino G, Stefanini L, Corbi S, Spera S, Matteoli MC et al. (1999). Raised antibodies to beta-casein in type 1 diabetes and coeliac disease but not in other autoimmune diseases. DIABETOLOGIA. vol. 42, A100-A100.
Visalli N, Sabastiani L, Adorisio E, Faldetta MRC, Buzzetti R, Multari G, Casu A, Songini M et al. (1999). Sex differences in the incidence of type 1 diabetes in two Italian regions: Lazio and Sardinia. DIABETOLOGIA. vol. 42, A85-A85.
Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R et al.(1999). A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (The IMDIAB VI). Diabetes/Metabolism Research and Reviews vol. 15, (3) 181-185.
10.1002/(SICI)1520-7560(199905/06)15:3<181::AID-DMRR31>3.0.CO;2-H
Biancone L, Signore A, Ronga G, Pozzilli P, Pallone F (1999). Activated intestinal lymphocytes in inactive Crohn's disease (CD) as a subclinical marker of early clinical relapse. GASTROENTEROLOGY. vol. 116, A791-A791.
Beales PE, Pozzilli P(1999). Caution is required with interferon α as a potential treatment for Type I diabetes [6]. Diabetologia vol. 42, (3)
10.1007/s001250051170
Kolb H, Pozzilli P(1999). Cow's milk and type I diabetes: The gut immune system deserves attention. Immunology Today vol. 20, (3) 108-110.
10.1016/S0167-5699(98)01425-X
Schloot NC, Pozzilli P, Mandrup-Poulsen T(1999). Immune markers for monitoring the progression of autoimmune disease. Diabetes/Metabolism Research and Reviews vol. 15, (2) 141-145.
10.1002/(SICI)1520-7560(199903/04)15:2<141::AID-DMRR19>3.0.CO;2-A
Pozzilli P(1999). "Christ at the pool of Betheseda" (detail). William Hogarth. 1697-1764. Journal of endocrinological investigation vol. 22, (9)
10.1007/bf03343637
Baroni MG, D'Andrea MP, Montali A, Pannitteri G, Barillà F, Campagna F, Mazzei E, Lovari S et al.(1999). A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology vol. 19, (12) 2975-2980.
10.1161/01.ATV.19.12.2975
Gross T, Visalli N, Fredrickson L, Pozzilli P (1999). A new formula for estimating insulin dose at diagnosis of type I diabetes. DIABETES. vol. 48, A351-A351.
Mansfield KJ, Wilson JE, Pozzilli P, Beales PE(1999). A new substrain of the non-obese diabetic mouse which develops cataracts (NOD/Ba/Lop19) [9]. British Journal of Ophthalmology vol. 83, (6)
10.1136/bjo.83.6.759
Pozzilli P, Leslie RDG(1999). Aspirin and diabetes. Practical Diabetes International vol. 16, (8) 259-261.
10.1002/pdi.1960160814
Baroni MG, Cavallo MG, Mark M, Monetini L, Stoehrer B, Pozzilli P(1999). Beta-cell gene expression and functional characterization of the human insulinoma cell line CM. Journal of Endocrinology vol. 161, (1) 59-68.
10.1677/joe.0.1610059
Beales PE, Burr LA, Webb GP, Mansfield KJ, Pozzilli P(1999). Diet can influence the ability of nicotinamide to prevent diabetes in the non-obese diabetic mouse: A preliminary study. Diabetes/Metabolism Research and Reviews vol. 15, (1) 21-28.
10.1002/(SICI)1520-7560(199901/02)15:1<21::AID-DMRR16>3.0.CO;2-9
Pozzilli P, Leslie RDG(1999). Glycaemic outcome in patients with type 2 diabetes referred to a hospital clinic because of poor control. Practical Diabetes International vol. 16, (8) 247-249.
10.1002/pdi.1960160809
Monetini L, Cavallo MG, Barone F, Valente L, Russo M, Walker B, Thorpe R, Pozzilli P(1999). T cell reactivity to human insulinoma cell line (CM) antigens in patients with type 1 diabetes. Autoimmunity vol. 29, (3) 171-177.
10.3109/08916939908998532
Giorgini AE, Beales PE, Mire-Sluis A, Scott D, Liddi R, Pozzilli P(1999). Troglitazone exhibits immunomodulatory activity on the cytokine production of activated human lymphocytes. Hormone and Metabolic Research vol. 31, (1) 1-4.
10.1055/s-2007-978686
Pozzilli P(1999). β-casein in cow's milk: A major antigenic determinant for type 1 diabetes?. Journal of Endocrinological Investigation vol. 22, (7) 562-567.
10.1007/BF03343610
Arca M, D'Andrea MP, Montali A, Mariano E, Campagna F, Ricci G, Pozzilli P, Urbinati G et al. (1998). A common mutation in the insulin receptor substrate-1 (IRS-1) gene is a genetic marker for the insulin resistance syndrome. CIRCULATION. vol. 98, 673-673.
Beales PE, Liddi R, Giorgini AE, Signore A, Procaccini E, Batchelor K, Pozzilli P(1998). Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse. European Journal of Pharmacology vol. 357, (2-3) 221-225.
10.1016/S0014-2999(98)00574-3
Cavallo MG, Monetini L, Tiberi F, Barone F, Valente L, Pozzilli P (1998). Cellular immunity to different cow's milk proteins in IDDM. DIABETOLOGIA. vol. 41, A94-A94.
Visalli N, Ghirlanda G, Pozzilli P, Grp IMDIABS (1998). High and standard dose of nicotinamide in recent onset insulin dependent diabetes (the IMDIAB 6 Study). DIABETOLOGIA. vol. 41, A89-A89.
Signore A, Chianelli M, Visalli N, Barone R, Annovazzi A, Di Leve G, Parisella MG, Pozzilli P et al. (1998). Identification of type 1 diabetic patients with insulitis at diagnosis by Tc-99m-IL2 scintigraphy. DIABETOLOGIA. vol. 41, A95-A95.
Beales PE, Liddi R, Matta G, Webb GP, Pozzilli P (1998). Incomplete Freund's adjuvant protects NOD mice from type 1 diabetes. DIABETOLOGIA. vol. 41, A90-A90.
Nistico L, Prichard L, Buzzetti R, De Cinti A, Di Genova G, Tosi R, Serrano-Rios M, Martinez MT et al. (1998). Mapping of IDDM 12 in southern European populations. DIABETOLOGIA. vol. 41, A79-A79.
McKinney PA, Rothwell P, Schober E, Ionescu-Tirgoviste C, Neu A, Pozzilli P, Gutnikov S, Grp EURODIABS (1998). Seasonality of birth in patients with childhood IDDM: The EURODIAB study. DIABETOLOGIA. vol. 41, A91-A91.
Schwingshackl A, Blasko I, Steiner E, Pozzilli P, Cavallo MG, Berger P, Grubeck-Loebenstein B(1998). Sex steroids do not prevent amylin-induced apoptosis in human cells. Experimental Cell Research vol. 241, (1) 265-268.
10.1006/excr.1998.4017
Pozzilli P(1998). Prevention of insulin-dependent diabetes mellitus 1998. Diabetes/Metabolism Reviews vol. 14, (1) 69-84.
10.1002/(SICI)1099-0895(199803)14:1<69::AID-DMR203>3.0.CO;2-E
Baroni MG, Pina d'Andrea M, Capici F, Buzzetti R, Cavallo MG, Fallucca F, Giovannini C, Pozzilli P(1998). High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis. Human Genetics vol. 102, (4) 479-482.
10.1007/s004390050725
Baroni MG, Arca M, D'Andrea MP, Campagna F, Capici F, Urbinati G, Pozzilli P (1998). A common mutation in the Insulin Receptor Substrate-1 gene is a genetic marker for the Insulin Resistance Syndrome in patients with coronary artery disease. DIABETES. vol. 47, A173-A173.
Cavallo MG, Monetini L, Barone F, Valente L, Pozzilli P, Grp IMDIAB (1998). Cellular immune response to multiple cow milk proteins in IDDM. DIABETES. vol. 47, A202-A202.
Nistico L, Pritchard L, Buzzetti R, De Cinti A, Di Genova G, Tosi R, Todd J, Pozzilli P (1998). Fine mapping of IDDM12. DIABETES. vol. 47, A229-A229.
Biancone L, Signore A, Ronga G, Pozzilli P, Pallone F (1998). Ex-vivo autoradiography and facs-scan analysis demonstration of a specific binding between IL2-receptor positive cells in Crohn's disease gut and 123I-interleukin-2 injected in vivo. Gastroenterology. vol. 114,
10.1016/s0016-5085(98)83793-1
Pozzilli P(1998). Cow's milk and Type 1 diabetes: New evidence about β casein. Practical Diabetes International vol. 15, (2) 49-50.
10.1002/pdi.1960150209
Pozzilli P(1998). Erratum: Prevention of Insulin-dependent Diabetes Mellitus 1998 (Diabetes/Metabolism Reviews (1998) 14(1) (69-84)). Diabetes/Metabolism Reviews vol. 14, (2)
Nakagawa Y, Kawaguchi Y, Twells RCJ, Muxworthy C, Hunter KMD, Wilson A, Merriman ME, Cox RD et al.(1998). Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. American Journal of Human Genetics vol. 63, (2) 547-556.
10.1086/301974
Esposito L, Hill NJ, Pritchard LE, Cucca F, Muxworthy C, Merriman ME, Wilson A, Julier C et al.(1998). Genetic analysis of chromosome 2 in type 1 diabetes: Analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. Diabetes vol. 47, (11) 1797-1799.
10.2337/diabetes.47.11.1797
Pozzilli P(1998). IDDM preventive trials: What's new?. Diabetes/Metabolism Reviews vol. 14, (3) 260-261.
10.1002/(sici)1099-0895(1998090)14:3<260::aid-dmr223>3.0.co;2-%23
Pozzilli P, Visalli N, Buzzetti R, Cavallo MG, Marietti G, Hawa M, Leslie RDG(1998). Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: A population-based study. Metabolism: Clinical and Experimental vol. 47, (10) 1205-1210.
10.1016/S0026-0495(98)90324-9
Barone R, Procaccini E, Chianelli M, Annovazzi A, Fiore V, Hawa M, Nardi G, Ronga G et al.(1998). Prognostic relevance of pancreatic uptake of technetium-99m labelled human polyclonal immunoglobulins in patients with type 1 diabetes. European Journal of Nuclear Medicine vol. 25, (5) 503-508.
10.1007/s002590050250
Sciullo E, Cardellini G, Baroni M, Torresi P, Mazziotti F, Pozzilli P, Fallucca F(1997). Glucose transporters (GLUT 1, GLUT 3) mRNA in human placenta of diabetic and non-diabetic pregnancies. Annali dell'Istituto Superiore di Sanita vol. 33, (3) 361-365.
Bennett ST, Wilson AJ, Esposito L, Bouzekri N, Undlien DE, Cucca F, Nisticò L, Buzzetti R et al.(1997). Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. Nature Genetics vol. 17, (3) 350-352.
10.1038/ng1197-350
Pozzilli P(1997). Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes. (vol 137, pg 234, 1997). EUROPEAN JOURNAL OF ENDOCRINOLOGY vol. 137, (5) 558-558.
Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C et al.(1997). Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study). European Journal of Endocrinology vol. 137, (3) 234-239.
10.1530/eje.0.1370234
Merriman T, Twells R, Merriman M, Eaves L, Cox R, Cucca F, McKinney P, Shield J et al.(1997). Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Human Molecular Genetics vol. 6, (7) 1003-1010.
10.1093/hmg/6.7.1003
Visalli N, Sebastiani L, Adorisio E, DeCicco AL, Pozzilli P (1997). Study on the incidence of insulin-dependent diabetes in the Lazio region (Central Italy) from 1989 to 1995. DIABETOLOGIA. vol. 40, 230-230.
Browne PD, Lampeter E, DeLeeuw I, Iafusco D, IonescuTirgoviste C, Kolouskova S, Linn T, Ludvigsson J et al. (1997). The GETREM study: New preliminary findings for the clinical remission in IDDM using logistic regression. DIABETOLOGIA. vol. 40, 1311-1311.
Baroni M, Vialettes B, Pozzilli P(1997). The glucose evaluation trial for remission (GETREM): A european effort to evaluate insulin-dependent diabetes mellitus in the first year after diagnosis. Diabetes and Metabolism vol. 23, (3) 264-265.
Giorgini A, Scott D, Liddi R, Beales P, Pozzilli P (1997). Troglitazone alters the cytokine production of activated lymphocytes from human donors. DIABETOLOGIA. vol. 40, 363-363.
Beales P, Giorgini A, Batchelor K, Pozzilli P (1997). Troglitazone reduces diabetes incidence in NOD mice. DIABETOLOGIA. vol. 40, 261-261.
Pozzilli P(1997). BCG vaccine in insulin-dependent diabetes mellitus [6]. Lancet vol. 349, (9064) 1520-1521.
10.1016/S0140-6736(05)62100-9
Leslie RDG, Taylor R, Pozzilli P(1997). The role of insulin resistance in the natural history of Type 1 diabetes. Diabetic Medicine vol. 14, (4) 327-331.
10.1002/(SICI)1096-9136(199704)14:4<327::AID-DIA315>3.0.CO;2-6
Signore A, Biancone L, Pallone F, Bonanno E, Chianelli M, Nardi G, Morrone S, Spagnoli LG et al.(1997). SP-5. Radiolabelled interleukin-2 scintigraphy for imaging CD25+ mononuclear cells in chronic inflammation. Nuclear Medicine Communications vol. 18, (5)
10.1097/00006231-199705000-00028
Cavallo MG, Leytze G, Buzzetti R, Nistico L, Linsley P, Pozzilli P (1997). Study of CTLA-4 gene expression in patients with IDDM. DIABETES. vol. 46, 1319-1319.
Pozzilli P, Leslie RDG(1997). Hyperexpression of GAD in the islets may be relevant but is it sufficient to induce antoimmune insulitis 3. Diabetologia vol. 40, (3) 357-361.
10.1007/s001250050688
Muntoni S, Fonte MT, Stoduto S, Marietti G, Bizzarri C, Crinò A, Ciampalini P, Multari G et al.(1997). Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy. Lancet vol. 349, (9046) 160-162.
10.1016/S0140-6736(96)04241-9
Wild T, Scherbaum WA, Gleichmann H, Landt M, Santiago J, Endl J, Landgraf R, Cavallo MG et al.(1997). Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: A multicenter study. Hormone and Metabolic Research vol. 29, (8) 403-406.
10.1055/s-2007-979064
Pozzilli P(1997). Erratum: Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (European Journal of Endocrinology (1997) 137 (234-239)). European Journal of Endocrinology vol. 137, (5)
Sciullo E, Cardellini G, Baroni MG, Torresi P, Buongiorno A, Pozzilli P, Fallucca F(1997). Glucose transporter (Glut1, Glut3) mRNA in human placenta of diabetic and non-diabetic pregnancies. Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy vol. 3, (3) 172-182.
Cavallo MG, Monetini L, Valente L, Barone F, Beales P, Russo M, Pozzilli P(1997). Glutathione protects a human insulinoma cell line from tumor necrosis factor-α-mediated cytotoxicity. International Journal of Clinical and Laboratory Research vol. 27, (1) 44-47.
10.1007/BF02827241
Signore A, Chianelli M, Picarelli A, Procaccini E, Barone R, Greco M, Annovazzi A, De Vincenzi M et al.(1997). In Vivo Detection of Activated Lymphocytes in Immune- Mediated Diseases by 123I-Interleukin-2 Scintigraphy. Radioactive Isotopes in Clinical Medicine and Research,
Beales PE, Giorgini A, Annovazzi A, Signore A, Parlapiano C, Pozzilli P(1997). Metformin does not alter diabetes incidence in the NOD mouse. Hormone and Metabolic Research vol. 29, (6) 261-263.
10.1055/s-2007-979033
Bellmann K, Liu H, Burkhart V, Pozzilli P, Cavallo MG, Jaatela M, Steensgaard P, Kolb H (1997). Nitric oxide and type I diabetes: Low toxicity of NO towards human beta cells due to hsp 70 expression. Immunobiology. vol. 197,
Gisella Cavallo M, Pozzilli P(1997). Pilot trials in pre-IDDM: yes but.... Diabetes/metabolism reviews vol. 13, (4)
Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie RDG(1997). Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes vol. 46, (8) 1270-1275.
10.2337/diab.46.8.1270
Cavallo MG, Monetini L, Walker B, Thorpe R, Pozzilli P(1996). Diabetes and cows' milk. The Lancet vol. 348, (9042)
10.1016/s0140-6736(05)65715-7
Pozzilli P(1996). Present facts and prospects. Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 9, (6) 306-309.
Pozzilli P(1996). Prevention of insulin-dependent diabetes - Present facts and prospects. DIABETES NUTRITION & METABOLISM vol. 9, (6) 306-309.
Cavallo MG, Fava D, Monetini L, Barone F, Pozzilli P(1996). Cell-mediated immune response to β casein in recent-onset insulin-dependent diabetes: Implications for disease pathogenesis. Lancet vol. 348, (9032) 926-928.
10.1016/S0140-6736(95)12065-3
Nistico L, Buzzetti R, Pritchard LE, Martinez MT, SerranoRios M, Barnett AH, Tosi R, Pozzilli P et al. (1996). CTLA-4 region predisposes to IDDM and Graves' disease. DIABETOLOGIA. vol. 39, 292-292.
Faldetta MC, Visalli N, Cavallo MG, Andreani D, Leslie RDG, Hava M, Pozzilli P (1996). GAD and IA-2 antibodies in relation to disease presentation and C-peptide secretion. DIABETOLOGIA. vol. 39, 343-343.
Muntoni S, Fonte MT, Stoduto S, Marietti G, Crino A, Bizzarri C, Ciampalini P, Multari G et al. (1996). Sardinians living in LAZIO retain their fivefold incidence of type 1 diabetes compared with the host population. DIABETOLOGIA. vol. 39, 53-53.
Nisticò L, Buzzetti R, Pritchard LE, Van Der Auwera B, Giovannini C, Bosi E, Martinez Larrad MT, Rios MS et al.(1996). The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Human Molecular Genetics vol. 5, (7) 1075-1080.
10.1093/hmg/5.7.1075
Leslie D, Hawa M, Rowe R, Lan M, Notkins A, Pozzilli P (1996). Characterising islet protein tyrosine phosphatase antibodies association with type 1 diabetes. DIABETES. vol. 45, 879-879.
Luo DF, Buzzetti R, Rotter JI, Maclaren NK, Raffel LJ, Nisticò L, Giovannini C, Pozzilli P et al.(1996). Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Human Molecular Genetics vol. 5, (5) 693-698.
10.1093/hmg/5.5.693
Signore A, Barone R, Procaccini E, Annovazzi A, Chianelli M, Scopinaro F, Ronga G, Multari G et al. (1996). In vivo measurement of immunoglobulin accumulation in the pancreas of recent onset type 1 diabetic patients. Clinical and Experimental Rheumatology. vol. 14,
Pozzilli P, Browne PD, Kolb H (1996). Nicotinamide increases C-peptide secretion in recent onset IDDM: Results of an international meta-analysis. DIABETES. vol. 45, 511-511.
Signore A, Picarelli A, Chianelli M, Biancone L, Annovazzi A, Tiberti C, Anastasi E, Multari G et al. (1996). <sup>123</sup>I-interleukin-2 scintigraphy: A new approach to assess disease activity in autoimmunity. Journal of Pediatric Endocrinology and Metabolism. vol. 9, 139-144.
10.1515/jpem.1996.9.s1.139
Sebastiani L, Visalli N, Adorisio E, Suppa MA, Buzzetti R, De Cicco AL, Giovannini C, Comerci MD et al.(1996). A 5-year (1989-1993) prospective study of the incidence of IDDM in Rome and the Lazio region in the age-group 0-14 years. Diabetes Care vol. 19, (1) 70-73.
10.2337/diacare.19.1.70
Cavallo MG, Dotta F, Monetini L, Dionisi S, Previti M, Valente L, Toto A, Di Mario U et al.(1996). Beta-cell markers and autoantigen expression by a human insulinoma cell line: Similarities to native beta cells. Journal of Endocrinology vol. 150, (1) 113-120.
10.1677/joe.0.1500113
Gray DWR, Cavallo MG, Monetini L, Walker B, Thorpe R, Pozzilli P, Murch S, Akerblom HK et al.(1996). Diabetes and cows' milk [1]. Lancet vol. 348, (9042) 1655-1657.
10.1016/S0140-6736(96)24050-4
Del Prato S, Pozzilli P(1996). FIRI: Fasting or false insulin resistance index? [26]. Lancet vol. 347, (8994)
10.1016/S0140-6736(96)90264-0
Pozzilli P, Lunadei M, Frati L, Leslie RDG, Farthing M(1996). From Erasmus to Socrates: Should mobility move from students to teachers? [13]. Lancet vol. 347, (9017)
10.1016/S0140-6736(96)90849-1
Pozzilli P, Browne PD, Kolb H(1996). Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. Diabetes Care vol. 19, (12) 1357-1363.
10.2337/diacare.19.12.1357
Pozzilli P, Buzzetti R, Nisticó L, Romiti A, Giovannini C (1996). Non-HLA genes and the susceptibility to insulin dependent diabetes: The role of the CTLA-4 gene. Acta Diabetologica. vol. 33, 250-252.
10.1007/BF00571558
Pozzilli P (1996). Prevention of insulin-dependent diabetes: Where are we now?. Diabetes/Metabolism Reviews. vol. 12, 127-135.
10.1002/(SICI)1099-0895(199607)12:2<127::AID-DMR160>3.0.CO;2-8
Beales PE, Delovitch TL, Signore A, Pozzilli P(1996). Standardizing experiments with NOD mice. Autoimmunity vol. 24, (2) 127-129.
10.3109/08916939609001954
Signore A, Fiore V, Chianelli M, Procaccini E, Barone R, Ronga G, Negri M, Pozzilli P(1996). The effect of metformin on liver blood flow in vivo in normal subjects and patients with non insulin dependent diabetes. Diabetes Research and Clinical Practice vol. 33, (2) 83-87.
10.1016/0168-8227(96)01280-6
Cavallo MG, Monetini L, Russo M, Thorpe R, Pozzilli P(1995). Mumps virus infection increases sensitivity to tumour necrosis factor-alpha and gamma-interferon induced cytotoxicity in a human insulinoma cell line. Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 8, (6) 319-323.
Letizia C, D'Ambrosio C, De Ciocchis A, Scavo D, Pozzilli P, Visalli N, Mesturino MA, Bocconi ML et al.(1995). Serum angiotensin-converting enzyme levels in patients with recent- onset insulin-dependent diabetes after one year of low-dose cyclosporin therapy. International Journal of Clinical Pharmacology Research vol. 15, (5-6) 209-213.
BROWNE PD, AMODEO BM, DELEEUW I, DUCAJU MVL, IONESCUTIRGOVISTE C, KOLOUSKOVA S, LAMPETER E, LINN T et al. (1995). A MULTICENTER EUROPEAN STUDY FOR THE EVALUATION OF SPONTANEOUS CLINICAL REMISSION IN IDDM. DIABETOLOGIA. vol. 38, A100-A100.
BARONI MG, GRAGNOLI C, CAVALLO MG, LATINI L, VALENTE L, ANDREANI D, POZZILLI P (1995). HUMAN INSULINOMA CELL-LINE EXPRESSING CONSTITUTIVE BETA-CELL GENES. DIABETOLOGIA. vol. 38, A46-A46.
SIGNORE A, CHIANELLI M, PICARELLI A, FERRETTI E, GRECO M, MULTARI M, DEMATTIA G, POZZILLI P (1995). IN-VIVO DETECTION OF ACTIVATED LYMPHOCYTES IN THE ENDOCRINE PANCREAS - A NEW TOOL FOR IDDM PREDICTION. DIABETOLOGIA. vol. 38, A38-A38.
BEALES PE, WEBB GP, GIORGINI A, ALBERTINI MC, BURR LA, MANSFIELD KJ, POZZILLI P (1995). NICOTINAMIDE TREATMENT IN NOD MICE CAN BE AFFECTED BY SUCROSE IN THE DIET. DIABETOLOGIA. vol. 38, A97-A97.
FALDETTA MC, VISALLI N, BOCCUMI ML, MESTURINO C, MATTEOLI MC, CRINO A, CICCONETTI CA, PACI F et al. (1995). NICOTINAMIDE VERSUS VITAMIN-E IN RECENT-ONSET IDDM - A RANDOMIZED TRIAL IN 85 PATIENTS. DIABETOLOGIA. vol. 38, A99-A99.
BUZZETTI R, NISTICO L, POZZILLI P, SERRANORIOS M, LARRAZ MT, TOSI R, GIOVANNINI C (1995). THE CTLA4 MICROSATELLITE IDENTIFIES A NEW REGION ON CHROMOSOME-2 LINKED TO IDDM. DIABETOLOGIA. vol. 38, A29-A29.
Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, Boccuni ML, Fava D et al.(1995). Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia vol. 38, (7) 848-852.
10.1007/s001250050362
Pozzilli P, Visalli N, Buzzetti R, Baroni MG, Boccuni ML, Fioriti E, Signore A, Mesturino C et al.(1995). Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years. Diabete et Metabolisme vol. 21, (1) 47-49.
NISTICO L, BUZZETTI R, POZZILLI P, CONTU L, SERRANORIOS M, LARRAZ MT, TOSI R, GIOVANNINI C (1995). IDENTIFICATION OF A NEW REGION LINKED TO IDDM IN AFFECTED MULTIPLEX FAMILIES FROM THE MEDITERRANEAN AREA. DIABETES. vol. 44, A17-A17.
Biancone L, Di Macio L, Marcheggiano A, Di Paolo MC, Paoluzi P, Scopinaro F, Pallone F (1995). Usefulness of scintigraphy using 99mTc-EMPAO labelled granulocytes (PMN) as early indicator of postoperative asymptomatic recurrence in Crohn's disease (CD). Gastroenterology. vol. 108,
10.1016/0016-5085(95)27440-5
Beales PE, Hawa M, Williams AJK, Albertini MC, Giorgini A, Pozzilli P(1995). Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse. Acta Diabetologica vol. 32, (1) 53-56.
10.1007/BF00581047
Signore A, Fiore V, Chianelli M, Ronga G, Pozzilli P(1995). Effect of metformin on liver insulin metabolism and regional blood flow. Diabetes/Metabolism Reviews vol. 11, (1 S) S13-S21.
10.1002/dmr.5610110504
Pozzilli P, Buzzetti R, Giovannini C, Gragnoli C, Leslie RDG(1995). New and old trends for treating organ-specific autoimmune endocrinopathies. Journal of Endocrinology vol. 145, (2) 195-199.
10.1677/joe.0.1450195
Pozzilli P, Dupre J(1995). New intervention modalities for the prevention of insulin-dependent diabetes. Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 8, (2) 69-73.
Pozzilli P, Buzzetti R, Bottazzo G, Tosi R(1995). Response from the authors. Diabetologia: Clinical and Experimental Diabetes and Metabolism vol. 38, (1) 126-126.
10.1007/BF02369369
Signore A, Procaccini E, Chianelli M, Pozzilli P(1995). Retrovirus and diabetes in animal models: Hypotheses for the induction of the disease. Diabete et Metabolisme vol. 21, (3) 147-155.
Levy-Marchal C, Patterson C, Green A, Schober E, Ullreich G, Vandewalle C, Svendsen A, Lounamaa R et al.(1995). Variation by age group and seasonally at diagnosis of childhood IDDM in Europe. Diabetologia vol. 38, (7) 823-830.
10.1007/s001250050359
Pozzilli P(1994). Prevention of Type I diabetes mellitus. Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 7, (2) 57-61.
VISALLI N, SIGNORE A, BARONI MG, BUZZETTI R, CAVALLO MG, BOCCUNI ML, ANDREANI D, LUCENTINI L et al. (1994). NICOTINAMIDE AT IDDM DIAGNOSIS - 1 YEAR RESULTS OF A LARGE DOUBLE-BLIND-STUDY. DIABETOLOGIA. vol. 37, A64-A64.
FERRETTI E, BARONE R, MANGO L, MULTARI G, ANDREANI D, POZZILLI P, SIGNORE A (1994). RADIOLABELED IMMUNOGLOBULINS FOR IMAGING PANCREATIC INFLAMMATION IN TYPE-1 DIABETES. DIABETOLOGIA. vol. 37, A91-A91.
POZZILLI P, BUZZETTI R, BOTTAZZO GF, TOSI R(1994). SELECTION OF CONTROL SUBJECTS FOR CASE/CONTROL ANALYSIS OF SUSCEPTIBILITY TO TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS - RESPONSE. DIABETOLOGIA vol. 37, (8) 846-846.
Staines A, Pozzilli P, Buzzetti R, Bottazzo GF, Tosi R(1994). Selection of control subjects for case/control analysis of susceptibility to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia vol. 37, (8) 845-846.
10.1007/BF00404345
Baroni MG, Alcolado JC, Gragnoli C, Franciosi AM, Cavallo MG, Fiore V, Pozzilli P, Galton DJ(1994). Affected sib-pair analysis of the GLUT1 glucose transporter gene locus in non-insulin-dependent diabetes mellitus (NIDDM): evidence for no linkage. Human Genetics vol. 93, (6) 675-680.
10.1007/BF00201569
Alcolado JC, Pozzilli P(1994). Selection of control subjects in genetic studies of diabetes mellitus. Diabetologia vol. 37, (6) 639-640.
10.1007/BF00403386
CAVALLO MG, MONETINI L, VALENTE L, DESANTIS R, POZZILLI P (1994). AUTOANTIBODIES IN NEWLY-DIAGNOSED IDDM SERA DETECTED USING A HUMAN INSULINOMA CELL-LINE AS SUBSTRATE. DIABETES. vol. 43, A154-A154.
BARONI MG, FRANCIOSI A, GRAGNOLI C, CAVALLO MG, MONETINI L, POZZILLI P (1994). EXPRESSION OF GLUT1, GLUT2 AND INSULIN GENES BY A HUMAN INSULINOMA CELL-LINE. DIABETES. vol. 43, A250-A250.
Signore A, Procaccini E, Toscano AM, Ferretti E, Pozzilli P, Williams AJK, Beales PE, Cugini P(1994). Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry vol. 101, (4) 263-269.
10.1007/BF00315913
Chianelli M, Mather SJ, Signore A, Ronga G, Pozzilli P, Fritzberg A(1994). 99mTc Labelling of Interleukin-2 for in Vivo Targeting of Activated T-Lymphocytes. Radiolabeled Blood Elements,
Buzzetti R, Nisticò L, Pozzilli P, Giovannini C(1994). Analysis of HLA-DQ Alpha and DQ Beta Genes in Type I (Insulin-dependent) Diabetes. Standardization of Epidemiologic Studies of Host Susceptibility,
Pozzilli P, Visalli N, Boccuni ML, Baroni MG, Buzzetti R, Fioriti E, Signore A, Cavallo MG et al.(1994). Combination of nicotinamide and steroid versus nicotinamide in recent- onset IDDM: The IMDIAB II study. Diabetes Care vol. 17, (8) 897-900.
10.2337/diacare.17.8.897
Cavallo MG, Pozzilli P, Thorpe R(1994). Cytokines and autoimmunity. Clinical and Experimental Immunology vol. 96, (1) 1-7.
10.1111/j.1365-2249.1994.tb06220.x
Pozzilli P, Leslie RDG(1994). Infections and Diabetes: Mechanisms and Prospects for Prevention. Diabetic Medicine vol. 11, (10) 935-941.
10.1111/j.1464-5491.1994.tb00250.x
Pozzilli P, Carotenuto P, Delitala G(1994). Lymphocytic traffic and homing into target tissue and the generation of endocrine autoimmunity. Clinical Endocrinology vol. 41, (5) 545-554.
10.1111/j.1365-2265.1994.tb01816.x
Signore A, Chianelli M, Ferretti E, Toscano A, Britton KE, Andreani D, Gale EAM, Pozzilli P(1994). New approach for in vivo detection of insulitis in type I diabetes: Activated lymphocyte targeting with <sup>123</sup>I-labelled interleukin 2. European Journal of Endocrinology vol. 131, (4) 431-436.
10.1530/eje.0.1310431
Pozzilli P, Visalli N, Boccuni ML, Baroni MG, Buzzetti R, Fioriti E, Signore A, Cavallo MG et al.(1994). Randomized Trial Comparing Nicotinamide and Nicotinamide Plus Cyclosporin in Recent Onset Insulin‐dependent Diabetes (IMDIAB 1). Diabetic Medicine vol. 11, (1) 98-104.
10.1111/j.1464-5491.1994.tb00237.x
Fava D, Leslie RDG, Pozzilli P(1994). Relationship between dairy product consumption and incidence of IDDM in childhood in Italy. Diabetes Care vol. 17, (12) 1488-1490.
10.2337/diacare.17.12.1488
Leslie RD, Pozzilli P(1994). Type I diabetes masquerading as type II diabetes. Possible implications for prevention and treatment. Diabetes care vol. 17, (10) 1214-1219.
10.2337/diacare.17.10.1214
Beales PE, Williams AJK, Albertini MC, Pozzilli P(1994). Vitamin E delays diabetes onset in the non-obese diabetic mouse. Hormone and Metabolic Research vol. 26, (10) 450-452.
10.1055/s-2007-1001731
Pozzilli P, Visalli N, Suppa A, Buzzetti R(1993). IDDM and rainfall. The Lancet vol. 342, (8885)
10.1016/0140-6736(93)92983-Z
POZZILLI P, KOLB H, ILKOVA HM(1993). NEW TRENDS FOR PREVENTION AND IMMUNOTHERAPY OF INSULIN-DEPENDENT DIABETES - PREFACE. DIABETES-METABOLISM REVIEWS vol. 9, (4) 237-237.
Pozzilli P, Buzzetti R, Bottazzo GF, Tosi R(1993). The selection of control subjects for case/control analysis of susceptibility to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia vol. 36, (11) 1208-1209.
10.1007/BF00401068
SEBASTIANI ML, SUPPA A, FIORITI E, MATTEOLI MC, PONTE E, GUGLIELMI A, FALDETTA MC, AMORETTI R et al. (1993). A RECORD OF TYPE-1 DIABETES OVER 4 CONSECUTIVE YEARS - EVIDENCE FOR CLIMATIC INFLUENCE ON DIABETES INCIDENCE. DIABETOLOGIA. vol. 36, A175-A175.
SIGNORE A, CHIANELLI M, FERRETTI E, MATHER SJ, GALE EAM, POZZILLI P (1993). IN-VIVO IMAGING OF ACTIVATED LYMPHOCYTES IN THE PANCREAS OF NEWLY-DIAGNOSED DIABETIC-PATIENTS. DIABETOLOGIA. vol. 36, A36-A36.
VISALLI N, BOCCUNI ML, LUCENTINI L, DEMATTIA GC, GHIRLANDA G, CICCONETTI CA, PISANO L, MULTARI G et al. (1993). NO DIFFERENCES IN CLINICAL AND METABOLIC CHARACTERISTICS BETWEEN NEWLY-DIAGNOSED IDDM CHILDREN AND ADULTS. DIABETOLOGIA. vol. 36, A58-A58.
FERRETTI E, CHIANELLI M, RONGA G, CIANCAMERIA M, MULTARI G, POZZILLI P, SIGNORE A (1993). RADIOLABELED IMMUNOGLOBULINS FOR IMAGING INSULITIS IN PREDIABETES. DIABETOLOGIA. vol. 36, A36-A36.
Williams AJK, Beales PE, Krug J, Procaccini E, Signore A, Xu S, Gale EAM, Pozzilli P(1993). Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse. Diabetologia vol. 36, (6) 487-492.
10.1007/BF02743262
PICARELLI A, FERRETTI E, CIANCAMERLA M, GRECO M, RONGA G, CORAZZIARI E, POZZILLI P, SIGNORE A (1993). INVIVO IMAGING OF SMALL-BOWEL LYMPHOCYTIC INFILTRATION IN CELIAC-DISEASE. GASTROENTEROLOGY. vol. 104, A271-A271.
Visalli N, Boccuni ML, Pozzilli P(1993). Acute administration of nicotinamide does not modify C-peptide and insulin secretion in normal subjects. Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 6, (3) 159-161.
Pozzilli P, Maclaren NK(1993). Immunotherapy at clinical diagnosis of insulin-dependent diabetes An approach still worth considering. Trends in Endocrinology and Metabolism vol. 4, (3) 101-105.
10.1016/1043-2760(93)90087-U
Muir A, Schatz DA, Pozzilli P, Maclaren NK(1993). Intervention therapies for insulin-dependent diabetes. Autoimmunity vol. 16, (4) 301-310.
10.3109/08916939309014650
Pozzilli P, Signore A, Williams AJK, Beales PE(1993). NOD mouse colonies around the world- recent facts and figures. Immunology Today vol. 14, (5) 193-196.
10.1016/0167-5699(93)90160-M
Leslie RDG, Carotenuto P, Pozzilli P (1993). New developments in non‐specific and semi‐specific immunosuppression in type I diabetes. Diabetes/Metabolism Reviews. vol. 9, 257-267.
10.1002/dmr.5610090406
Beales PE, Williams AJK, Signore A, Procaccini E, Xu S, Pozzilli P(1993). The effect of a heparin analogue, ITF-5005, on diabetes incidence and insulitis in the non-obese diabetic mouse. Diabetes Research and Clinical Practice vol. 21, (1) 5-9.
10.1016/0168-8227(93)90090-R
Pozzilli P, Andreani D(1993). The potential role of nicotinamide in the secondary prevention of IDDM. Diabetes/Metabolism Reviews vol. 9, (3) 219-230.
10.1002/dmr.5610090305
Baroni MG, Fiore V, Maestripieri PL, Caccamo C, Gragnoli C, Franciosi A, Negri M, Pozzilli P(1993). Therapy with a thymic extract and reduced recurrence of low urinary tract infections in patients with diabetes mellitus. Acta Therapeutica vol. 19, (3) 283-294.
Pozzilli P, Signore A, Andreani D(1992). What future for therapeutic prevention of Type I (insulin-dependent) diabetes mellitus?. Diabetologia vol. 35, (11) 1093-1095.
10.1007/BF02221687
SIGNORE A, CHIANELLI M, TOSCANO A, MONETINI L, RONGA G, NIMMON CC, BRITTON KE, POZZILLI P et al.(1992). A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studies. Nuclear Medicine Communications vol. 13, (10) 713-722.
10.1097/00006231-199210000-00003
Al Sakkaf L, Pozzilli P, Bingley PJ, Lowdell MW, Thomas JM, Bonifacio E, Gale EAM, Bottazzo GF(1992). Early T-cell defects in pre-type 1 diabetes. Acta Diabetologica vol. 28, (3-4) 189-192.
10.1007/BF00778996
BEALES PE, TOSCANO A, PETRUZZIELLO R, MASTROMARINO P, SIGNORE A, POZZILLI P (1992). ANTICOMPLEMENT ACTIVITY IN NOD MOUSE - PROTECTIVE ROLE IN BETA-CELL AUTOIMMUNITY. DIABETOLOGIA. vol. 35, A207-A207.
BUZZETTI R, NISTICO L, SORRENTINO R, POZZILLI P, GIOVANNINI C, TOSI R (1992). COMBINED ANALYSIS OF BOTH DQA1 AND DQB1 GENE POLYMORPHISMS IS REQUIRED TO EVALUATE THE RISK FOR TYPE-1 DIABETES. DIABETOLOGIA. vol. 35, A138-A138.
VISALLI N, LUCENTINI L, CRINO A, CICCONETTI CA, TEODONIO C, AMORETTI R, PISANO L, PENNAFINA MG et al. (1992). COMPARISON BETWEEN NICOTINAMIDE AND NICOTINAMIDE + DEFLAZACORT IN RECENT ONSET TYPE-1 DIABETES. DIABETOLOGIA. vol. 35, A218-A218.
SIGNORE A, CHIANELLI M, FERRETTI E, TOMEI E, RONGA G, ANDREANI D, POZZILLI P (1992). DETECTION OF PANCREATIC INSULITIS IN TYPE-1 DIABETES BY USING 1231I-LABELED INTERLEUKIN-2. DIABETOLOGIA. vol. 35, A214-A214.
SIGNORE A, CHIANELLI M, FERRETTI E, TOMEI E, POZZILLI P, RONGA G, CANTARANO G, ANDREANI D (1992). DETECTION OF PANCREATIC INSULITIS IN TYPE-1 DIABETES BY USING 123I-LABELED INTERLEUKIN-2. EUROPEAN JOURNAL OF NUCLEAR MEDICINE. vol. 19, 583-583.
BARONI MG, ALCOLADO JC, GALTON DJ, ANDREANI D, POZZILLI P(1992). SIB-PAIR ANALYSIS OF THE GLUT1 GLUCOSE TRANSPORTER GENE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS. DIABETOLOGIA vol. 35, A72-A72.
CAVALLO MG, DOTTA F, MONETINI L, TOTO A, ANDREANI D, POZZILLI P (1992). STUDY OF BETA-CELL MARKERS AND ANTIGEN EXPRESSION BY A HUMAN INSULINOMA CELL-LINE. DIABETOLOGIA. vol. 35, A207-A207.
Visalli N, Pozzilli P, Boccuni ML, Suppa MA, Messina R, Buzzetti R, Andreani D(1992). Immunointervention in insulin dependent diabetes: implications for the epidemiology of the disease. Annali di igiene : medicina preventiva e di comunita vol. 4, (3) 159-163.
Baroni MG, Oelbaum RS, Pozzilli P, Stocks J, Li SR, Fiore V, Galton DJ(1992). Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM). Human Genetics vol. 88, (5) 557-561.
10.1007/BF00219344
Signore A, Chianelli M, Toscano A, Monetini L, Ronga G, Nimmon CC, Britton KE, Pozzilli P et al.(1992). A radiopharmaceutical for imaging areas of lymphocytic infiltration:<sup>123</sup>I-interleukin-2. labelling procedure and animal studies. Nuclear Medicine Communications vol. 13, (10) 713-722.
10.1097/00006231-199213100-00003
Pozzilli P, Buzzetti R, Dotta F, Andreani D(1992). Acute onset of seeming IDDM in an AIDS patient [2]. Diabetes Care vol. 15, (11) 1824-1825.
Beales PE, Williams A, Krug J, Signore A, Chianelli M, Andreani D, Pozzilli P(1992). Effecs of Tenidap®, a novel anti-inflammatory compound on islet lymphocytic infiltration and diabetes incidence in the non obese diabetic (NOD) mouse. Diabete et Metabolisme vol. 18, (1) 48-53.
Krug J, Lampeter EF, Williams AJK, Procaccini E, Cartledge C, Signore A, Beales PE, Pozzilli P(1992). Immunotherapy with ciamexon in the non obese diabetic (NOD) mouse. Hormone and Metabolic Research vol. 24, (1) 1-4.
10.1055/s-2007-1003240
Cugini P, Lucia P, Di Palma L, Pozzilli P, Re M, Canova R, Gasbarrone L, Cianetti A(1992). Interactions between the circadian rhythm of vasoactive intestinal peptide (VIP) and T lymphocyte subpopulations: Evidence of VIP-induced immunoregulation. Immunologia Clinica vol. 11, (1) 15-22.
Baroni MG, Alcolado JC, Pozzilli P, Cavallo MG, Li S, Galton DJ(1992). Polymorphisms at the GLUT2 (β‐cell/liver) glucose transporter gene and non‐insulin‐dependent diabetes mellitus (NIDDM): analysis in affected pedigree members. Clinical Genetics vol. 41, (5) 229-234.
10.1111/j.1399-0004.1992.tb03671.x
Cugini P, Battisti P, Di Palma L, Cavallini M, Pozzilli P, Scibilia G, Letizia C, Cassisi A et al.(1992). Secondary aldosteronism documented by plasma renin and aldosterone circadian rhythm in subjects with kidney or heart transplantation. Renal Failure vol. 14, (1) 69-76.
10.3109/08860229209039119
Baroni MG, Alcolado JC, Needham EWA, Pozzilli P, Stocks J, Galton DJ(1992). Sib-pair analysis of adenosine deaminase locus in NIDDM. Diabetes vol. 41, (12) 1640-1643.
10.2337/diab.41.12.1640
Cugini P, Gasbarrone L, Lucia P, Cianetti A, Canova R, Di Palma L, Sepe FA, Pozzilli P et al.(1992). The circadian rhythm of plasma vasoactive intestinal peptide, atrial natriuretic peptide, renin activity, aldosterone and cortisol in heart transplantation. The effects of immunosuppressive therapy. Cardiologia (Rome, Italy) vol. 37, (10) 693-699.
Cavallo MG, Baroni MG, Toto A, Gearing AJH, Forsey T, Andreani D, Thorpe R, Pozzilli P(1992). Viral infection induces cytokine release by beta islet cells. Immunology vol. 75, (4) 664-668.
Buzzetti R, Pozzilli P, Giovannini C(1991). Human lymphocytes and the hypothalamus pituitary secretory axis as seen by an endocrinological point of view. EOS Rivista di Immunologia ed Immunofarmacologia vol. 11, (4) 131-134.
Cugini P, Lucia P, Di Palma L, Pozzilli P, Re M, Canova R, Gasbarrone L, Cianetti A(1991). Temporal interrelationships between circadian rhythms of vasoactive intestinal peptide and T lymphocyte subpopulations. Journal of Clinical and Laboratory Immunology vol. 34, (2) 49-54.
Pozzilli P, Visalli N, Signore A, Andreani D, Quatraro A, Minei A, Torella R, Ceriello A et al.(1991). Clinical remission in patients with IDDM and family history of NIDDM. The Lancet vol. 337, (8750)
10.1016/0140-6736(91)92835-P
Cugini P, Cavallini M, Pozzilli P, Letizia C, Sepe M, Di Palma L, Battisti P(1991). Circadian rhythm of T-lymphocyte subsets, cortisol and cyclosporin in kidney-transplanted subjects. Nephrology Dialysis Transplantation vol. 6, (7) 512-517.
10.1093/ndt/6.7.512
Cugini P, Battisti P, Di Palma L, Cavallini M, Pozzilli P, Scibilia G, Letizia C, Sepe M et al.(1991). Circadian rhythm of renin-angiotensin-aldosterone system in kidney and heart transplanted subjects. Recenti Progressi in Medicina vol. 82, (1) 4-8.
Pozzilli P, Bottazzo GF(1991). Coffee or sugar: Which is to blame in IDDM? [1]. Diabetes Care vol. 14, (2) 144-145.
10.2337/diacare.14.2.144
CAVALLO MG, POZZILLI JP, BIRD C, WADHWA M, MEAGER A, VISALLI N, GEARING AJH, ANDREANI D et al.(1991). Cytokines in sera from insulin‐dependent diabetic patients at diagnosis. Clinical &amp; Experimental Immunology vol. 86, (2) 256-259.
10.1111/j.1365-2249.1991.tb05806.x
Krug J, Williams A, Beales P, Procaccini E, Chianelli M, Signore A, Negri M, Tonnarini GF et al.(1991). Effect of an anti-protein denaturant and immunomodulator (bendazac lysine salt) on the incidence of diabetes and insulitis in the non obese diabetic mouse. Acta Therapeutica vol. 17, (3) 245-252.
DORMAN JS, BESSAOUD K, DESEREDAY M, MARTI M, SCHOBER E, FRANCO L, NEGRATO C, RUSSO E et al.(1991). FAMILIAL INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) EPIDEMIOLOGY - STANDARDIZATION OF DATA FOR THE DIAMOND PROJECT. BULLETIN OF THE WORLD HEALTH ORGANIZATION vol. 69, (6) 767-777.
Krug J, Williams AJK, Beales PE, Doniach I, Gale EAM, Pozzilli P(1991). Parathyroiditis in the non-obese diabetic mouse - A new finding. Journal of Endocrinology vol. 131, (2) 193-196.
10.1677/joe.0.1310193
Andreani D, Di Mario U, Pozzilli P(1991). Prediction, prevention, and early intervention in insulin‐dependent diabetes. Diabetes/Metabolism Reviews vol. 7, (1) 61-77.
10.1002/dmr.5610070107
Pozzilli P, Pagani S, Buzzetti R, Cruciani L, Beales PE, Cucinotta D, Benzi L, Porta M et al.(1991). Prevalence of serological markers for hepatitis‐B in patients with insulin‐dependent diabetes. Practical Diabetes International vol. 8, (1) 5-6.
10.1002/pdi.1960080103
Cugini P, Lucia P, Di Palma L, Pozzilli P, Re M, Canova R, Gasbarrone L, Cianetti A(1991). Vasoactive intestinal peptide: A chronoimmunomodulator?. Biochemical Medicine and Metabolic Biology vol. 46, (2) 274-276.
10.1016/0885-4505(91)90077-X
Bach JF, Dupre J, Eisenbarth GS, Harrison LC, Maclaren NK, Nerup J, Pozzilli P(1990). Immunotherapy in pre-Type 1 diabetes mellitus. Diabetologia vol. 33, (12)
10.1007/BF00400349
Boccuni ML, De Mattia G, Laurenti O, Bravi C, Messina R, Bruno MR, Visalli N, Pozzilli P(1990). Recent advances in pathogenesis and immunotherapy of type 1 diabetes. Folia Allergologica et Immunologica Clinica vol. 37, (2) 67-76.
Krug J, Lohmann D, Andreani D, Pozzilli P(1990). The immunoregulatory system in Type I (insulin-dependent) diabetes. Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 3, (4) 351-358.
Williams AJK, Krug J, Lampeter EF, Mansfield K, Beales PE, Signore A, Gale EAM, Pozzilli P(1990). Raised temperature reduces the incidence of diabetes in the NOD mouse. Diabetologia vol. 33, (10) 635-637.
10.1007/BF00400211
Colle E, Lounamaa R, Tuomilehto J, De Beaufort, Balzano E, Bruno G, Cacciari E, Cerutti F et al.(1990). The epidemiology and immunogenetics of IDDM in Italian-heritage populations. Diabetes Epidemiology Research International (DERI) Study Group. Diabetes Metab Rev vol. 6, (2) 63-69.
10.1002/dmr.5610060201
Sensi M, Valente L, Casini A, Bruno MR, Cioccia G, Pozzilli P(1990). Reduction of the non-enzymic glycation of a short lived protein (retinol binding protein) induced by Bendazac. Medical Science Research vol. 18, (3) 107-108.
Lampeter EF, Pozzilli P, Signore A, Williams A, Mansfield K, Gale EAM(1990). Ciamexone treatment in the NOD mice — Failure to suppress insulitis. Journal of Autoimmunity vol. 3, (1)
10.1016/0896-8411(90)90067-3
Cugini P, Cavallini M, Pozzilli P, Scibilia G, Letizia C, Di Palma L, Battisti P, Sepe M et al.(1990). Circadian rhythms of T lymphocyte subpopulations and cortisol in kidney and heart transplantation. Progress in clinical and biological research vol. 341 A, 543-553.
Signore A, Chianelli M, Ronga G, Pozzilli P, Beverley PC(1990). In vivo labelling of activated T lymphocytes by i.v. injection of 123I-IL2 for detection of insulitis in type 1 diabetes. Progress in clinical and biological research vol. 355, 229-238.
Cugini P, Cavallini M, Pozzilli P, Palestini M, Letizia C, Di Palma L, Sepe M, Battisti P(1990). Lymphocyte subpopulations, plasma cortisol and cyclosporine in kidney transplantation. Giornale Italiano di Nefrologia vol. 7, (3) 191-200.
Sensi M, Bruno MR, Valente L, Cioccia GP, Chianelli M, Pozzilli P(1990). Retinol binding protein: a short half life determinant of protein non enzymatic glycation in diabetes. Diabetes research (Edinburgh, Lothian) vol. 13, (4) 195-198.
Cugini P, Cavallini M, Pozzilli P, Palestini M, Letizia C, Di Palma L, Battisti P(1990). T lymphocyte subpopulations, plasma cortisol and ciclosporin in kidney-transplanted subjects: a chronobiologic approach to the adrenal-immune system. Contributions to nephrology vol. 83, 264-269.
10.1159/000418810
Pozzilli P, Andreani D(1990). Type 1 Diabetes at Presentation: the Scene Changes. Diabetic Medicine vol. 7, (9) 762-763.
10.1111/j.1464-5491.1990.tb01488.x
Pozzilli P, Buzzetti R, McLoughlin L(1989). Bidirectional interaction between the hypophysis-adrenal axis and the immune system. Immunologia Clinica vol. 8, (4) 171-184.
Buzzetti R, McLoughlin L, Rees LH, Pozzilli P (1989). Human lymphocytes and production of pro-opiomelanocortin (POMC) derived peptides: State of art. Journal of Endocrinological Investigation. vol. 12, 43-48.
Pagani S, Cruciani L, Chianelli M, Procaccini E, Pozzilli P(1989). Thymopentin administration and increase of sero-conversion after B-hepatitis vaccine in diabetic patients. Diabetes Research vol. 12, (4) 199-201.
Buzzetti R, Valente L, Barletta C, Scavo D, Pozzilli P(1989). Thymopentin induces release of acth-like immunoreactivity by human lymphocytes. Journal of Clinical and Laboratory Immunology vol. 29, (4) 157-159.
Lampeter EF, Signore A, Gale EAM, Pozzilli P(1989). Lessons from the NOD mouse for the pathogenesis and immunotherapy of human Type 1 (insulin-dependent) diabetes mellitus. Diabetologia vol. 32, (10) 703-708.
10.1007/BF00274528
Kolb H, Bach JF, Eisenbarth GS, Harrison LC, Maclaren NK, Pozzilli P, Skyler JS, Stiller CR(1989). CRITERIA FOR IMMUNE TRIALS IN TYPE I DIABETES. The Lancet vol. 334, (8664)
10.1016/S0140-6736(89)90937-9
Al-Sakkaf L, Pozzilli P, Tarn AC, Schwarz G, Gale EAM, Bottazzo GF(1989). Persistent reduction of CD4/CD8 lymphocyte ratio amd cell activation before the onset of Type 1 (insulin-dependent) diabetes. Diabetologia vol. 32, (5) 322-325.
10.1007/BF00265550
Signore A, Pozzilli P, Gale EAM, Andreani D, Beverley PCL(1989). The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia vol. 32, (5) 282-289.
10.1007/BF00265543
Cugini P, Letizia C, Di Palma L, Sepe M, Battisti P, Pozzilli P, Cassisi A, Cioli AR et al.(1989). 24-Hour behaviour of T lymphocyte subpopulations in patients with stable heart transplant during cyclosporine therapy. Cardiologia vol. 34, (6) 537-550.
Buttinelli C, Signore A, Salvetti M, Pozzilli C, Fieschi C, Pozzilli P(1989). A longitudinal study of lymphocyte activation in multiple sclerosis. Medical Science Research vol. 17, (14) 603-604.
Di Mario U, Vitillo M, Perfetti R, Mancuso M, Morellini M, Cappellacci S, Pozzilli P, Andreani D(1989). Humoral and cellular immunological factors as possible markers of clinical relapse in HLA-typed Graves' patients followed with time. Hormone and Metabolic Research vol. 21, (5) 267-271.
10.1055/s-2007-1009209
Pozzilli P, Kolb H(1989). Immunotherapy in type 1 diabetes: present status. Immunology Today vol. 10, (10) 321-322.
10.1016/0167-5699(89)90180-1
Cavallo MG, Signore A, Baroni MG, Andreani D, Pozzilli P(1989). Interleukin 2 (IL2) production and IL2 receptor release in type I diabetes mellitus. Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 2, (3) 179-183.
Pozzilli P, Visalli N, Ghirlanda G, Manna R, Andreani D(1989). Nicotinamide Increases C‐peptide Secretion in Patients with Recent Onset Type 1 Diabetes. Diabetic Medicine vol. 6, (7) 568-572.
10.1111/j.1464-5491.1989.tb01229.x
Sensi M, Tanzi P, Bruno MR, Pozzilli P, Mancuso M, Gambardella S, Di Mario U(1989). Nonenzymic glycation of isolated human glomerular basement membrane changes its physicochemical characteristics and binding properties. Nephron vol. 52, (3) 222-226.
10.1159/000185646
Signore A, Lampeter E, Cavallo MG, Visalli N, Pozzilli P(1989). The immunological network in the pathogenesis of type 1 diabetes mellitus. EOS Rivista di Immunologia ed Immunofarmacologia vol. 9, (2) 63-67.
Pozzilli P, Pagani S, Visalli N, Boccuni ML, Cruciani L, Negri M(1989). Thymopentin administration and antibody titre following anti-influenza vaccine in diabetic patients. Medical Science Research vol. 17, (13) 549-550.
Bruno MR, Sensi M, Cioccia GP, Valente L, Negri M, Ghirlanda G, Pozzilli P(1988). Inhibition of protein non-enzymic glycation induced by bendazac. Diabetes Research vol. 9, (1) 11-14.
Signore A, Beverley PC, Negri M, Pozzilli P(1988). Labelling of interleukin 2 with 123 iodine and its administration to animals susceptible to diabetes for the visualization of lymphocytic infiltration in the pancreas. Minerva Endocrinologica vol. 13, (4) 279-285.
Pozzilli P, Fighi V, Fiore V, Casanica M, Giaccari A, Sbraccia P, Tamburrano G(1988). Effects of Acarbose on Insulin Sensitivity and Liver Uptake in Patients with Type I Diabetes. Acarbose for the Treatment of Diabetes Mellitus,
Pozzilli P(1988). Immunotherapy in Type 1 Diabetes. Diabetic Medicine vol. 5, (8) 734-738.
10.1111/j.1464-5491.1988.tb01099.x
Pozzilli P, Visalli N, Andreani D(1988). Immunotherapy of Type I diabetes: Facts and recommendations. Diabetes, Nutrition and Metabolism - Clinical and Experimental vol. 1, (4) 269-271.
Di Mario U, Cavatorta FP, Perfetti R, Pugliese G, Pozzilli P, Sutherland J, Vitillo M, Andreani D(1988). Quantitative immunological differences between newly diagnosed Graves’ disease patients and relapsed patients. Journal of Endocrinological Investigation vol. 11, (2) 85-89.
10.1007/BF03350108
Pozzilli P, Occhigrossi F, Buzzetti R, Fiore V(1988). Record books and patients with NIDDM. Waste of time?. Diabetes care vol. 11, (3) 299-300.
10.2337/diacare.11.3.299
Sensi M, Cioccia GP, Bruno MR, Ghirlanda G, Valente L, Negri M, Tonnarini G, Pozzilli P(1988). The in vitro effect of Bendazac on the expression of interleukin 2 receptors and lymphocyte transformation in normal and diabetic patients. Medical Science Research vol. 16, (7) 327-328.
Signore A, Pozzilli P, Tamburrano G, Andreani D(1988). The in vivo visualization of insulitis. A new marker of prediabetes. Advances in experimental medicine and biology vol. 246, 119-125.
10.1007/978-1-4684-5616-5_15
Pozzilli P, Visalli N, Cavallo MG, Beales P, Negri M, Ghirlanda G, Papa V, Andreani D(1987). Normalization of the CD4/CD8 lymphocyte ratio and increased B lymphocytes in long standing diabetic patients following therapy with thymopentin. Diabetes Research vol. 6, (2) 51-56.
Signore A, Cooke A, Pozzilli P, Butcher G, Simpson E, Beverley PCL(1987). Class-II and IL 2 receptor positive cells in the pancreas of NOD mice. Diabetologia vol. 30, (11) 902-905.
10.1007/BF00274802
Pozzilli P, Arduini P, Visalli N, Sutherland J, Pezzella M, Galli C, Corradini SG, Biasio L et al.(1987). Reduced protection against hepatitis B virus following vaccination in patients with Type 1 (insulin-dependent) diabetes. Diabetologia vol. 30, (10) 817-819.
10.1007/BF00275749
Lampeter EF, Krug J, Beales P, Sutherland J, Cossel L, Pozzilli P(1987). Ultrastructure of lymphocyte subsets and of activated lymphocytes in type 1 diabetes as defined by monoclonal antibodies and the immunogold technique. Diabetes Research vol. 5, (2) 59-66.
Signore A, Pozzilli P, Parman A, Andreani D, Beverley PCL(1987). DETECTION OF ACTIVATED LYMPHOCYTES IN ENDOCRINE PANCREAS OF BB/W RATS BY INJECTION OF <sup>123</sup>I-INTERLEUKIN-2: AN EARLY SIGN OF TYPE 1 DIABETES. The Lancet vol. 330, (8558) 537-540.
10.1016/S0140-6736(87)92925-4
Signore A, Negri M, Pozzilli P(1987). Toxicity of indium-111 on lymphocytes. Journal of Nuclear Medicine vol. 28, (8)
Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M(1987). Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut vol. 28, (6) 745-753.
10.1136/gut.28.6.745
Pozzilli P, Signore A, Negri M(1987). Immunological markers and immunotherapy in insulin dependent (Type I) diabetes. Medical Science Research vol. 15, (22) 1363-1365.
Pozzilli P(1987). Immunosuppressive Type 1 diabetes. New Acquisitions. Recenti Progressi in Medicina vol. 78, (11) 514-516.
Di Mario U, Crisa L, Pozzilli P, Andreani D(1987). Immunotherapy of type 1 diabetes: Utopia or reality?. Giornale Italiano di Diabetologia vol. 7, (4) 293-297.
Sensi M, Bruno MR, Pozzilli P(1987). In vitro inhibition of non-enzymatic glycosylation induced by aspirin. Medical Science Research vol. 15, (2) 99-100.
Pozzilli P, Pagani S, Arduini P, Visalli N, Cioccia GP, Negri M, Andreani D(1987). In vivo determination of cell mediated immune response in diabetic patients using a multiple intradermal antigen dispenser. Diabetes Research vol. 6, (1) 5-8.
Sinclair AJ, Signore A, Bomanji J, Britton KE, Pozzilli P, Gale E(1987). In vivo kinetics of<sup>123</sup>I-labelled insulin: Studies in normal subjects and patients with diabetes mellitus. Nuclear Medicine Communications vol. 8, (10) 779-786.
10.1097/00006231-198710000-00003
Casanica M, Busco S, Buzzetti R, Negri M, Beales PE, Pozzilli P(1987). Intravenous infusion of thymopentin does not change pituitary and pancreatic hormone secretion in man. Medical Science Research vol. 15, (15) 915-916.
Signore A, Beverley PCL, Parman A, Negri M, Pozzilli P(1987). Labelling of Interleukin-2 (IL-2) with 123-Iodine with Retention of Its Capacity to Bind to Activated Lymphocytes. Experimental and Clinical Endocrinology and Diabetes vol. 89, (3) 301-306.
10.1055/s-0029-1210654
Tanzi P, Vitillo M, Mancuso M, Fiore V, Pozzilli P, Di Mario U, Andreani D(1987). The Effect of High Doses of Carbimazole in Patients with Graves’disease and in Subjects with Thyroid Antibodies. Thyroid Autoimmunity,
Pozzilli P, Visalli N, Corcos A, Andreani D(1987). Why do so few diabetic patients attend dialysis centers in Central Italy?. Journal of Diabetic Complications vol. 1, (1) 4-6.
10.1016/S0891-6632(87)80017-X
Pozzilli P, Gale EAM, Visallil N, Baroni M, Crovari P, Frighi V, Cavallo MG, Andreani D(1986). The immune response to influenza vaccination in diabetic patients. Diabetologia vol. 29, (12) 850-854.
10.1007/BF00870139
Pozzilli P, Ghirlanda G, Manna R, Alfano G, Greco AV, Andreani D(1986). White cells transfusion in recent onset type 1 diabetes. Diabetes Research vol. 3, (5) 273-276.
Pozzilli P, Signore A, Andreani D(1986). Does the current knowledge on the pathogenesis of type 1 diabetes justify immunotherapeutic intervention?. Recenti progressi in medicina vol. 77, (5) 245-248.
Pozzilli P, Signore A, Pozzilli C(1986). Development and applications of the marking technique of lymphocytes with Indium-111 in the study of the organ pathology. EOS Rivista di Immunologia ed Immunofarmacologia vol. 6, (1) 47-50.
Pozzilli P, Negri M, Visalli N(1986). Impaired CD4/CD8 lymphocyte ratio in patients with long standing diabetes mellitus. IRCS Medical Science vol. 14, (7) 648-649.
Pozzilli P, Colletti F, Tarentini M(1986). Mechanisms of damage to the islands of Langerhans in type I diabetes. Minerva endocrinologica vol. 11, (1) 45-48.
Al-Sakkaf L, Pozzilli P, Sensi M, Irving WL, Bottazzo GF(1985). A cell surface monoclonal antibody (H366) helps to discriminate human cytotoxic from suppressor T cells. Clinical and Experimental Immunology vol. 62, (3) 594-599.
Frighi V, Pozzilli P(1985). Diabetic cardiopathy: An overview. Cardiologia vol. 30, (3) 177-182.
Signore A, Pozzilli C, Negri M, Lenzi GL, Pozzilli P(1985). Homing and circulation of indium-111-labelled leucocytes. A post-mortem study. Diagnostic Imaging in Clinical Medicine vol. 54, (6) 315-317.
Pozzilli P, Tarn AC, Gale EAM(1985). HLA-DR3 AND ACTIVATED LYMPHOCYTES: SIGNIFICANCE IN AUTOIMMUNITY. The Lancet vol. 326, (8461) 954-955.
10.1016/S0140-6736(85)90892-X
Signore A, Cugini P, Letizia C, Lucia P, Murano G, Pozzilli P(1985). Study of the diurnal variation of human lymphocyte subsets. Journal of Clinical and Laboratory Immunology vol. 17, (1) 25-28.
Sensi M, Zuccarini O, Spencer KM, Beales P, Pujol-Borrell R, Pozzilli P(1985). In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with Type 1 diabetes. Diabetes Research vol. 2, (1) 1-4.
Signore A, Pozzilli P, Di Mario U, Sensi M, Beales P, Andreani D(1985). Inhibition of the receptor for interleukin-2 induced by carbimazole: Relevance for the therapy of autoimmune thyroid disease. Clinical and Experimental Immunology vol. 60, (1) 111-116.
Signore A, Sensi M, Pozzilli C, Negri M, Lenzi GL, Pozzilli P(1985). Effect of unlabeled indium oxine and indium tropolone on the function of isolated human lymphocytes. J Nucl Med vol. 26, (6) 612-615.
Fais S, Pallone F, Squarcia O, Boirivant M, Pozzilli P(1985). T cell early activation antigens expressed by peripheral lymphocytes in Crohn's Disease. Journal of Clinical and Laboratory Immunology vol. 16, (2) 75-76.
Kennedy R, Di Mario U, Pozzilli P, Guy K, Leonardi M, Sensi M, Andreani D(1985). Activated T cells in Graves' disease before treatment. Clinical and Experimental Immunology vol. 59, (2) 377-382.
Pozzilli P, Corcos A(1985). Immunology in the natural history of diabetes mellitus. Minerva Endocrinologica vol. 10, (2) 71-78.
Zuccarini O, Sensi M, Gargiulo P, Pozzilli P, Tiberti C, Pachi A, Fallucca F(1985). Sera from diabetic pregnant women contain reduced titres of inhibiting factors on killer cell activity. Diabetologia vol. 28, (2) 95-98.
10.1007/BF00279923
Pozzilli P, Signore A, Andreani D(1985). Does the present knowledge of the pathogenesis of type 1 diabetes justify an immunotherapeutic approach?. Italian Journal of Medicine vol. 1, (2-3) 92-95.
Pozzilli C, Lenzi GL, Argentino C, Carolei A, Rasura M, Signore A, Bozzao L, Pozzilli P(1985). Imaging of leukocytic infiltration in human cerebral infarcts. Stroke vol. 16, (2) 251-255.
10.1161/01.STR.16.2.251
Lenzi GL, Fazio F, Pozzilli C, Negri M, Bozzao L, Fantozzi LM, Gerundini P, Colombo F et al.(1985). New Approaches to the Study of Cerebral Ischemia in Man Using Single Photon Labeled Indicators. Cerebral Blood Flow and Metabolism Measurement,
Pozzilli P, Zuccarini O, Sensi M, Spencer KM, Bottazzo G(1984). Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus. Biomedica Biochimica Acta vol. 43, (5) 621-625.
Pozzilli P, Signore A, Pozzilli C(1984). Detrimental effect of indium-111 on human lymphocytes. Journal of Nuclear Medicine vol. 25, (7)
Pozzilli P, Sensi M, Al-Sakkaf L, Tarn A, Zuccarini O, Bottazzo GF(1984). Prospective study of lymphocyte subsets in subjects genetically susceptible to Type 1 (insulin-dependent) diabetes. Diabetologia vol. 27, (1 Supplement) 132-135.
10.1007/BF00275670
Sensi M, Pozzilli P, Di Mario U(1984). A method to facilitate the reading of up to 60 samples of monoclonal antibody-fluorescence stained cells using medicell HLA-DR plates. Journal of Clinical and Laboratory Immunology vol. 13, (2) 101-102.
Pozzilli P, Sensi M(1984). Alpha-2-macroglobulin levels in Type 1 diabetes at diagnosis and in subjects at risk for the disease. IRCS Medical Science vol. 12, (10) 947-948.
Andreani D, Di Mario U, Zuccarini O, Franco M, Sensi M, Iavicoli M, Pozzilli P(1984). Lymphocyte subsets and immune complexes in long standing diabetic patients: Relation with the presence of microangiopathy. Immunology Letters vol. 8, (1) 17-21.
10.1016/0165-2478(84)90098-1
Di Mario U, Pozzilli P, Andreani D(1983). Immunology in the early stages of type I diabetes. Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology vol. 6, (5) 395-400.
10.1007/BF03347624
Sensi M, Di Mario U, Pozzilli P(1983). Inhibition of antibody dependent cellular cytotoxicity induced by sera from patients with insulin dependent (Type I) diabetes. IRCS Medical Science vol. 11, (7)
Signore A, Beales P, Sensi M, Zuccarini O, Pozzilli P(1983). Labelling of lymphocytes with indium 111 oxine: Effect on cell surface phenotype and antibody-dependent cellular cytotoxicity. Immunology Letters vol. 6, (3) 151-154.
10.1016/0165-2478(83)90097-4
Tamburrano G, Pozzilli P(1983). Metabolic and hormonal effect of 19-norandrostenolone in type 2 (insulin independent) diabetes mellitus. Acta Therapeutica vol. 9, (3) 253-262.
Pozzilli P, Zuccarini O, Iavicoli M, Andreani D, Sensi M, Spencer KM, Bottazzo GF, Beverley PC et al.(1983). Monoclonal antibodies defined abnormalities of T-lymphocytes in type I (insulin-dependent) diabetes. Diabetes vol. 32, (1) 91-94.
10.2337/diab.32.1.91
Pallone F, Montano S, Fais S, Boirivant M, Signore A, Pozzilli P(1983). Studies of peripheral blood lymphocytes in crohn's disease: Circulating activated t cells. Scandinavian Journal of Gastroenterology vol. 18, (8) 1003-1008.
10.3109/00365528309181833
POZZILLI P, POZZILLI C, PANTANO P, NEGRI M, ANDREANI D, CUDWORTH AG(1983). TRACKING OF INDIUM‐111‐OXINE LABELLED LYMPHOCYTES IN AUTOIMMUNE THYROID DISEASE. Clinical Endocrinology vol. 19, (1) 111-116.
10.1111/j.1365-2265.1983.tb00749.x
Pozzilli P, Di Mario U, Andreani D(1982). Cell-mediated immunity and immune complexes in the pathogenesis of type 1 (insulin-dependent) diabetes. Acta Diabetologica Latina vol. 19, (4) 295-300.
10.1007/BF02629252
Sensi M, Pozzilli P, Ventriglia L, Doniach I, Cudworth AG(1982). Histology of the islets of Langerhans following administration of human lymphocytes into athymic mice. Clinical and Experimental Immunology vol. 49, (1) 81-86.
Pozzilli P, Cudworth AG, Andreani D(1982). Cell mediated immunity in the pathogenesis of insulin dependent (type I) diabetes mellitus. Giornale Italiano di Diabetologia vol. 2, (2) 157-163.
Iavicoli M, Di Mario U, Pozzilli P, Canalese J, Ventriglia L, Galfo C, Andreani D(1982). Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathy. Diabetes vol. 31, (1) 7-11.
10.2337/diab.31.1.7
Iavicoli M, Di Mario U, Pozzilli P, Canalese J, Ventriglia L, Galfo C, Andreani D(1982). Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathy. Diabetes vol. 31, (1) 7-11.
10.2337/diab.31.1.7
Pozzilli P, Andreani D(1982). Increased 'killer' cells in Graves' disease. Hormone and Metabolic Research vol. 14, (1)
10.1055/s-2007-1018922
Pozzilli P, Sensi M, Andreani D(1982). Inhibition of killer cell cytotoxicity induced by carbimazole in vitro. Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology vol. 5, (3) 149-152.
10.1007/BF03349469
Sensi M, Pozzilli P, Cudworth AG(1981). Antibody-dependent and natural killer cytotoxicity in type 1 diabetes. Acta Diabetologica Latina vol. 18, (4) 339-344.
10.1007/BF02042818
Sensi M, Pozzilli P, Gorsuch AN, Bottazzo GF, Cudworth AG(1981). Increased killer cell activity in insulin dependent (Type 1) diabetes mellitus. Diabetologia vol. 20, (2) 106-109.
10.1007/BF00262010
Pozzilli P, Sensi M, Meschini C(1981). Low affinity and high affinity E-rosetting cells: A study with the 3A1 monoclonal antibody. IRCS Medical Science vol. 9, (11) 1047-1048.
Negri M, Tamburrano G, Pozzilli P(1981). Prolactin (PRL) and cortisol dynamic secretion in hirsute females treated with 12 mg cyproterone acetate (CA). Progresso Medico vol. 37, (17) 747-749.
Pozzilli P, Sensi M, Dean B, Gorsuch A, Cudworth A(1980). The importance of measuring Fc<sup>+</sup> (killer) cells in insulin-dependent (type 1) diabetes. Acta Diabetologica Latina vol. 17, (2) 119-122.
10.1007/BF02580993
Pozzilli P, Di Mario U, Javicoli M, Chinca M, Orsini M(1980). Alpha 2 macroglobulin: Its variability in diabetes. Hormone and Metabolic Research vol. 12, (8) 409-410.
10.1055/s-2007-999158
Sensi M, Pozzilli P, Cattell WR(1980). Gentamicin nephrotoxicity in experimental acute renal failure. Acta Therapeutica vol. 6, (1) 65-73.
Pozzilli P, Sensi M, Cudworth AG(1980). Identification of high risk subjects for Type 1 diabetes by means of HLA family study and leucocyte migration inhibition test. Diabetologia Croatica vol. 9, (Suppl 1) 132-135.
Pozzilli P, Di Mario U, Javicoli M, Menzinger G, Andreani D(1980). Inhibition of allogeneic lymphocyte E-rosettes induced by sera from newly diagnosed type I diabetics. Acta Endocrinologica vol. 93, (1) 49-53.
10.1530/acta.0.0930049
Pozzilli P(1980). The cell-mediated immunity in juvenile onset-insulin dependent (type I) diabetes. Rassegna di Medicina Interna vol. 1, (2) 211-218.
Pozzilli P, Gorsuch A, Sensi M, Bottazzo GF, Cudworth AG(1979). EVIDENCE FOR RAISED K-CELL LEVELS IN TYPE-I DIABETES. The Lancet vol. 314, (8135) 173-175.
10.1016/S0140-6736(79)91436-3
Tamburrano G, Pozzilli P, Gaspardone A, Mazzei E(1979). Hormonal changes induced by undecilate 19-norandrostenolone in normal subjects. Policlinico - Sezione Medica vol. 86, (6) 480-490.
Iavicoli M, Pozzilli P, Di Mario U(1979). Increased lymphocyte transformation by insulin induced hypoglycaemia in normal subjects. Journal of Clinical and Laboratory Immunology vol. 1, (4) 351-353.
Puddu PE, Pozzilli P, Rulli V(1978). Cycloergometric stress test, coronarography and metabolic parameters in high risk patients. Cardiologia Pratica vol. 29, (2) 81-84.
Irvine WJ, Di Mario U, Guy K, Iavicoli M, Pozzilli P, Lumbroso B, Andreani D(1978). Immune complexes and diabetic microangiopathy. Journal of Clinical and Laboratory Immunology vol. 1, (3) 187-191.
Pozzilli P, Di Mario U, Pintor A, Javicoli M(1978). Hyperglycaemia-induced lymphocyte reactivity depression in normal subjects. Folia Allergologica et Immunologica Clinica vol. 25, (1) 53-56.
Pozzilli P, Tamburrano G, Mercalli ME, Javicoli M(1978). Raised alpha-2-macroglobulin levels in acromegaly. Hormone and Metabolic Research vol. 10, (4)
10.1055/s-0028-1095834
Negri M, Pozzilli P, Pozzi V, Aragona C(1977). Correlation between serum prolactin levels and testosterone dynamic findings in selected hirsute females. Patologia e Clinica Ostetrica e Ginecologica vol. 5, (6) 267-270.
Die Mario U, Pozzilli P, Scarsella M(1977). Depressed lymphocyte transformation to phytohemagglutinin in normal subjects by intravenous glucose administration (IVGA). Diabetologia vol. 13, (4)
Return to top